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DNA methylation is considered one of the oldest epigenetic modifications and is associated 
with repression of transcriptional activity. Embryonic development sees dynamic changes in 
this mark. Initially, widespread demethylation occurs with the establishment of pluripotency in 
the developing zygote. This is then followed by a wave of de novo methylation in the 
implanting blastocyst, coincident with lineage specification, which continues until tissue 
specific patterns of DNA methylation are laid down.  
Disruptions in DNA methylation, and mutations in genes that form part of the DNA 
methylation machinery, are associated with neurodevelopmental disorders. Therefore, 
understanding the mechanisms of DNA methylation during neurodevelopment is key if we 
are to understand the pathology underlying these conditions. Investigating this has, thus far, 
proven difficult due to the lack of available models that survive into adulthood. Therefore the 
consequences of dysregulated DNA methylation during neurodevelopment on the mature 
brain are unknown. 
The DNA methyltransferase enzymes are responsible for the deposition of DNA methyl 
marks, although less is known about the cofactors required for their targeting and activity. 
Lsh (lymphoid specific helicase), a chromatin remodeller, has been described to play a key 
role in de novo methylation during development. The importance of this protein is highlighted 
by the fact that knockout mice die within a few hours of birth. Furthermore, whilst I was 
pursuing this project, Thijsen et al described mutations in this gene being causative for 
Immunodeficiency, Centromeric instability and Facial anomalies syndrome (ICF), in which a 
large proportion of patients suffer from intellectual disability (Thijssen et al., 2015). 
At the beginning of this project, nothing was known about the role of Lsh during 
neurodevelopment, nor why mutations in this gene should result in neurological defects. This 
thesis aims to determine the contribution of Lsh to DNA methylation during 
neurodevelopment and to investigate the consequences of its absence on the mature brain. 
In order to investigate the roles of Lsh at early stages of neurogenesis I made use of an in 
vitro neurodifferentiation system to investigate the differentiation of Lsh-/- mouse embryonic 
stem cells down neural lineage. This revealed an enhanced differentiation of these cells 
down neural lineage compared to wild type. Genome-wide methylome analysis uncovered a 
key role for Lsh in establishing appropriate DNA methylation at repetitive sequences during 
this developmental window.  
Previous papers, investigating selected loci, have suggested a role for Lsh in methylating 
promoters of single copy genes thereby controlling their transcription. By investigating 
transcription genome–wide, I noted a key role for Lsh in regulating genes associated with 
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developmental processes. This regulation was not, however, related to their promoter 
methylation status. This led me to investigate the regulation of the Polycomb system in these 
cells, another key repressive epigenetic system involved in developmental gene 
transcriptional regulation.   
This analysis uncovered wide-scale redistribution of the polycomb mark H3K27me3 from 
target genes to hypomethylated repeats, similar to what is seen in other hypomethylated 
models. Whilst this could account for the dysregulation of developmental gene expression, I 
also discovered preliminary evidence of a role for Lsh in regulating transcription at these 
sites independent of its role in DNA methylation. 
To investigate the role of Lsh in vivo, I used a novel Nestin-Cre knockout mouse model. This 
new targeted mouse model, unlike previous models, survived to adulthood. This allowed 
investigation of the effects that disruption of DNA methylation during development has on the 
mature brain. This mouse displayed no gross changes in brain morphology or behaviour. 
DNA methylation analysis revealed gross hypomethylation at repeat sequences particularly 
in the knockout cerebellum. A consequence of this was aberrant repeat transcription. RNA-
Seq revealed activation of innate immune response genes. This led me to propose a model 
by which aberrant repeat transcription results in an immune response due to cellular 
detection of cytoplasmic double stranded DNA generated via reverse transcription. This 
opens up exciting new avenues of research into the underlying pathology of the neurological 
















Each cell in the body contains the same DNA, yet a brain cell is very different from a liver cell 
for example. This is due to the fact that different genes will be switched on or off in different 
cell types. One of the ways this is achieved is through adding different chemical tags to the 
DNA. One important example is the addition of a methyl group onto the DNA. This DNA 
methylation plays an important role in switching off genes and so called “junk DNA”, that is 
sections of DNA that do not contain any genes. 
After fertilisation of an egg, the DNA methylation marks from both parents are erased to 
produce a “clean slate”. During development of the embryo there is then a wave of DNA 
methylation ensuring the correct genes are switched off in each cell type. As a psychiatrist I 
am particularly interested in this process, as defects in it are associated with developmental 
disorders of the brain. Yet we still do not fully understand what factors are important in DNA 
methylation or how problems in it can result in brain disorders. 
One protein known to be of importance in DNA methylation during development is Lsh, 
however we do not know the role of this protein specifically in brain development. Mutations 
in Lsh can cause ICF syndrome (Immunodeficiency, Centromeric instability and Facial 
anomalies) in which the majority of patients suffer from intellectual disability. 
During this project I aimed to determine the role of Lsh in DNA methylation during brain 
development. To do this I used mouse embryonic stem cells lacking Lsh, which models the 
early stage of embryonic development just before the wave of DNA methylation occurs. I 
then stimulated them to develop into early brain cells. I also used a mouse model lacking Lsh 
in brain cells only. I found that Lsh was required for normal DNA methylation during the early 
stages of brain development, particularly at DNA sequences called repetitive elements which 
make up the majority of so called “junk DNA”. This resulted in a failure to switch off these 
elements. This is particularly important as activation of repetitive sequences can have many 
detrimental consequences. 
Another exciting discovery was the activation of the immune system in the brains of mice 
lacking Lsh, which I propose is a result of the activation of repetitive elements. This could be 
a potential explanation for why patients with ICF suffer from intellectual disability and 
certainly opens up further avenues of research in this area. 
To conclude, the work presented in this thesis advances our understanding of DNA 
methylation mechanisms during brain development. Furthermore, I have uncovered potential 
pathways which may explain the occurrence of intellectual disability in patients with ICF 
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Chapter 1. Introduction 
1.1 Epigenetics 
Every cell in a mammalian organism contains an identical genome, with a few exceptions in 
the immune and reproductive systems. The underlying genetic sequence therefore cannot 
account for differences in cellular phenotype. Similarly, during development hundreds of cell 
types arise from a single pluripotent cell and these progeny will display a different phenotype 
dependent upon their stage of development. It is the differences, therefore, in gene 
expression that account for these differences in cellular phenotype. Epigenetics is the study 
of certain mechanisms important in this transcriptional control. 
Epigenetics was a term coined by the embryologist Conrad Waddington in the 1940’s who 
defined it as “the branch of biology which studies the causal interactions between genes and 
their products which bring the phenotype into being” (Waddington, 1968, 2012). 
Waddington’s concept of the epigenetic landscape was concerned with the decisions made 
by a cell during differentiation. He likened a pluripotent cell to a marble, rolling down a hilly 
landscape in which it takes specific paths leading to different cell fates. Each time it takes a 
decision to enter a certain path on rolling down the hill its final destination options become 
more restricted; beautifully describing the stages of cell differentiation.  
This original description referred to all the molecular pathways influencing expression of a 
genotype. However, over the years this term has been co-opted by geneticists and molecular 
biologists, resulting in more narrowed definitions to describe mechanisms that influence 
gene transcription. This led to the generally accepted modern definition of epigenetics as 
“heritable changes in gene expression which are not due to changes in the underlying DNA 
sequence”(Bird, 2007). However, the idea of heritability does not hold true in all situations, 
for example there are alterations in epigenetic marks and gene transcripts in response to 
activity in post-mitotic neurons (Guo et al., 2011; Lubin et al., 2008; Ma et al., 2009; Yu et al., 
2015). There is also a growing recognition that epigenetic states may be a consequence of 
transcriptional activity rather than a cause (Henikoff and Shilatifard, 2011; Sproul and 
Meehan, 2013). Therefore, perhaps a more relevant definition is “the structural adaptation of 
chromosomal regions so as to register, signal or perpetuate altered activity states”(Bird, 
2007). 
Today, epigenetics most frequently, but not exclusively, refers to covalent modifications on 
DNA and histones that may alter their biological properties. This network of chemical tags 
can be referred to as the “epigenome”. The role of non-coding RNA’s in regulating gene 
activity are also now part of the epigenetics canon (Deichmann, 2016).  
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The role of epigenetics in somatic cells is very interesting, particularly in the field of 
neuroepigenetics where it may offer up exciting insights into how the brain functions in health 
and disease. However, it is during embryogenesis that we see the most dramatic alterations 
in the epigenome, which occur in parallel with the orchestration of cell differentiation during 
the development of a highly complex organism. 
During this research project, I have attempted to delve deeper into our understanding of 
epigenetic mechanisms during the early stages of neurodevelopment, with a focus on the 
most well studied epigenetic modification - that of DNA methylation. Specifically, I have 
studied the contribution of the chromatin remodeller, lymphoid specific helicase (Lsh), to 
DNA methylation reprogramming during neurodevelopment using both a cell culture and a 
mouse model system.  
In this chapter, I will discuss DNA methylation and its dynamics during development. I will 
also review the known or speculated roles of Lsh into its establishment. The importance of 
research into this area is highlighted with a discussion of neurodevelopmental disorders 
associated with perturbation of DNA methylation pathways during development.  
 
1.2 Chromatin Organisation 
In order to understand the effects of different epigenetic modifications, one has to have an 
understanding of how DNA is organised within a cell.  
In mammalian cells an astonishing 2 meters of DNA has to be packaged into a nucleus only 
6μm in diameter. This is achieved by compacting the DNA into chromatin. The basic unit of 
chromatin is the nucleosome, which is comprised of 146bp of DNA wrapped around a 
globular histone octamer composed of the 4 core histone proteins H2A, H2B, H3 AND H4 
(Burlingame et al., 1985; Luger et al., 1997). 
The positioning of these nucleosomes will determine the degree of chromatin compaction. 
Densely compacted chromatin is referred to as heterochromatin, exemplified by constitutive 
heterochromatin at mouse centromeric regions, which results in DNA being inaccessible and 
hence may prevent binding of transcription factors (TFs). Genes are therefore 
transcriptionally silenced at heterochromatin. Alternatively, compaction can be relaxed to 
form euchromatin in which the DNA is accessible and amenable to transcription factor 
binding, and therefore can be actively transcribed. This lower order chromatin structure has 
to be dynamic: particularly during development where extensive remodelling occurs to allow 
vast changes in gene expression. A summary of chromatin organisation and the key 




Figure 1.1. Chromatin Organisation. Diagrammatic representation of how DNA is 
compacted into chromatin. Chromosomes are composed of tightly compacted chromatin 
fibres. The basic unit of chromatin is the nucleosome. This consists of 146bp of DNA 
wrapped around a globular histone octamer composed of the 4 core histone proteins H2A, 
H2B, H3 AND H4. These histone proteins have N terminal tails which are subject to 
modifications including methylation and acetylation. When nucleosomes are tightly 
compacted DNA is inaccessible and this is referred to as heterochromatin. In contrast 
transcriptionally permissive euchromatin is characterised by less nucleosome dense regions. 
DNA methylation is an important epigenetic mark involved in maintaining a heterochromatic 
state. The methyl group is deposited on the 5th carbon position of the pyrimidine ring of 
cytosine bases adjacent to guanine by the DNA methyltransferases. Cytosine bases can 
also be hydroxymethylated which may be part of a demethylation process. 
 
There are also higher order levels of chromatin organisation within the nucleus. For example, 
heterochromatin tends to be located towards the nuclear periphery and euchromatin 
clustered centrally (Rae and Franke, 1972). Furthermore, regulatory gene regions can be 
brought into contact with target genes hundreds of kilobases away, via the formation of 
chromatin loops, to regulate transcription (Carter et al., 2002; Tolhuis et al., 2002). This 
leads to the view of a network of chromatin based mechanisms, in which epigenetics play a 
constituent part, which regulate gene expression. Development itself is underpinned by 
essential signalling and transcription factor (TF) networks that are reinforced by epigenetic 
pathways that ultimately define cell identity in differentiated cells (Bogdanovic and Lister, 






1.2.1 Histone Modifications 
Post-translational modifications on histone proteins form part of the epigenome. They have 
the ability to alter chromatin structure by directly affecting nucleosome-DNA electrostatic 
interactions, or indirectly by binding or preventing binding of chromatin modifying proteins. 
These modifications occur predominantly on the histone N terminal tails which extend out 
from the nucleosome, although they do also occur on the globular core domains (Figure 1.1). 
N terminal tails can be subject to many modifications including: methylation, acetylation, 
ubiquitination, citrullination, phosphorylation, biotinylation and sumoylation (Bannister and 
Kouzarides, 2011). The most extensively studied modifications are those of methylation and 
acetylation at lysine residues. 
Lysine residues can be mono-, di- or tri-methylated (me1, me2, me3) (Lorenzo and Bedford, 
2011; Martin and Zhang, 2005). These modifications are deposited and removed by groups 
of enzymes known as histone methyltransferases (HMTs) and histone demethylases 
(HDMTs). These enzymes target specific lysines and methylate them to a specific extent 
(Collins et al., 2005). The transcriptional effect of histone methylation depends upon which 
residue is methylated and to what extent. Similarly, histone demethylases show high 
specificity to their substrate and its degree of methylation (Tsai et al., 2014).  
Numerous different protein domains have been found to recognise lysine methylation 
including PHD fingers, chromodomains, PWWP, MBT and Tudor domains (Champagne and 
Kutateladze, 2009; Kim et al., 2006) allowing the binding of many different proteins and 
complexes which then act downstream to affect chromatin structure. As well as recruiting 
chromatin associated factors, lysine methylation can also maintain chromatin structure by 
preventing binding of complexes which would lead to remodelling (Zegerman et al., 2002).  
Histone acetylation at lysine residues was linked to transcriptional activity many years ago 
(Allfrey et al., 1964). Histone acetyl transferases (HATs) and histone deacetylases (HDACs) 
catalyse its deposition and removal (Krajewski and Becker, 1998). These enzymes show 
much less specificity than their HMT/HDMT counterparts and are often found in large 
complexes where they are present with other proteins capable of altering transcription (Yang 
and Seto, 2007). Unlike lysine methylation, acetylation can directly affect chromatin structure 
as the deposition of an acetyl group neutralises the lysine’s positive charge; weakening 
affinity between histones and the DNA backbone, which is negatively charged, thereby 
decompacting chromatin (McGhee and Felsenfeld, 1980). As well as this direct effect, 
acetylated lysines are also targeted by proteins containing bromodomains which can recruit 
other remodelling complexes (Zeng et al., 2010). 
In reality, however, one histone mark does not equate to one transcriptional outcome. Rather 
this depends upon the pattern of marks and how they interact with each other. This “histone 
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code”, or signature, is a complex system given the vast number of patterns that can be 
conceived (Yuan et al., 2011).  
 
1.2.2 Formation of euchromatin 
As mentioned above, histone acetylation is a key regulator of euchromatin formation. Hence, 
this modification is enriched at enhancers and gene promoters (Wang et al., 2008). Certain 
histone methylation marks are also associated with euchromatin. For example methylation of 
H3K4 is associated with transcriptionally active regions with H3K4me1 and H3K4me2 being 
found at enhancers and H3K4me2 and H3K4me3 at the promoters of active genes (Hon et 
al., 2009; Schneider et al., 2004).  
Amongst the complexes recruited to the sites of these histone modifications are chromatin 
remodellers. These are large multi-protein complexes, capable of remodelling nucleosomes 
to create a relaxed euchromatic environment permissive for transcription. Remodelling 
enzymes are subdivided into 4 main families: SWI/SNF (switch/sucrose-non-fermenting), 
ISWI (imitation switch), CHD (chromodomain-helicase-DNA binding) and INO80 (inositol 
requiring 80)(Tyagi et al., 2016).  All contain a highly conserved ATPase domain and it is 
with the energy derived from ATP hydrolysis that these enzymes have the power to 
restructure chromatin by mobilising, ejecting, exchanging or assembling nucleosomes. The 
other variable domains play a role in recruitment and regulation of the enzyme providing it 
with its unique biological function. 
There are various ways these enzymes can remodel nucleosomes to alter transcription. One 
way in which the nucleosome can be modified is through the incorporation of histone 
variants. With the exception of H4, all other histones have been shown to have non-
canonical variants whose presence can alter nucleosome positioning and local chromatin 
structure (Thakar et al., 2009). For example, H2A can be exchanged for H2A.Z by the 
nucleosome remodeller SWR1, enhancing transcription at promoters and enhancers (Barski 
et al., 2007; Schones et al., 2008). Other methods include mobilisation of the nucleosomes 
along the DNA, or complete eviction to clear them from actively transcribed regions allowing 
access of RNA Polymerase II (Meersseman et al., 1992; Whitehouse et al., 1999) (Figure 
1.2).  
Although the focus here has been on the role of chromatin remodellers in transcriptional 
activation, they can also act to create more tightly compacted nucleosomes with some 
capable of nucleosome assembly and hence can be associated with transcriptional 




Figure 1.2. Nucleosome remodelling. ATP-dependent chromatin remodellers utilise the 
energy derived from ATP hydrolysis to alter access to DNA by evicting nucleosomes, 
causing sliding of nucleosomes along the DNA or by exchanging histone octamers. The 
diagram illustrates nucleosomes composed of 146bp of DNA wrapped around a globular 
histone octamer. 
 
1.2.3 Formation of Heterochromatin 
Heterochromatin can be further subdivided into facultative or constitutive. The term 
facultative is derived from “facultus”, the Latin for opportunity. It therefore describes areas of 
heterochromatin that have the opportunity to become euchromatic, and hence 
transcriptionally active in response to developmental or environmental cues (Grewal and Jia, 
2007). The most prominent histone modification at facultative heterochromatin is H3K27me3, 
which is deposited by the Polycomb group proteins (PcG) (Cao et al., 2002). 
Of particular interest during mammalian development is the presence of both the repressive 
H3K27me3 mark and the active H3K4me3 mark at a set of genes with a high CG content; so 
called CpG islands (CGIs) (Bernstein et al., 2006). These regions are referred to as 
“bivalent” chromatin enriched at developmentally important genes. It is thought that this 
chromatin state allows the gene to remain poised for either activation or permanent silencing 
upon differentiation (Mikkelsen et al., 2007). 
Constitutive heterochromatin is highly condensed and is required to protect certain 
sequences, such as repetitive elements, from the transcriptional machinery maintaining their 
repressed state. The bulk of constitutive heterochromatin forms at pericentromeric regions, 
which are gene poor and rich in repeat sequences. A hallmark of constitutive 
heterochromatin is H3K9me3, which binds the protein HP1 via its chromodomain. This is 
proposed to create a scaffold for recruitment of HMTs and HDACs to create a positive 
feedback loop to maintain a heterochromatic state (Lachner et al., 2001). This positive 
feedback loop can also promote the spreading of heterochromatin to neighbouring regions, 
forming large areas of heterochromatic domains that may have consequences for the 
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transcription of nearby genes. The ability of heterochromatin to promote its own spreading 
necessitates the presence of mechanisms to restrict its expansion, in order to prevent 
erroneous gene silencing. Such mechanisms include DNA sequences that are unfavourable 
for nucleosome assembly and recruitment of proteins with anti-silencing activities (Allshire 
and Madhani, 2018).  
Somewhat counterintuitively, transcripts from heterochromatic regions may also play a role 
in heterochromatin formation. In yeast, RNA from pericentromeric transcripts is cleaved to 
form short-interfering RNAs (siRNAs), which can recruit transcriptional silencing complexes 
and HMTs (Lippman and Martienssen, 2004). 
Another key epigenetic modification associated with the formation of heterochromatin is DNA 
methylation. 
 
1.3 DNA Methylation 
Considered the oldest in evolutionary terms and most stable of epigenetic modifications is 
DNA methylation. It is believed that this mark evolved as a defence mechanism against 
foreign DNA integration into the host genome but was then adopted during evolution for 
transcriptional regulation. 
In mammals DNA methylation is mainly found on the 5th carbon position of the pyrimidine 
ring of cytosine bases adjacent to guanine in a 5’-CpG-3’ dinucleotide context, with around 
70% of these positions being methylated (Cooper and Krawczak, 1989). Its presence in the 
genomic landscape exerts a key repressive action on transcriptional regulation (Kass et al., 
1993; Keshet et al., 1985). There are, of course, exceptions to this dogma, as advanced 
sequencing techniques have allowed the identification of non-CpG methylation, and it has 
become clear that the effects of DNA methylation can vary depending on context (Lister et 
al., 2009). There are also controversial reports of methylation at adenine bases in mammals 
(Jeltsch et al., 2018; Lentini et al., 2018; Wu et al., 2016; Xiao et al., 2018).  
 
1.3.1 Key roles of DNA methylation 
The key and most established role for DNA methylation is that of maintaining stable 
transcriptional repression as highlighted in the three biological contexts below: genomic 





1.3.1.1 Genomic Imprinting 
Imprinted genes are those that are expressed from one allele only. Which gene copy is 
silenced, and which is expressed, depends upon their parent of origin, and is determined by 
differential DNA methylation established during gametogenesis, which is maintained in the 
resultant offspring (Ferguson-Smith, 2011). Several human diseases can occur when 
imprinting is disturbed. 
In some instances, it is DNA methylation at a gene promoter that directly determines its 
silencing, and hence monoallelic expression. Often, however, transcriptional control is more 
complex and DNA methylation at imprinting control regions (ICRs) can influence expression 
of distal genes or gene clusters by different mechanisms. 
One method by which DNA methylation achieves monoallelic expression is through 
insulators, which are elements that can block enhancer and promoter interactions. An 
example of this is the paternally methylated ICR 2kb upstream of H19 and 80kb downstream 
of Igf2. This ICR on the maternal allele is free to bind the insulator protein CTCF, which 
blocks the access of Igf2 to downstream enhancers shared with H19, allowing exclusive 
unrivalled access of H19 to these enhancers. In contrast, methylation at this site on the 
paternal allele prevents CTCF binding allowing access of Igf2 to the enhancers. Thereby 
facilitating monoallelic expression of Igf2 from the paternal chromosome and H19 from the 
maternal (Hark et al., 2000; Thorvaldsen et al., 1998). 
Another method is by influencing expression of long non-coding RNAs (lncRNas). For 
example in mouse, a maternally methylated ICR at the promoter of a lncRNA transcript, Air, 
causes repression on the maternal chromosome. In contrast on the paternal chromosome 
lacking this methyl mark Air is expressed and acts to repress a neighbouring imprinted gene 
cluster causing these genes to be expressed from the maternal chromosome in a 
monoallelic manner (Sleutels et al., 2002). The method by which Air does this appears to be 
via the recruitment of repressive histone modifying proteins (Nagano et al., 2008). 
1.3.1.2 X Chromosome Inactivation 
Mammalian female cells contain 2 copies of the X chromosome. In order to prevent a 
doubling in expression of X linked genes in females, one of these copies is randomly 
inactivated so that in female somatic cells there is a single active X (Xa) and inactivated X 
(Xi). This inactivation occurs in the epiblast and is maintained through all further cell divisions 
(Migeon, 2016). 
Initial events in X chromosome inactivation actually do not involve DNA methylation. This is 
evidenced by the fact that embryos lacking the de novo methyltransferases retain the ability 
to establish it (Sado et al., 2004). The initial silencing instead occurs via the action of the 
lncRNA Xist, expressed from the Xi, which then coats this chromosome recruiting other 
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silencing complexes, resulting in the deposition of repressive histone marks and the 
formation of heterochromatin (Chen et al., 2016; Chu et al., 2015; Clemson et al., 1996). 
DNA methylation then becomes important in maintaining this silenced state as deletion of the 
maintenance DNA methyltransferase, Dnmt1, in mouse somatic cells results in 
decompaction and reactivation of the Xi genes (Sado et al., 2000). Increased DNA 
methylation can be seen over silenced gene promoters on the Xi (Sharp et al., 2011). 
Furthermore methylation of the Xist promoter itself on the Xa prevents aberrant transcription 
from this chromosome (Sado et al., 2004). 
1.3.1.3 Suppression of Repetitive Elements 
The final key role for DNA methylation is in the suppression of repetitive elements (Crichton 
et al., 2014). Recent estimates suggest up to 70% of the human genome is repetitive or 
derived from repeats (de Koning et al., 2011). Repression of these elements is necessary to 
maintain genome stability.  
Repeat sequences are classed as tandem or interspersed. Satellite sequences are tandemly 
repeated non-coding clusters, which overlap the centromere and pericentromeric regions 
and play an essential role in centromere function (Garrido-Ramos, 2017). DNA methylation 
of satellite elements plays a key role in formation of heterochromatin at centromeres. 
Hypomethylation of these regions, as seen in human diseases such as Immunodeficiency, 
centromeric region instability, facial anomalies (ICF) syndrome and cancer or induced by 
experimental means, results in chromosomal instability with mis-segregation during mitosis 
(Costa et al., 2006; Hassan et al., 2001; Prada et al., 2012; Widschwendter et al., 2004). 
Transposable elements (TEs) are the remnants of exogenous retroviral infection of the 
ancestral germline. They are interspersed throughout the genome and can be classed into 
those that require reverse transcription in order to transpose and those that do not. The latter 
are known as DNA transposons composing about 1% of the mammalian genome (Waterston 
et al., 2002). These elements encode a transposase which is required for their excision and 
insertion into the genome via a “cut and paste” mechanism. These elements are no longer 
capable of mobilising having not been active for the last 37 million years of primate evolution 
(Pace and Feschotte, 2007). 
The other class of TEs are termed retrotransposons, composed of long terminal repeats 
(LTRs) and non-LTRs, which make up 40% of the mammalian genome (Waterston et al., 
2002). These elements do not encode a transposase, but instead rely on the process of 
reverse transcription for their mobility. 
LTRs are also known as endogenous retroviruses (ERVs). They are flanked at their 5’ and 3’ 
ends by long terminal repeats, which drive RNA transcription and maturation from the 
endogenous retrovirus. These ERVs also contain Gag and Pol genes, which encode proteins 
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involved in retrotransposition. Due to high rates of homologous recombination between 
flanking LTRs, the intervening ERV sequence is often deleted, resulting in the presence of 
many solo LTRs in the genome (Belshaw et al., 2007).  
ERV retrotransposition occurs within the mouse genome via a “copy and paste” mechanism, 
whereby the transcribed RNAs are transported to the cytoplasm and packaged into virus-like 
particles by Gag and reverse transcribed by Pol, the dsDNA is then transported back into the 
nucleus where the integrase activity of Pol can insert it back into the genome (Mager and 
Stoye, 2015). In humans there are no known ERVs still capable of retrotransposition. 
Non-LTRs are subdivided into long and short interspersed nuclear elements (LINEs and 
SINEs). The majority of LINEs are of subclass LINE1 (L1s) which are the only active repeat 
capable of autonomous retrotransposition in humans. The 5’ UTR contains a promoter with 
both sense and antisense activity and the 3’UTR contains a poly(A) tail. LINE1s also contain 
2 important open reading frames (ORF1 and ORF2). ORF1 encodes an RNA binding protein 
with nucleic acid chaperone activity, and ORF2 encodes a protein with reverse transcriptase 
and endonuclease activity allowing integration of newly generated cDNA into a new site in 
the genome (Macia et al., 2015; Mager and Stoye, 2015). Most L1s are 5’ truncated probably 
due to incomplete reverse transcription during retrotransposition (Waterston et al., 2002). 
SINEs have to hijack LINE1 machinery in order to retrotranspose. A summary of repeat 










Figure 1.3. Repetitive elements in the murine genome. Structure of the main repeat 
classes in the mouse genome with estimates of their abundancy as a percentage of the 
mouse genome (Waterston et al., 2002). The length in bp of a full length i.e. intact repeat 
unit is displayed. A red dashed line through the env (envelope) gene of the LTR indicates 
that some LTR retrotransposons e.g. IAPs have lost this gene. ITR (Inverted terminal 
repeat), gag (group specific antigen), prt (protease), pol (polymerase), LTR (long terminal 
repeat). SINEs contain A and B box promoter sequences of RNA Pol iii. Concept for this 
figure was taken from (Martens et al., 2005) 
The consequences of retrotransposition are potentially severe as new insertions could result 
in insertional muatagenesis or genomic instability. 10-12% of spontaneous mutations in mice 
are the result of retrotransposition (Maksakova et al., 2006). In humans there are over 120 
identified retrotransposition events resulting in disease (Hancks and Kazazian, 2016). 
Furthermore retrotransposons could alter the expression of neighbouring genes for example 
by causing aberrant splicing, by recruiting silencing complexes or acting as alternative 
promoters or enhancers for host genes as many LTRs contain TF binding sites (Garcia-
Perez et al., 2016). Furthermore, proteins expressed by the retrotransposon may impact on 
cell function.  Therefore suppression of these events is vital. 
Transcriptional repression through DNA methylation plays a major role in this; indeed the 
bulk of methylation is found at repetitive sites, and it has been proposed that DNA 
methylation is present in mammals specifically for the purpose of suppressing these 
elements (Zemach and Zilberman, 2010).  
It is also recognised that retrotransposition events have had evolutionary advantages in the 
past. Indeed the co-option of transposable element sequences by the host genome has 
allowed the advantageous expression of genes or different gene isoforms in particular 
tissues (Cordaux and Batzer, 2009). An important example of this is in the immune system 
where certain ERVs in human and mouse are found to be enriched near interferon 
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responsive genes. These ERVs contain binding sites for the TF STAT1, which plays a role in 
mediating the interferon response, and drive expression of downstream immune genes. The 
deletion of one such ERV in human cell lines impairs the antiviral response (Chuong et al., 
2016). They therefore can act as a vital resource for evolution and expansion of the 
transcriptome. 
It was previously believed that retrotransposition events only occurred in the early 
developing embryo, germ cells and tumour tissue (Adams, 2017; Hancks and Kazazian, 
2012; Kano et al., 2009; Shukla et al., 2013; Solyom et al., 2012; van den Hurk et al., 2007). 
However, in recent years there has been a growing body of evidence for somatic 
retrotransposition of LINEs during neurogenesis.  
 
Firstly, it has been shown that many LINE1s contain Sox2 and TCF/LEF (important in Wnt 
signalling) TF binding sites within their promoter. In neural stem cells, Sox2 can bind to the 
5’UTR of LINE1 and repress its promoter activity. During neural differentiation, however, 
Sox2 is down-regulated, resulting in de-repression. This is coupled with up-regulation of 
activating Wnt signalling, resulting in expression of LINE1s (Kuwabara et al., 2009; Muotri et 
al., 2005). 
 
Retrotransposition assays have demonstrated the ability of an engineered LINE1 reporter 
construct to fully retrotranspose in human tissue culture models of neural development 
(Coufal et al., 2009) and in rodent brains (Muotri et al., 2005) although this gives no 
information regarding endogenous retrotransposition. Mosaicism found within the human 
brain, however, would support somatic retrotransposition events, with brain specific LINE1 
insertions being found in human post-mortem tissue (Baillie et al., 2011; Evrony et al., 2012; 
Upton K  et al., 2015). There are conflicting reports on the frequency of these 
retrotransposition events due to different methodologies used: with estimates ranging from 
0.07 (Evrony et al., 2012) to 13.7 somatic insertions per neuron (Upton K  et al., 2015). 
Furthermore, post-mitotic human neurons have also been shown to support 
retrotransposition of an engineered LINE1 vector in vitro (Macia et al., 2017).  
 
This may be an important source of generation of neural diversity within the brain. On the 
other hand, retrotransposon deregulation has been associated with neurological diseases 
including multiple sclerosis and several psychiatric disorders.  Studies reporting such 
associations include those which identify an insertion that may cause a disease and those 
reporting an increase in mRNA levels or retrotransposon copy numbers (reviewed in (Bodea 





1.3.2 Distribution of DNA methylation 
DNA methylation is not evenly dispersed throughout the genome, but instead shows 
preferential distribution at certain sites dependent on underlying DNA sequence, and 
performs different roles depending on its genomic context. 
 
1.3.2.1 CpG Islands and promoters 
As mentioned earlier around 70% of CpG sites are methylated, however, there exists within 
the genome ~1kb stretches with higher than expected CpG content termed “CpG islands” 
(CGIs) which break this observation as they are largely unmethylated (Bird et al., 1985). 
Given their unmethylated state, the majority (~80%) of CGIs are generally transcriptionally 
permissive (Tazi and Bird, 1990) it is therefore unsurprising that ~70% of annotated gene 
promoters are associated with a CGI (Saxonov et al., 2006). 
CpG dinucleotides occur less frequently than would be expected in the genome given the 
abundancy of cytosine and guanine bases. This is thought to be due to the spontaneous 
deamination of methylated cytosine to yield thymine (Bird, 1980; Coulondre et al., 1978). 
CGIs at promoter sequences may therefore play important roles in protecting these 
regulatory sequences from mutation. 
Their importance in maintaining a transcriptionally active state is highlighted by the fact that 
almost all housekeeping gene promoters, which must remain active in all cell types, are 
associated with a CGI; whereas promoters not associated with CGIs tend to be at genes with 
tissue specific expression, thereby allowing developmental regulation of these genes in 
differentiated tissues (Larsen et al., 1992; Zhou et al., 2008). CGIs typically contain the 
active H3K4me2 mark, which may enable maintenance of a hypomethylated state by 
preventing binding of the DNA methylation machinery (Guenther et al., 2007). Indeed, 
Dnmt3l, a cofactor for DNA methylation, only recognises and recruits the DNA methylation 
machinery to unmodified H3K4 (Ooi et al., 2007). 
Methylation at promoters as a whole is low, but is correlated with CpG density. These 
regions have been divided into high-density, intermediate-density and low-density CpG 
promoters (HCPs, ICPs and LCPs). LCPs are more likely to be highly methylated, but this 
does not correlate with transcriptional repression. In contrast HCPs are usually 
unmethylated, but on the occasion that they are methylated the nearby gene is repressed.  
ICPs, although generally unmethylated in pluripotent cells, are more likely to become 
methylated as development proceeds and this is associated with gene silencing (Meissner et 




1.3.2.2 Gene body methylation 
In contrast to CGIs, the remainder of the mammalian genome is extensively methylated - in a 
large part to repress transposable elements in somatic cells. Gene bodies also demonstrate 
this extensive methylation, although the function of this is less well understood. 
Methylation at gene bodies actually appears to be a feature of transcriptionally active genes 
(Wolf et al., 1984). One proposed role is that this prevents spurious transcription from 
occurring outside of the transcription start site (TSS) from non-canonical promoters within 
gene bodies (Neri et al., 2017). Another proposed function is in control of splicing. Exons are 
more highly methylated than introns and constitutively spliced exons contain higher levels of 
DNA methylation than do alternative exons (Choi, 2010; Gelfman et al., 2013). DNA 
methylation at exons may recruit MECP2 and HDACS causing slowing of Pol II elongation 
resulting in exon inclusion (Maunakea et al., 2013).  
1.3.2.3 Non CpG Methylation 
In mammalian genomes, methylation was previously thought to occur only in the CpG 
context: even though non-CpG methylation is widespread in plant genomes (Feng et al., 
2010b). This was until advanced sequencing techniques allowed the discovery of non-CpG 
methylation in mouse and human embryonic stem cells, in which it accounts for almost 25% 
of methylated cytosines (Lister et al., 2011; Ramsahoye et al., 2000; Ziller et al., 2011). This 
non-CpG methylation then largely disappears upon differentiation, is almost absent from 
somatic cells, and is regained in induced pluripotent cells (Laurent et al., 2010; Lister et al., 
2011; Ziller et al., 2011). CpA was found to be the most abundant non-CpG methylated site 
and this was the site that lost most methylation upon differentiation, suggesting a specific 
role in pluripotency (Laurent et al., 2010). 
In most somatic cells non-CpG methylation is lost. Neurons are an exception to this, as it is 
found to be particularly prevalent in adult neural tissue (Guo et al., 2014; Lister et al., 2013). 
Whole genome bisulphite sequencing on human and mouse fetal and adult frontal cortex 
revealed negligible non-CpG methylation in fetal brain tissue, but accumulation of this mark 
in the postnatal brain. The greatest rate of accumulation is seen during the developmentally 
important processes of synaptogenesis and pruning, disruption of which is thought to be an 
aetiological factor for psychiatric disorders (Uhlhaas and Singer, 2011). Maximum levels of 
1.3 - 1.5% genome wide are reached at the end of adolescence, at which point non-CpG 
methylation is actually the dominant form of methylation in neurons at 53% vs 47% CpG 
methylation, given that non-CpG sites are more abundant than CpGs (Lister et al., 2013). 
This de novo methylation during neuronal maturation correlates with the ongoing high 
expression of the de novo DNA methyltransferase, Dnmt3a, in neurons (Feng et al., 2005; 
Watanabe et al., 2006). Indeed, Guo et al demonstrated that Dnmt3a is required for neuronal 
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non-CpG methylation, as siRNA knock down of Dnmt3a in the adult mouse dentate gyrus 
resulted in depletion of this mark (Guo et al., 2014).  
Sites of non-CpG methylation in the brain are largely conserved between individuals and to a 
lesser extent between mice and humans (Guo et al., 2014; Lister et al., 2013). Whether this 
is consistent with a functional role or due to conserved chromatin structure is unclear. These 
findings broaden the potential role of DNA methylation in the brain, as opposed to other 
somatic tissues, suggesting important roles in maturation of neural circuits into adult life. 
 
1.3.3 5-hydroxmethylcytosine 
DNA methylation can be a reversible process. Demethylation can occur in a passive manner 
upon cell division simply by the lack of methylation maintenance on daughter strands. 
However, it has long been recognised that an active demethylation process must also exist. 
This was recognised by the fact that, in early development, the paternal genome in the 
mouse zygote undergoes rapid demethylation prior to any DNA replication taking place 
(Mayer et al., 2000; Oswald et al., 2000; Santos et al., 2002), although this is not a feature of 
zygotic development in all mammals (Beaujean et al., 2004a; Beaujean et al., 2004b; Young 
and Beaujean, 2004). In addition, outside an embryonic context, DNA demethylation has 
been demonstrated in post-mitotic cells (Klug et al., 2010). 
The mechanisms behind this active demethylation remained elusive until relatively recently. 
The conundrum being that direct removal of the methyl group is a thermodynamically 
unfavourable reaction, with no evidence that this could occur under physiological conditions. 
However, the rediscovery of 5-hydroxymethylcytosine (5hmC), an oxidised form of 5mC 
(Penn et al., 1972), and the ten-eleven translocation (TET) enzymes shed new light on 
potential demethylation pathways. The TET enzymes belong to the TET/J-binding family of 
α-ketoglutarate iron-dependent dioxygenases. In mammals, 3 have been described to date 
(TET1-3). In vitro work demonstrated that TET enzymes could oxidise 5mC containing 
oligonucleotide substrates to 5hmc and then further oxidise this to 5-formylcytosine (5fC) and 
5-carboxylcytosine (5caC) (He et al., 2011; Ito et al., 2010; Ito et al., 2011; Tahiliani et al., 
2009). These oxidised bases are then recognised and removed by thymine DNA glycosylase 
(TDG) and replaced by unmodified cytosine bases as part of DNA repair pathway activity 
(Cortazar et al., 2011; He et al., 2011). 
Far from simply being a demethylation intermediate, 5hmC is considered an epigenetic mark 
in its own right (Thomson and Meehan, 2017). The mark is several hundred fold more 
abundant than 5fC and 5caC (Ito et al., 2011), suggesting that a small subset of 5hmC 
marks are committed to demethylation but the majority may be playing a different role, 
although it could be the case that 5fC and 5caC are turned over more rapidly. 
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Unlike 5mC, which is relatively evenly distributed between different tissues, 5hmC levels 
vary and are particularly abundant in the brain and accumulate during development 
(Globisch et al., 2010; Kriaucionis and Heintz, 2009; Nestor et al., 2012; Szulwach et al., 
2011). The mark is found to be enriched over actively transcribed gene bodies related to 
neural function and is largely absent from non-genic regions (Hahn et al., 2013; Jin et al., 
2011; Lister et al., 2013; Mellen et al., 2012). 5hmC is enriched in genes relating to synaptic 
plasticity, which need to continually change their expression in the context of activity: 
therefore demethylation mechanisms may play a key role in the accumulation of 5hmC 
(Khare et al., 2012).  
 
1.4 Mechanisms of DNA methylation 
The deposition of 5mC occurs in two different contexts; that of maintenance and that of de 
novo methylation. The requirement to inherit methylation marks upon cell division relies on 
maintenance methylation, where methyl marks on the parent strand are faithfully replicated 
on the daughter strand during replication. On the other hand, de novo methylation refers to 
the acquisition of novel 5mC sites as would occur during differentiation. 
The enzymes responsible for catalysing the methylation of cytosine are the DNA 
Methyltransferases (DNMTs), which are highly conserved between species (Kumar et al., 
1994). In mammals, the main DNMTs are the maintenance Dnmt1 and the de novo 
methyltransferases Dnmt3a and Dnmt3b (Barau et al., 2016; Goll and Bestor, 2005; Okano 




1.4.1 The DNA methyltransferases 
1.4.1.1 Dnmt1  
Maintenance of DNA methylation is achieved primarily through Dnmt1. The Dnmt1 enzyme 
shows a 5-30 fold preference for binding hemi-methylated substrates - such as would be 
found during DNA replication with the parent strand retaining methyl marks, but the nascent 
strand lacking these (Goyal et al., 2006; Yoder et al., 1997). As one might expect, Dnmt1 is 
therefore highly expressed in dividing cells and is localised to replication foci during S phase 
(Goll and Bestor, 2005; Leonhardt et al., 1992). Despite being called the maintenance 
methyltransferase, Dnmt1 may also have roles in de novo methylation. For example, it has 
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been shown to have greater de novo methylation activity on unmethylated substrates than 
the Dnmt3s in vitro (Jair et al., 2006). 
Dnmt1-/- mouse ES cells are viable despite having a severely hypomethylated genome but 
undergo apoptosis when induced to differentiate (Fouse et al., 2008; Lei et al., 1996; Li et al., 
1993; Panning and Jaenisch, 1996). Its importance during differentiation and development is 
highlighted by the fact that knockout mice are embryonically lethal by E8.5 showing global 
hypomethylation, retrotransposon activation and misexpression of imprinted and X 
chromosome genes (Lei et al., 1996; Walsh et al., 1998). However, nuclear transfer 
experiments demonstrated that hypomethylated nuclei from ES cells null for all three Dnmts 
could support mouse pre-implantation development right up to the blastocyst stage in an 
equivalent fashion to WT ES nuclei. Dnmt null cells also contributed to normally 
hypomethylated extra-embryonic tissues. These observations suggest that extraembryonic-
lineage cells, ES cells and zygotes during pre-implantation development, can survive and 
proliferate in the absence of DNA methylation (Sakaue et al., 2010). 
1.4.1.2 Dnmt3s 
The DNMT3s are primarily responsible for de novo DNA methylation allowing the 
establishment of new methylation patterns during development. They were discovered after 
the generation of Dnmt1 null ES cells demonstrated retention of a small amount of DNA 
methylation (Lei et al., 1996). These enzymes are highly expressed in ES cells, but are 
down-regulated after differentiation and expressed at low levels in somatic cells, with some 
exceptions, including in the nervous system (Feng et al., 2005; Goto et al., 1994; Okano et 
al., 1998).  
These enzymes are highly homologous in their catalytic C-terminal domains, but show subtle 
differences in their regulatory N terminal domains, which may account for their non-
overlapping target specificity (Chen et al., 2004; Dhayalan et al., 2010; Ge et al., 2004; Otani 
et al., 2009; Zhang et al., 2010). For example Dnmt3a, but not Dnmt3b, is required for 
imprinting in germ cells (Kaneda et al., 2004) and Dnmt3b is required for methylation of 
pericentromeric repeats - a function that cannot be replaced by Dnmt3a (Okano et al., 1999). 
There does, however, seem to be some redundancy between the Dnmt3s as only double 
knockout, and not single knockout, ES cells failed to methylate injected retroviral vectors 
(Okano et al., 1999).  
In keeping with their different roles, Dnmt3a-/- and Dnmt3b-/- mice show different phenotypes. 
Dnmt3a-/- mice appear normal at birth but become runted and die at 4 weeks. Conditional 
germ cell mutants show hypomethylation at imprinted regions resulting in infertile males and 
offspring of mutant mothers are lethal by E11.5 (Kaneda et al., 2004). Dnmt3b knockout 
mice on the other hand are embryonic lethal at E14.5-E16.5, with hypomethylation of 
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satellite repeats, growth impairment and rostral neural tube defects. Double knockout 
embryos show a similar phenotype to Dnmt1-/- mice with development arresting shorty after 
gastrulation and retrotransposon hypomethylation, although not to the same extent (Okano 
et al., 1999). 
It has been proposed that DNMT3 enzymes are also capable of maintenance methylation, at 
least in vitro, as prolonged culture of Dnmt3a−/− Dnmt3b−/− ES cells resulted in progressive 
loss of methylation at both repeats and single copy genes, which was not seen in prolonged 
culture of wild type or single knockout cells (Chen et al., 2003)(Chen et al., 2003)(Chen et 
al., 2003)(Chen et al., 2003)(Chen, Ueda et al. 2003). As Dnmt1-/- cells demonstrate an 
immediate 90% loss of DNA methylation, but these double knockout cells required prolonged 
passage to achieve similar levels of hypomethylation; the authors proposed that while Dnmt1 
is the major maintenance methyltransferase, the Dnmt3s may act as “proof-readers” filling in 
hemi-methylated sites missed by Dnmt1.  
Dnmt3c was recently discovered in rodents. Previously annotated as a pseudogene, it was 
found to be exclusively expressed in male germ cells - where it plays a role in methylating 
and repressing evolutionary young retrotransposons with knockout male mice being sterile 
(Barau et al., 2016).    
 
1.4.2 Methyl binding proteins 
DNA methylation may directly prevent transcription by inhibiting the binding of regulatory 
proteins or transcription factors, or indirectly result in a more compacted chromatin structure. 
This occurs as 5mC is recognised or “read” by methyl binding proteins which then recruit co-
repressors. There are three main families of methylation readers; the methyl-CpG-binding 
domain (MBD) family (Hendrich and Bird, 1998; Meehan et al., 1989), the Kaiso-like protein 
family (Prokhortchouk et al., 2001) and the SET and RING-finger associated (SRA) domain 
proteins (Johnson et al., 2007).  
The MBD family is the best characterised of these, and contains multiple proteins MBD1-6 
and MECP1&2 (Brown et al., 2008; Laget et al., 2010; Meehan et al., 1992; Meehan et al., 
1989; Ohki et al., 2001; Scarsdale et al., 2011; Screaton et al., 2003). Although all contain 
methyl binding domains, each protein shows a different affinity for binding 5mC and has 
different functions (Hendrich and Bird, 1998; Hendrich et al., 1999). In mammals, MBD1, 
MBD2 and MECP2 can bind to methylated CpG sites resulting in transcriptional repression 
through the recruitment of co-repressor complexes, which vary depending on the MBD 
protein in question but include histone deacetylases, lysine methyltransferases and 




Despite the extensive evidence for the role of MBDs in gene repression, it should be borne in 
mind that they are not essential for development in mouse knockout models with most only 
having mild phenotypes, at least in comparison to Dnmt knockouts, and limited de-
repression of genes (Guy et al., 2001; Hendrich et al., 2001; Martin Caballero et al., 2009; 
Prokhortchouk et al., 2006; Sasai and Defossez, 2009). This could be due to some 
redundancy between the proteins, or that DNA methylation without recruitment of methyl 
binding proteins is sufficient to maintain repression. 
1.4.3 Cofactors of DNA Methylation 
There are several proteins which have been shown to be of import in facilitating DNA 
methylation. These cofactors can exert their influence by recruiting DNMTs, stimulating their 
activity or by modifying the local chromatin structure to alter the accessibility of the DNA. In 
this section, I will discuss known cofactors which will lead onto a discussion about the protein 
of interest in this dissertation, Lsh. 
 
1.4.3.1 Dnmt3l 
Another mammalian specific member of the Dnmt family is Dnmt3l. This protein shares some 
sequence homology to the DNMT3s, however is truncated and missing critical amino acid 
motifs associated with catalytic activity (Aapola et al., 2000).  
On its own, Dnmt3l has not been shown to have any methyltransferase activity - however it 
can increase the catalytic activity of Dnmt3a and Dnmt3b by around 15 fold by directly 
binding to the catalytic domains and inducing a conformational change (Gowher et al., 2005). 
That it plays a role in de novo methylation is supported by its expression pattern being high 
in the early embryo and becoming down-regulated in somatic cells. It is also expressed at 
particular stages during germ cell development that coincide with peaks of de novo 
methylation (2011; Bourc'his et al., 2001; Sakai et al., 2004). 
Knockout mice are viable and survive to adulthood - but males are azoospermic, which may 
be due to the inappropriate activation of retrotransposons during spermatogenesis. 
Conversely, female knockout mice are fertile but their heterozygous offspring die in mid-
gestation. This is due to the fact that oocytes from knockout females showed grossly 
reduced methylation at ICRs, with embryos having biallelic expression of imprinted genes 
(Bourc'his et al., 2001; Hata et al., 2002). This closely resembles the phenotype of targeted 
knockout of Dnmt3a in germ cells (Kaneda et al., 2004). 
1.4.3.2 Uhrf1 
An essential cofactor for Dnmt1 is Uhrf1. This protein contains a SET and ring-associated 
domain that binds to hemi-methylated CpGs (Achour et al., 2008; Arita et al., 2008; 
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Avvakumov et al., 2008) and co-localises with Dnmt1 during S phase at DNA replication 
sites thereby demonstrating its role in targeting Dnmt1 to hemi-methylated replicating DNA 
(Bostick et al., 2007; Sharif et al., 2007). Uhrf1-/- embryos show a very similar phenotype to 
Dnmt1-/- , with global hypomethylation and loss of repression at retrotransposons and 




Of particular interest is another DNA methylation cofactor lymphoid specific helicase (Lsh) so 
named because it was initially identified as a transcript highly expressed in lymphocytes 
(Geiman et al., 1998; Jarvis et al., 1996). In fact it is highly expressed in proliferating cells, 
therefore postnatally there is preferential expression in the thymus, bone marrow, spleen and 
testis however it is ubiquitously expressed during embryonic development, including being 
highly expressed in the developing mouse embryonic brain (Raabe et al., 2001). 
Its potential role in DNA methylation was implied following the discovery that a mutated 
version of  its homolog in Arabidopsis thaliana, named Ddm1 (Decrease in DNA Methylation 
1), resulted in a 70% reduction of methylation (Vongs et al., 1993). Subsequently Lsh-/- mice 
were shown to have a 30-40% reduction in global DNA methylation levels predominantly at 
satellite repeats (Dennis et al., 2001; Geiman et al., 2001; Tao et al., 2011). 
 
1.5.1 Lsh structure and classification 
Lsh may also be referred to as Smarca6 (SWI/SNF related matrix associated actin- 
dependent regulator of chromatin subfamily a member 6), Pasg (proliferation associated 
SNF2-like gene) and Hells (helicase, lymphoid specific). In this thesis Lsh will refer to the 
murine homolog and Hells to the human homolog. 
In mice, the gene is found on chromosome 19 at C3-D1 and in humans at position 10q23.33 
(Geiman et al., 1998). The Lsh gene contains 22 coding exons encoding important 
conserved functional domains including the ATP binding domain and the DEAH box vital for 
its function (Ren et al., 2015; UniProt Consortium, 2018). Lsh is highly conserved in 
mammals, showing a 91% overall sequence homology and 95% sequence homology within 




Figure 1.4. The murine Lsh gene. Exons are displayed in black with the conserved 
helicase domains and structural domains highlighted. 
 
Due to homology in sequence across the ATPase domain and helicase motifs, Lsh is 
classified as a member of the SNF2-like family of chromatin remodellers (Geiman et al., 
1998). Members of this family utilise energy derived from ATP hydrolysis to alter chromatin 
structure at the level of the nucleosome. SNF2 ATPases are usually found in large multi-
subunit complexes. However, to date, Lsh has not been found to act within a large complex 
(Myant and Stancheva, 2008). It is an exclusively nuclear protein and accumulates at 
pericentromeric heterochromatin, in keeping with its important role in methylating satellite 
sequences found at these sites (Yan et al., 2003). 
As previously stated, it is highly expressed in proliferating cells: therefore is universally 
expressed in the early embryo. However, expression becomes more restricted as 
development proceeds. High expression is seen in the brain at E12.5-E14.5 but expression 
in adult tissue becomes restricted to those with proliferative activity including testis, small 
intestine, thymus, bone marrow and spleen (Raabe et al., 2001).  
 
1.5.2 Lsh-/- Mice 
The absolute requirement for Lsh for normal murine development is demonstrated in a non-
viable knockout mouse generated by Geiman et al. This mouse carries a deletion across 
helicase domains I, Ia and part of domain II thereby spanning the ATPase domain and 
DEAH box. Knockout pups survive to term but die within a few hours of birth. No pathology is 
found in the knockout embryos before gestational day 14. However, new born pups exhibit 
growth retardation and severe renal lesions. Histology of many other organs including the 
brain revealed no abnormalities (Geiman et al., 2001). 
Sun et al generated an alternative knockout mouse model carrying a deletion across exons 
10-12 of the Lsh gene containing helicase domains II, III and IV. This resulted in a 
hypomorphic mutation encoding a truncated form of the LSH protein expressed at low levels. 
60% of these mice die shortly after birth, although 40% survive up to a few weeks following 
birth. Growth retardation is noted in these mice from E12.5 and becomes more severe as 
development proceeds. At birth, histopathological examination revealed diffuse alveolar 
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atelectasis but other organs examined, including the brain and kidney, showed no 
abnormalities. In those pups that survived the postnatal period, an early aging phenotype 
was observed with development of grey hair, alopecia, cachexia, unstable gait and kyphosis. 
Histopathological examination at 2 weeks of age revealed lymphoid depletion in the thymus 
and renal degeneration (Sun et al., 2004). Lsh is therefore essential for murine survival. 
1.5.3 Lsh and DNA methylation 
Similar to Ddm1 mutant plants, Lsh-/- mice show defects in DNA methylation at repetitive 
elements. Sun et al demonstrated a 30% reduction in global methylation in E13.5 
hypomorphic embryos and a specific hypomethylation at minor satellite and Intracisternal A 
Particles (IAPs), a type of LTR, with derepression of IAPs in tissue from 15 day old mice 
(Sun et al., 2004). Similarly, repeat hypomethylation is seen in tissues derived from the 
Geiman knockout mouse model described previously. This was demonstrated by Southern 
analysis of satellite, SINEs, IAPs and LINE1s repeats. In this study hypomethylation of a 
small number (3) of selected single copy genes and the ICR of the H19 gene was also 
demonstrated (Dennis et al., 2001). 
Other studies have also pointed towards Lsh playing a role in methylation at single copy 
genes. This includes a specific role in methylating stem cell genes - as demonstrated by 
siRNA knockdown of Lsh in mESCs, in which promoter DNA methylation and subsequent 
repression of pluripotency associated genes upon differentiation was impaired. Inappropriate 
promoter hypomethylation and expression of Oct4 was also seen in E8.5 embryos but by 
E18.5 Oct4 was successfully repressed despite continued hypomethylation (Xi et al., 2009). 
Other developmentally important genes have been reported to be inappropriately regulated 
in the absence of Lsh. These include promoter hypomethylation and biallelic expression of 
the imprinted Cdkn1c gene in Lsh-/- embryos (Fan et al., 2005b). Hox genes are clusters of 
genes which are silenced as differentiation proceeds. However, these genes remain 
inappropriately expressed in Lsh-/- MEFs and tissues derived from Lsh-/- embryos at day 18 of 
gestation - which authors propose is due, at least in part, to promoter hypomethylation (Xi et 
al., 2007). 
The disadvantage in these studies is the investigation of methylation and transcription at only 
selected loci. The use of genome-wide sequencing has revealed further information into the 
role of Lsh. Whole genome bisulphite sequencing by Yu et al in Lsh-/- MEFs confirmed ~60% 
hypomethylation at repeat elements with a subset of these, in particular ERVs and satellites, 
being derepressed as shown by RNA-Seq. This form of analysis also revealed large 
chromosomal domains which were hypomethylated in the absence of Lsh and that these 
regions frequently overlapped with lamin B1 attachment domains (LADs), gene poor repeat 
rich regions of the genome. Lsh may therefore be targeted to nuclear compartments rather 
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than to underlying sequences. Sequencing also revealed that the majority of promoter 
regions in KO cells have reduced methylation, particularly those of low CpG content, 
although only 2% of genes showed differential expression (Yu et al., 2014b). Providing 
further evidence for Lsh influencing methylation over discrete chromosomal domains, Tao et 
al produceded a methylation map of Lsh-/- MEFs using methylated DNA immunoprecipitation 
(MeDIP) combined with whole-genome tiling microarray and found the average size of 
differentially methylated regions to be 50-200kb with well-defined boundaries (Tao et al., 
2011). 
Myant et al found many (1246) genes were differentially expressed in Lsh-/- MEFs - including 
imprinted and Hox genes. However, only 10% of these were associated with a change in 
promoter methylation. This study used methyl-CpG binding domain affinity purification (MAP) 
combined with promoter-specific microarrays, to demonstrate hypomethylation at ~20% of 
promoter regions. This also revealed hypermethylation at 5% of promoters tested indicating 
a rearrangement of DNA methylation patterns at other loci throughout the genome (Myant et 
al., 2011). 
At the beginning of this project it was unknown when Lsh contributed to DNA methylation. 
Then Ren et al derived mES cells from Lsh-/- blastocysts, induced them to differentiate into 
neuroepithelial lineage, and examined DNA methylation at repeat sequences by bisulphite 
sequencing. This revealed that, despite the fact that Lsh is highly expressed in ES cells and 
down-regulated upon differentiation, it was required for methylation upon differentiation and 
reintroduction into ES cells did not restore DNA methylation until the cells were 
differentiated. Upon retinoic acid induced differentiation KO cells displayed hypomethylation 
at IAP sequences (86% versus 49%), minor satellite sequences (79% versus 28%), and 
LINE1 elements (80% versus 55%). This methylation defect was rescued by re-expression of 
WT Lsh, but not Lsh carrying a mutation in the ATP or DEAH domain. This beautifully 
demonstrated that Lsh was not required to maintain DNA methylation in ES cells, but 
contributes to DNA methylation in the context of differentiation (Ren et al., 2015).  
1.5.4 Lsh and de novo methylation  
Lsh is predominantly thought to contribute to de novo methylation. This conclusion has been 
drawn from several bodies of evidence. Firstly by transfecting episomal vectors into Lsh-/- 
MEFs it was demonstrated that Lsh was required to establish novel methylation patterns but 
was not required for maintenance of previously methylated vectors (Zhu et al., 2006). 
Secondly, in the study by Ren et al mentioned above, methylation was gained at repeat 
sequences upon differentiation in the absence of Lsh; just not to the same extent as in WT 
cells suggesting deficits in the de novo methylation pathway (Ren et al., 2015). Finally co-
immunoprecipitation studies have revealed interactions between Lsh and the de novo 
methyltransferases Dnmt3a and Dnmt3b (Myant and Stancheva, 2008; Zhu et al., 2006). 
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However, one cannot completely exclude a role for Lsh in maintenance methylation as 
knockdown of Lsh in primary human fibroblasts leads to progressive loss of methylation at 
repeat sequences (Suzuki et al., 2008) and it has also been shown to directly interact with 
the maintenance methyltransferase Dnmt1 (Dunican et al., 2015). 
1.5.5 Mechanisms of action 
How Lsh contributes to DNA methylation patterns and transcriptional repression is less clear. 
It contains no known methyltransferase domain, therefore must exert its action indirectly. 
There is evidence for its action as a chromatin remodeller similar to Ddm1 in Arabidopsis, 
also there is evidence for it acting as a recruiting protein for DNMTs. Finally, it has been 
shown to act in concert with other histone modifications, which may together influence local 
chromatin structure. Evidence for these mechanisms of action will be discussed below.  
1.5.5.1 Recruitment of Dnmts 
The association between Lsh and Dnmts has been well demonstrated, as it has been shown 
to co-immunoprecipitate with these enzymes (Dunican et al., 2015; Myant and Stancheva, 
2008; Xi et al., 2009; Zhu et al., 2006). In keeping with its proposed role in de novo 
methylation most evidence is for an association with Dnmt3b activity. Association of Dnmt3b 
at target loci such as IAP elements and Hox genes is lost in the absence of Lsh (Ren et al., 
2015) (Xi et al., 2009; Xi et al., 2007). Furthermore the ability of Lsh to repress a reporter 
gene was impaired on knockout of DNMTs but interestingly the catalytic activity of DNMTS 
was not required for repression (Myant and Stancheva, 2008). If this was the major 
mechanism by which Lsh influences DNA methylation, one may expect to see similarity 
between Lsh-/- and Dnmt3b-/- hypomethylated regions. Indeed this is the case as investigated 
by Dunican et al in MEFs. However, this paper also reported that compared to Dnmt3b-/- 
MEFs,  Lsh-/- MEFs had more severe hypomethylation defects in LTRs and greater 
expression of hypomethylated satellite and IAP sequences (Dunican et al., 2013). It would 
therefore appear that Lsh acts primarily in concert with Dnmt3b, however does have a role 
independent of this enzyme at certain loci. 
Lsh may therefore act as a scaffolding protein recruiting DNMTs to target sites. However 
Ren et al demonstrated that the ATPase activity of Lsh is essential for DNA methlation and 
DNMT3B recruitment to repeat sequences (Ren et al., 2015) pointing to a primary action in 
chromatin remodelling as will be discussed in the next section. 
 
1.5.5.2 Chromatin remodelling 
As previously stated, Lsh is classed as a member of the SNF2-like family of chromatin 
remodellers. Its homolog Ddm1 was shown several years ago to directly induce nucleosome 
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remodelling (Brzeski and Jerzmanowski, 2003). However, demonstration of this activity in 
Lsh remained elusive until recently. Indeed Jenness et al found purified HELLS possessed 
little remodelling activity in a restriction enzyme accessibility assay, whereby remodelling 
exposes a restriction site within the nucleosome. However, addition of CDCA7, which is 
incapable of remodelling action on its own, resulted in robust remodelling activity. These 
proteins were shown to form a stoichiometric complex on chromatin and act as a bipartite 
nucleosome remodelling complex the authors termed the CDCA7-HELLS ICF-related 
nucleosome remodelling complex (CHIRCC) (Jenness et al., 2018). 
This remodelling has been proposed to allow access for the DNMTs to the DNA (Meehan et 
al., 2001). Indeed nucleosomal DNA cannot be efficiently methylated by Dnmts unless in the 
presence of chromatin remodellers (Felle et al., 2011; Schrader et al., 2015; Takeshima et 
al., 2006). Ddm1 has been suggested to promote accessibility at H1 dense repressed 
heterochromatin, improving deposition of DNA methylation at these sites (Zemach et al., 
2013). Evidence for Lsh acting as a nucleosome remodeller in vivo came from the 
aforementioned study by Ren et al who differentiated Lsh-/- ES cells. In order to create a 
simultaneous map of nucleosome footprint and DNA methylation they carried out 
nucleosome occupancy and methylome sequencing assay (NOMe Seq). This reported high 
nucleosome occupancy at IAP and LINE1 elements in both KO and WT ES cells, but 
reduced occupancy in KO cells following differentiation at 59% vs 98% at IAPs and 59% vs 
85% at LINE1s, which also demonstrated hypomethylation. Nucleosome occupancy was 
restored by reintroduction of WT Lsh but not ATP or DEAH domain mutants (Ren et al., 
2015). This indicates a requirement for Lsh for nucleosome density at these repeat sites, 
however does not necessarily indicate that this nucleosome occupancy is a direct 
consequence of Lsh remodelling, nor that it occurs prior to DNA methylation.  
This same group more recently attempted to further the understanding of the dynamics 
involved by creating a tethering system recruiting a Gal4-Lsh fusion protein to an engineered 
Oct4 locus and investigated a range of epigenetic modifications at this site. In ES cells 
association of this protein to the tethered site reduced chromatin accessibility and active 
histone modifications, whilst having no effect on expression (as assessed by GFP reporter 
gene expression) or DNA methylation. When these cells were induced to differentiate there 
was an increase in repressive histone modifications, gain of DNA methylation, and 
transcriptional repression of the reporter gene (Ren et al., 2018). This provides evidence for 
chromatin remodelling occurring prior to de novo DNA methylation pointing to a priming role 
for Lsh in ES cells whereby local changes in chromatin structure at this stage prime the gene 
for later DNA methylation and repression. This may explain why Lsh is expressed so highly 
in ES cells despite the lack of evidence for it playing a great contribution to DNA methylation 
at this stage. 
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1.5.5.3 Lsh and histone modifications 
Lsh has been proposed to influence the epigenome through mechanisms other than DNA 
methylation, which will be discussed here. 
A wide-spread disturbance of histone modifications have been observed in Lsh-/- models. 
Dunican et al demonstrated changes in the histone code over repeats, correlating with 
transcription with a decrease in repressive H3K9me3 at de-repressed IAPs and satellites 
and gains of active H3K4me3. The gains in active histone modifications were also seen over 
LINE1s, which did not demonstrate transcriptional de-repression, but loss of H3K9me3 was 
not detected at these sites. Accumulation of repressive H3K27me3 was also seen over 
repeats (Dunican et al., 2013). 
H3K27me3 is deposited by Polycomb group proteins, and other authors have associated 
these proteins with Lsh. Xi et al immunoprecipitated components of the Polycomb repressive 
complex 1 (PRC1) and found Lsh associates with these. Furthermore, in Lsh-/- MEFs there 
was a reduction in the PRC1 mark H2A-K116 ubiquitination and the PRC2 mark H3K27me3 
across target Hox loci (Xi et al., 2007).  
Lsh may maintain a repressive state via recruitment of HDACs, as it has been shown to 
immunoprecipitate with these enzymes and histone deacetylase activity has also been 
shown to be essential for Lsh mediated repression at the p16 promoter (Zhou et al., 2009). 
It has also been proposed to co-operate with the G9a/Glp complex responsible for most of 
the dimethylation at H3K9 (Tachibana et al., 2008) as there was failure of this complex to 
associate with target loci in Lsh-/- MEFs, with a subsequent reduction in H3K9me2 at these 
sites (Myant et al., 2011). 
Regions differentially enriched for H3K4me1, a mark of putative enhancers, have also been 
noted in Lsh-/- MEFs. Interestingly these putative novel enhancers were clustered near 
neuronal lineage genes. When these cells were reprogrammed to iPSCs they maintained 
these marks and subsequently demonstrated enhanced neurodifferentiation potential (Yu et 
al., 2014a). 
The main role of Lsh is therefore in DNA methylation. However, either through direct or 








1.5.6 Genomic instability 
Lsh, most probably through its role in DNA methylation at satellite sequences near the 
centromere, plays a key role in maintaining genome stability. Fibroblasts derived from Lsh-/- 
mice display replicative senescence with increased centrosome numbers and multipolar 
spindle formation similar to the phenotype of WT MEFs treated with 5-Aza-2’-deoxycytidine, 
a demethylating agent (Fan et al., 2003) although it should be noted that one paper 
demonstrated that this was not the case for fibroblasts derived from patients with mutations 
in Hells (Toubiana et al., 2018). 
It is also important in maintaining genome stability during meiosis. Lsh null oocytes show 
incomplete synapsis of chromosomes, non-resolution of double strand breaks in asynapsed 
chromosomes and failure of homologous recombination resulting in severe oocyte loss (De 
La Fuente et al., 2006).  
There is also evidence that Lsh’s role in maintaining genome stability is independent of its 
role in DNA methylation. Burrage et al treated Lsh deficient mouse and human fibroblasts 
with ionizing radiation and found insufficient repair of DNA double strand breaks. These 
results were not seen in Dnmt1-/- MEFs suggesting they were independent from DNA 
methylation defects (Burrage et al., 2012). Unoki et al also showed evidence for a role for 
Lsh in non-homologous end-joining (Unoki et al., 2019). 
The importance of Lsh in DNA methylation and maintenance of genomic stability in humans 
is reflected by its misregulation in cancer (Fan et al., 2008; Jia et al., 2017; Liu and Tao, 
2016; von Eyss et al., 2012; Wang et al., 2015), and by the fact that mutations in this gene 
are causative for ICF syndrome. 
  
1.5.7 ICF syndrome 
Immunodeficiency, Centromeric Instability and Facial Anomalies syndrome (ICF) is a rare 
autosomal recessive disorder. In 50% of cases it is caused by mutations in Dnmt3b and a 
further 30% are accounted for by mutations in zinc-finger and BTB domain containing 24 
(Zbtb24) (de Greef et al., 2011). In 2015 Thijssen et al also identified causative mutations in 
cell division cycle associated 7 (Cdca7) and Hells (Thijssen et al., 2015).  
Individuals suffer from recurrent infections which often prove fatal due to immunoglobulin 
deficiency. They also present with facial dysmorphism which can include hypertelorism, a flat 
nasal bridge and epicanthus, growth retardation and intellectual disability (Ehrlich et al., 
2008). Centromeric instability in mitogen stimulated lymphocytes is a hallmark of this 
syndrome involving the pericentromeric regions on chromosomes 1, 9, 16 and rarely 2 due 
to hypomethylation and decondensation at satellite repeats (Jeanpierre et al., 1993; Tuck-
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Muller et al., 2000). Treatments involve immunoglobulin infusions and allogenic stem cell 
transplantation but life expectancy remains poor at 8 years. 
Although there is variability in the presentation of ICF syndrome, there are 3 diagnostic 
criteria which are: immunodeficiency despite the presence of B cells, hypomethylation in 
satellite DNA and characteristic rearrangements in chromosome 1 and/or 16 in mitogen 
stimulated lymphocytes (Ehrlich et al., 2006). These rearrangements include pericentromeric 
breaks, whole arm deletions, multibranched chromosomes, translocations and 
isochromosomes (Ehrlich, 2003). 
The juxtacentromeric hypomethylation is seen across all studied tissues from ICF patients. 
However, DNA rearrangements are thought mainly to occur in lymphocytes, rather than 
other tissues - and even in these cells they are thought to occur at a very low rate in vivo 
(Ehrlich, 2003; Sawyer et al., 1995). 
Mouse models have been generated carrying Dnmt3b mutations causative for ICF. The 
majority of these mice display low birth weight and die within 1 day of birth of unknown 
cause. A very small number survived past weaning age and had facial features reminiscent 
of ICF syndrome. Newborn pups displayed hypomethylation of satellite repeats and a 
deficient immune system although unlike in humans this was due to a defect in the T cell 
lineage (Ueda et al., 2006). 
Seven ICF syndrome patients across five families have been identified with causative 
mutations in Hells. The mutations seen in each proband are summarised in Figure 1.5 





The fact that mutations in several different genes can all lead to ICF syndrome has led to the 
subdivision of this syndrome into: type 1 with causative mutations in Dnmt3b, type 2 with 
causative mutations in Zbtb24, type 3 with causative mutations in Cdca7 and type 4 with 
causative mutations in Hells. Patients with each subtype have been proposed to display 
differing phenotypes (Velasco et al., 2018a). For example, patients with type 2-4 are said to 
suffer more from neurological than immunological defects compared to patients with type 1, 
although the small number of cases and the heterogeneity between individuals limits the 
extent to which one can draw such conclusions.   
A comparative analysis of patients with ICF revealed that each subtype could be 
distinguished by the methylome.  All subtypes contained hypomethylation of pericentromeric 
repeats and a few common loci, but distinct loci were affected in each subtype. Types 2-4 
clustered together and displayed greater hypomethylation at CpG poor regions, with 
heterochromatic features and at genes implicated in neuronal development. It should be 
noted that this analysis included only one patient with type 4 ICF (Velasco et al., 2018a).  
 
 
1.6 Epigenetic dynamics during development 
Epigenetic mechanisms are at their most dynamic during embryonic development. Initially 
this requires a return to a pluripotent state at fertilisation following fusion of cells that have 
acquired all the epigenetic marks of germ cells. Following this, cells with identical DNA 
Figure 1.5. Mutations in Hells in ICF patients. Schematic representation of Hells 
protein with mutations identified in 7 patients highlighted. Proband A is a compound 
heterozygote for a nonsense mutation at Lys204 and a duplication causing insertion of a 
stop codon at Lys128. Probands B and C were compound heterozygotes with a 
missense mutation at Gln699 within a conserved helicase domain and an intronic 
mutation leading to destruction of a splice donor site.  Proband D carries a homozygous 
out-of-frame deletion at Ser762 resulting in a frameshift mutation and introduction of a 
premature stop codon at exon 20.Probands E-G carry a homozygous in-frame deletion 
at Leu801. (Adapted from (Thijssen et al., 2015)) 
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sequence must rapidly divide and follow different differentiation trajectories to establish 
different transcriptional profiles. This is achieved through transcription factor networks and 
wide-scale remodelling of the epigenome. 
1.6.1 DNA methylation in the early embryo 
During embryonic development extensive demethylation occurs in two separate waves. The 
first wave occurs in the zygote following fertilisation, and the second in the primordial germ 
cells (PGC’s)(Santos et al., 2002).  
The first wave of demethylation is coincident with restoration of pluripotency in the 
developing zygote. This involves extensive loss of DNA methyl marks, such that by the early 
blastocyst stage methylation levels are at their lowest. Demethylation however is not 
complete as methylation at imprinted regions, and some, but not all, repetitive elements are 
preserved (Brandeis et al., 1993; Lane et al., 2003). The kinetics of demethylation differs 
between the paternal and maternal genome, occurring much more rapidly in the paternal. 
This led to the conclusion that the paternal genome underwent an active demethylation 
process whereas the maternal genome underwent a passive, replication dependent, 
demethylation (Oswald et al., 2000; Santos et al., 2002). This, however, has been called into 
question by the presence of oxidised cytosines bases and demethylation beyond what would 
be expected from replication dependent means in the maternal genome suggesting a degree 
of active demethylation also (Wang et al., 2014). The importance of this extensive 
demethylation however is unclear as it does not occur in all mammals (Beaujean et al., 
2004a). 
The TET enzyme pathway of demethylation described in section 1.3.3 has been proposed as 
a strong candidate for this active demethylation in zygotes. Evidence for this includes the 
fact that TETs and 5hmC are enriched in male pronuclei compared to female. Furthermore, 
Tet3 deficient zygotes failed to convert 5mC to 5hmC in the paternal genome (Gu et al., 
2011). One reason why active demethylation in female pronuclei is far less pronounced may 
be the higher expression of the PGC7 protein, which associates with H3K9me2 and reduces 
affinity of TET3 to these sites (Nakamura et al., 2012; Szabo and Pfeifer, 2012).  
There is, however, evidence against the TET enzyme pathway being the main mode of 
active demethylation in the zygote. Importantly the increase in 5hmC levels in male pronuclei 
does not occur in concert with the reduction in 5mC, but instead is delayed. This was 
demonstrated by Amouroux et al, who also proposed 5hmC was actually derived from de 
novo methylation by Dnmt3a after they demonstrated a significant decline of 5hmC levels, 
with no disturbance of 5mC levels in male pronuclei of zygotes treated with a 
methyltransferase inhibitor (Amouroux et al., 2016). The fact that 5hmC is a stable mark 
retained through all cleavage stage embryos suggests it may play an important role during 
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development, and is not just the by-product of 5mC demethylation (Iqbal et al., 2011; 
Wossidlo et al., 2011). 
The second demethylation wave occurs in PGCs at E8.5-E12.5. As PGCs are derived from 
cells at a later stage of differentiation than the hypomethylated inner cell mass (ICM), they 
have already begun to accumulate somatic epigenetic features. Therefore, these newly 
acquired DNA methyl marks need to be removed to restore totipotency and allow laying 
down of germ-line specific epigenetic patterns. This demethylation goes further than the first 
wave, as it also has to remove imprinted marks to allow reestablishment in a sex dependent 
manner (Hajkova et al., 2008).  
The initial demethylation event necessitates a subsequent wave of de novo methylation in 
the implanting blastocyst to allow cell fate specification. In this wave 5mC is established at 
promoters of stem cell specific, germ-line and tissue specific genes dependent on cell fate 
(Mohn et al., 2008; Ng et al., 2008). This wave continues until tissue specific patterns of DNA 
methylation are laid down largely by E6.5 (Borgel et al., 2010). De novo methylation in PGCs 
occurs at E14.5 in males and not until postnatally in females (Li et al., 2004; Lucifero et al., 
2004) (Figure 1.6). In general DNA methylation is seen as a relatively stable mark that 




Figure 1.6. DNA methylation during murine embryogenesis. Diagram of DNA 
methylation patterns during murine embryogenesis. Blue lines represent the paternal 
genome and pink the maternal. Days of embryonic development are displayed on the x axis. 
Following fertilisation there is a wave of demethylation resulting in the lowest levels of 
methylation in the inner cell mass (ICM) of the implanting blastocyst. A wave of de novo 
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methylation then begins and continues until tissue specific patterns of DNA methylation are 
laid down. At E8.5 demethylation occurs in the migrating primordial germ cells (PGCs). De 
novo methylation then occurs to establish sex specific patterns. This occurs at E13.5 in the 
male but not until postnatally (P21) in the growing oocyte. 
 
1.6.2 Polycomb during development 
As well as profound changes in DNA methylation, histone modifications are also dynamically 
turned over during development. In section 1.2.3 I alluded to the importance of Polycomb 
proteins in this process. 
Polycomb proteins are highly conserved key chromatin modifiers. They are found in 
complexes termed Polycomb repressive complex 1(PRC1) and PRC2. PRC1 complexes can 
be formed of multiple different proteins, however 2 core proteins are present in all; a RING1 
protein which mediates ubiquitination of H2AK119 and a Polycomb group ring-finger domain 
protein. The canonical PRC1 complex also contains a chromobox protein that binds 
H3K27me3. The functional core of PRC2 contains the histone methyltransferase enhancer of 
zeste (EZH1 or 2) responsible for depositing the H3K27me3 mark, suppressor of zeste 
(SUZ12), embryonic ectoderm development (EED) involved in histone deacetylation and 
histone binding protein RBBP4 or 7 (van der Vlag and Otte, 1999). The counterparts of 
Polycomb proteins are the Trithorax group proteins which can remove the repressive 
Polycomb marks and can deposit the transcriptionally permissive mark H3K4me3 
(Schuettengruber et al., 2017). 
The established model of Polycomb gene repression is that PRC2 is recruited and deposits 
H3K27me3  providing a binding site for the chromodomain of PRC1, which then catalyses 
deposition of the repressive mark H2AK119ub1 (Endoh et al., 2012; Nakagawa et al., 2008; 
Stock et al., 2007; Zhou et al., 2008). However this model cannot be a complete story as the 
complexes have some non-overlapping targets, non-canonical PRC1 complexes lack a 
chromodomain and some organisms, whilst having H3K27me3 lack a PRC1 homolog (Gao 
et al., 2012; Ku et al., 2008; Leeb et al., 2010; Schuettengruber et al., 2007). It has also been 
proposed that PRC1 can recruit PRC2 via recognition of H2AK119ub1 creating a positive 
feedback loop perpetuating the mark (Blackledge et al., 2014; Cooper et al., 2014). 
Furthermore the catalytic activity of RING1B does not appear to be essential for Polycomb 
function in all contexts (Illingworth et al., 2015). Another means by which the mark could be 
perpetuated is by influencing higher order chromatin structure. PRC1 complexes can form 
tightly compacted chromatin structures and bring together distal genomic regions, and this 
action appears to be independent of ubiquitination (Kundu et al., 2017). 
There seems to be some form of cross talk between Polycomb and DNA methylation as they 
tend to be mutually exclusive, i.e. promoters with high levels of DNA methylation are 
depleted for H3K27me3 mark and vice versa (Hawkins et al., 2010; Meissner et al., 2008a). 
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Furthermore, in models of DNA hypomethylation there appears to be redistribution of the 
H3K27me3 mark to previously methylated regions (Lynch et al., 2012; Reddington et al., 
2013).  
Polycomb targets are enriched for tissue-specific transcription factors and developmental 
regulators, such as Hox genes, highlighting a role for Polycomb in regulating cell fate during 
development (Boyer et al., 2006; Lee et al., 2006). In ES cells many important 
developmental genes are bivalently marked. That is, they are marked by both the active 
H3K4me3 mark and the repressive H3K27me3 mark. In this situation Polycomb is playing a 
key role in silencing developmental genes, thereby maintaining pluripotency. This is 
demonstrated in the spontaneous differentiation of ES cells deficient in Suz12 or Eed which 
also show de-repression of developmental genes (Boyer et al., 2006; Lee et al., 2006). The 
necessity for intact Polycomb regulation during development is further highlighted by the 
embryonic lethality of knockout mouse models (Faust et al., 1998; O'Carroll et al., 2001; 
Pasini et al., 2004).  
Repression of developmental genes necessarily has to be transient to allow differentiation to 
occur at the appropriate developmental time point. Bivalently marked genes are silent but 
poised for later transcription upon cell fate determination, when they lose their H3K27me3 
mark or become more stably repressed, losing H3K4me3 dependent on cell type (Mikkelsen 
et al., 2007). Poised RNA polymerase II is associated with bivalently marked genes to allow 
rapid transcription upon differentiation (Brookes et al., 2012). These bivalent regions are not 
exclusive to ES cells, indeed new bivalent domains arise in neural progenitors for example 
(Mohn et al., 2008). During neural differentiation of ES cells many more promoters lose and 
gain H3K27me3 at different stages of neurodifferentiation than change their DNA 
methylation status (Mohn et al., 2008).  
1.6.3 Epigenetic dynamics during neurodevelopment 
1.6.3.1 Neurogenesis  
The nervous system arises from the neural tube, divisions of which will form the major 
structures with the hollow interior forming the spinal cord and ventricular system. This tube is 
lined by a single layer of neuroepithelial cells which will eventually give rise to all 3 neural 
lineages: neurons, astrocytes and oligodendrocytes. This occurs in a timely manner, with 
neurogenesis preceding astrogenesis, which precedes generation of oligodendrocytes. 
These processes occur during embryogenesis and early postnatal stages with only niche 
areas of neurogenesis remaining in the adult. At around E11 in the mouse the transcriptional 
profile of the neuroepithelial cells, located in the ventricular and subventricular zones, 
change and they transform to radial glial cells. These are elongated cells with apical and 
basal processes spanning the width of the cerebral wall from the ventricular cavity to the pial 
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surface. This allows them not only to act as a scaffold for migrating neurons, but also to 
receive important differentiation signals from the cerebrospinal fluid. They undergo 
asymmetric division to produce another radial glial cell and an immature neuron or 
intermediate progenitor cell which are capable of 1-3 self-renewal symmetric divisions before 
division to form 2 neurons. The mouse cerebral neocortex is made up of 6 horizontal layers. 
The formation of this neocortex occurs in an inside out manner, in which neurons destined 
for deep layers are generated before younger neurons which migrate past them to more 
superficial layers. In late embryogenesis and early postnatal stages the radial glial cells 
detach from the ventricular surface and transform into astrocytes and oligodendrocytes with 
some remaining to form the adult stem cell pool (Reviewed in(Okano and Temple, 2009; Yao 
et al., 2016)) (Figure 1.7). 
 
 
Figure 1.7. Embryonic Neurogenesis. In mice, neuroepithelial (NEP) cells lining the neural 
tube transform to radial glial cells (RGCs) around E11. These RGCs undergo asymmetric 
division to self-renew and form either a neuron or an intermediate progenitor cell (IPC). 
These newly formed cells use RGC processes as scaffolding to migrate to the appropriate 
cortical layer. IPCs have the capacity to undergo a limited number of asymmetric divisions 
before the generation of 2 neurons. Later in development RGCs form astrocytes and 
oligodendrocytes. Concept for figure from (Paridaen and Huttner, 2014). 
If the steps of neurogenesis do not occur in a timely manner, abnormal brain size, cellular 
composition or malformations can result (Bansod et al., 2017; Desikan and Barkovich, 2016; 
Dwyer et al., 2016). Timing is therefore tightly controlled by a range of factors which include 
extracellular signalling pathways, intrinsic TF networks and epigenetic modifications. The 
importance of cell intrinsic programs is highlighted in cells differentiated in culture which 
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recapitulate the timing of neurogenesis and astrogenesis, making this a valid system for 
investigation of this process (Qian et al., 2000; Ravin et al., 2008; Shen et al., 2006).  
 
1.6.3.2 Dynamic DNA methylation during neurodevelopment 
One of the ways in which this timing of neurogenesis is controlled is through DNA 
methylation. The Dnmts are differentially expressed depending on the stage of 
neurogenesis. Dnmt1 is ubiquitously expressed in NPCs and postmitotic neurons. Dnmt3b is 
expressed in early neural progenitor cells but is down-regulated after E13.5 being 
undetectable after E15.5. In contrast Dnmt3a is not detectable until later in development 
around E10.5-E13.5 and continues to be expressed in adult neurons (Feng et al., 2005; 
Watanabe et al., 2006). 
Dnmt3a-/- NPCs in culture demonstrate down-regulation of neurogenic genes and up-
regulation of genes involved in astrocyte and oligodendrocyte differentiation; these genes 
having lost their promoter methylation, resulting in 10-fold fewer neurons being produced 
(Wu et al., 2010; Wu et al., 2012). This premature glial differentiation is seen in other 
hypomethylated mutants. In Dnmt1 KO NPCs methylation is lost from astroglial genes and 
genes essential in JAK-STAT signalling, a downstream target of which is activation of GFAP 
which is required for astrocyte differentiation, resulting in premature astrogenesis (Fan et al., 
2005a).  
Whilst cellular demethylation, remethylation programmes (CDRs) were previously thought 
only to occur in totipotent and germ cells, there is now evidence for this process occurring in 
post-mitotic neurons. Sharma et al examined methylation at different stages of neurogenesis 
in 2 cell lineages. Firstly in ES cells, secondly in dorsal and ventral telencephalic NPCs, then 
in immature and finally mature hippocampal and striatal neurons. They found an initial 
genome wide methylation during progenitor proliferation, which was followed by a loss of 
methylation upon the transition to immature neurons, and finally there was a further wave of 
methylation during maturation of these neurons. The wave of demethylation on progenitor to 
immature neuron transition corresponded to a peak in Tet3 expression. Methylation and 
transcription were very similar between the 2 lineages at progenitor and immature neuron 
stages. Subtype-specific changes in methylation and transcription occurred during the 
maturation phase with methylation changes occurring preferentially at intergenic sequences 
with enhancer like activity at both CpG and non-CpG sites. This was blocked by conditionally 
inactivating Dnmt3a (Sharma et al., 2016).  
The timing and extent of this CDR appears individual to each neuronal cell type. Another 
group reported that the most extensive CDR occurs in cerebellar Purkinje cells, which 
undergo an extensive CDR at P14-30 in the mouse brain, coinciding with dendritogenesis 
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and synaptogenesis (Zhou et al., 2016). As one of the largest neurons with the most 
extensive synaptic network, one might hypothesise that a wider scale reprogramming event 
would be necessary for their generation. Much smaller scale demethylation, remethylation 
events may also occur in response to neuronal activity (Guo et al., 2011; Martinowich et al., 
2003). 
 
1.6.4 Neurological disorders associated with abnormal DNA methylation 
The importance of furthering our understanding of DNA methylation mechanisms during 
neurodevelopment is highlighted by the fact that several neurodevelopmental disorders, 
other than ICF syndrome discussed previously, are associated with abnormal deposition of 
DNA methylation during development or by mutations in proteins forming part of the 
methylation machinery. Examples of these are discussed below. 
Rett syndrome is caused by mutations in the methyl binding protein MECP2. It is 
characterized by onset of severe intellectual impairment, loss of speech and motor skills, 
deceleration of head growth and repetitive stereotypies between 6-18 months of age (Neul et 
al., 2010). Although classed as a neurodevelopmental disorder, the phenotype can be 
reversed upon restoration of MECP2 (Guy et al., 2007) and removal of MECP2 in adult mice 
results in the same phenotype (McGraw et al., 2011; Nguyen et al., 2012), which suggests it 
is actually required for neuronal function throughout life. As mentioned earlier MECP2 is 
considered a repressor of transcriptional activity. Retrotransposon transcripts are moderately 
increased in MECP2 knockouts and increased L1 retrotransposition has been reported in 
neurological models of Rett syndrome (Muotri et al., 2010).  
A group of neurodegenerative conditions are caused by mutations in Dnmt1, namely 
Hereditary and Sensory Autonomic Neuropathy (HSAN) and Autosomal Dominant Cerebellar 
Ataxia, Deafness and Narcolepsy (ADCA-DN) (Klein et al., 2011; Winkelmann et al., 2012). 
Although classified as separate entities, it is more likely they represent a spectrum of 
disease. Patients present in early adult life with a range of symptoms which can include 
neuropathies, hearing loss, cerebellar ataxias, psychosis and early onset dementia (Baets et 
al., 2015). Global hypomethylation has been found in peripheral blood DNA from these 
patients, although at modest levels, and pathway analysis revealed that genes with 
differentially methylated regions were associated with diverse neurological disorders (Sun et 
al., 2014). However DMRs only had between 5-10% reductions in methylation and, if 
hypomethylation was the main pathogenic mechanism, it does beg the question as to why 
the disease onset is in adult life. It could be argued that a relatively small reduction in 
methylation has no effect during development but has an accumulating impact on the 
nervous system over time. A second pathogenic mechanism may be due to misfolding and 
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aggregation of the mutant DNMT1 protein causing cellular stress and eventually death 
(Baets et al., 2015). However it could also be due to an unknown role for Dnmt1 in 
postmitotic neurons. 
Abnormal hypo/hypermethylation at certain sites has been associated with a variety of 
neurological disorders. For example Fragile X syndrome, an inherited cause of intellectual 
disability and autism, is caused by a trinucleotide repeat expansion in the Fmr1 gene which 
encodes FMRP, a protein which plays several roles in the brain: including nucleocytoplasmic 
shuttling of mRNA, synaptic protein synthesis and dendritic localization of mRNA. These 
CGG repeat expansions become abnormally hypermethylated, resulting in silencing of the 
Fmr1 gene (Bell et al., 1991). There is also preliminary evidence for aberrant methylation 
patterns in patients with psychosis (Xiao et al., 2014).  
1.6.5 Mouse Models  
In order to gain a better understanding of how abnormal DNA methylation during 
development can result in neurological disease, several mouse models have been 
generated. As previously mentioned full Dnmt and Lsh knockout models die prematurely. 
This means that one cannot study the consequences on the mature brain. 
Models have therefore been generated with targeted knockout in the neural system. Fan et 
al generated mice in which Dnmt1 was knocked out in NPCs using a Nestin-Cre model, or in 
postmitotic neurons using CamK-Cre. In NPCs this resulted in significant hypomethylation, 
including in postmitotic progeny. Mice in which there was a 95% recombination efficiency 
died within an hour following C-section delivery at E18.5-E19.5 due to respiratory failure, 
whilst those who had only a 30% recombination efficiency survived into adulthood. In these 
survivors the hypomethylated neurons were selected against and so eliminated from the 
brain during postnatal development. In contrast, knockout in postmitotic neurons did not 
affect methylation levels and had no effect on survival of mutant mice (Fan et al., 2001). 
Then again CamK-Cre drivers are selective for glutamatergic neurons, and in adult brain 
Dnmt1 is mainly expressed in GABAergic neurons. Therefore one cannot exclude a role for 
Dnmt1 mediated methylation in these postmitotic cells. 
The same group then used the Emx1-Cre system to knock out Dnmt1 in precursors of 
forebrain excitatory neurons. Resultant mice survived into adulthood but showed abnormal 
neurodevelopment with indistinct cortical lamination (Golshani et al., 2005). The 
hypomethylated neurons were selected against during development with severe neuronal 
death between E14.5 and 3 weeks postnatally causing cortical and hippocampal 
degeneration. Some hypomethylated neurons escaped this selection process accounting for 
20-30% of neurons in the adult brain. Mutant neurons showed abnormal dendritic 
arborisation and excitability. Adult mice exhibited hyperactivity, learning and memory 
38 
 
defects. There was differential expression of 1500 genes including those involved in cortical 
layer specification, neural activity and cell death (Hutnick et al., 2009). The difficulty in 
interpreting this data is that as Dnmt1 was not knocked out in inhibitory interneurons in this 
model, it is presumed there will be a greater percentage of these in mutant brains. This 
would have consequences upon transcriptome analysis and behaviour.  
A Dnmt3a-/- Nestin-Cre mouse model showed evidence of hypo activity by 8 weeks and 
behavioural testing at 12 weeks demonstrated neuromuscular defects with abnormal gait, 
weakened grip strength and motor coordination and died prematurely at 18 weeks. 
Histological analysis suggested this was due to decreased numbers of motor neurons and 
fragmentation of endplates at neuromuscular junctions. IAP methylation, which was used as 
a proxy for global methylation, however appeared to be unperturbed (Nguyen et al., 2007). 
Feng et al generated mice with targeted deletion of Dnmt3a, Dnmt1 or both in postmitotic 
neurons using CamK-Cre. They found only double mutants demonstrated a phenotype. They 
had normal lifespan and did not display any obvious phenotype on observation in the cage. 
Histological examination revealed smaller hippocampal volume and abnormal synaptic 
plasticity. This correlated to deficits in learning and memory. Global methylation analysis 
revealed a 20% reduction in methylation in double mutant brains.  A small number of genes 
(91) were misexpressed in the double mutant brains important in synaptic function, learning 
and memory. This suggests that Dnmt1 and Dnmt3a may play redundant roles in postmitotic 
neurons (Feng et al., 2010a). 
Targeted deletion of Uhrf1 in an Emx1-Cre system whilst having little effect on embryonic 
development, resulted in global DNA hypomethylation with activation of IAPs and severe 
postnatal neurodegeneration. This study also revealed that perturbed DNA methylation 
caused by a factor only expressed in earlier stages of differentiation, can have long-reaching 
consequences beyond the time-point when the protein is expressed (Ramesh et al., 2016). 
These models, whilst informative, are not ideal for studying the effects of hypomethylation 
during neurodevelopment on the adult brain due to premature death, lack of effect on DNA 
methylation or only a subset of neurons being targeted. A model in which methylation is 
perturbed from NPC stage that survives into adulthood, retaining hypomethylated neurons, 
would therefore be desirable in order to investigate molecular and phenotypic consequences 







1.7 Thesis aims 
The wide scale remodelling of DNA methylation during embryogenesis to restore 
pluripotency, and then increasingly restrict cell fate during differentiation, is one of the most 
impressive examples of epigenetics in action. This is particularly true in the developing brain. 
Indeed, the disruption of this process is associated with various neurological disorders. 
Despite this, the mechanisms behind DNA methylation during this period are still to be fully 
understood. Furthermore, how disruptions in this process may lead to disease in the mature 
brain remains unknown largely as a result of the lack of available models. 
Lsh, a chromatin remodeller, is known to be essential for DNA methylation during 
development. Mutations in this gene are also causative for ICF syndrome, a symptom of 
which is intellectual disability. Despite the fact that Lsh is down-regulated upon 
differentiation, the majority of research into Lsh function has been carried out in somatic 
cells. Furthermore, how mutations in this gene lead to neurological symptoms is unknown as 
knockout models die prematurely with multi-system failures, preventing analysis of the 
mature brain. 
In this thesis I intend to utilise a neurodifferentiation cell culture system with Lsh-/- ES cells 
and a neurally targeted Lsh-/- mouse model to further our understanding of these unknowns. 
The main aims being as follows: 
 To utilise a neurodifferentiation protocol to analyse the requirement for Lsh 
for normal neurogenesis and its contribution to DNA methylation during early 
neurogenesis. 
 To analyse the methylome of Lsh-/- neural progenitor cells, taking a genome-
wide approach as the majority of previous studies have focused only on 
selected sites. 
 To analyse the transcriptome of Lsh deficient neural progenitors and its 
relation to DNA methylation defects. 
 To characterise a novel mouse model in which Lsh knockout is targeted to 
neural tissue. This was done with the intention of generating a model in 
which the consequences of defects in DNA methylation during development 
upon the mature brain could be analysed.    
 This characterisation will include genome-wide analysis of the methylome 
and transcriptome in the Lsh-/- mouse brain. Something which has not been 
reported on before. It is hoped this may reveal insights into potential 




Chapter 2.  Materials and Methods 
2.1 Cell culture 
In order to model embryonic development, one has to start with a culture of pluripotent cells. 
These cells have the ability to differentiate into any of the three primary germ layers, and so, 
can contribute to any tissue in the developing organism. 
The most commonly used pluripotent stem cell model is that of mouse ESCs derived from 
the ICM of the blastocyst. When maintained in appropriate media these cells have the ability 
to self-renew, making them ideal for propagation of long term stable cultures and for genetic 
manipulation to create transgenic lines (Evans and Kaufman, 1981; Martin, 1981). 
Appropriate media contains foetal calf serum, a key component of which is bone 
morphogenic protein 4 (BMP4). This signalling molecule results in expression of Inhibition of 
differentiation genes via SMAD signalling pathways thereby aiding to suppress differentiation 
in culture (Ying et al., 2003a). Another important component of mESC culture media is 
Leukaemia Inhibitory Factor (LIF). This cytokine stimulates expression of pluripotency genes 
by activating JAK/STAT pathways (Hirai et al., 2011). mESCs, even after extensive culture, 
have the ability to differentiate to cells of all three germ layers and when injected into the 
blastocyst can contribute to all tissues in the developing embryo (Bradley et al., 1984). I have 
therefore selected this system to model early neurogenesis. 
2.1.1 mESC culture 
All cells were grown in cell culture grade tissue culture flasks or plates (ThermoFisher 
Scientific) coated in 0.1% gelatin.  
mESC media was composed of Glasgow Modification Eagles Medium (GMEM, Gibco) 
supplemented with 15% foetal calf serum (HGU technical services), 1% sodium pyruvate 
(Sigma), 1% non-essential amino acids (Sigma), 1000 U/ml penicillin and 650 µg/ml 
streptomycin (HGU technical services), 1% L-glutamine (HGU technical services), 0.1 mM β-
mercaptoethanol (Invitrogen) and 500 units/ml of LIF (Millipore) and stored in a humidified 
atmosphere at 370C and 5% CO2. Media was changed every 1-2 days. 
Cells were passaged every 2-3 days when reaching 80% confluency. This was done by 
rinsing cells with PBS (Sigma) following removal of media to remove traces of serum. Cells 
were then incubated with 1x trypsin-EDTA v/v (Sigma) at 370C for 2 minutes. Cells were 
dislodged by gentle agitation and trypsin inactivated by the addition of serum containing 
media. The sample was then centrifuged for 5 minutes at 300 x g. After removal of media the 
cell pellet was then resuspended in fresh media and split into new flasks.  
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Supernumerary cells were rinsed in PBS, centrifuged and resuspended in CryoStor cell 
cryopreservation media (Sigma) in cryovials. These were then placed in a “Mr Frosty” 
(ThermoFisher Scientific) at 40C for 15 minutes, then placed at -800C to allow a controlled 
reduction in temperature of 10C per minute for 24 hours, for optimal cell preservation, before 
transfer to liquid nitrogen for long term storage.  
On recovering cells from liquid nitrogen storage, they were rapidly thawed in a 370C water 
bath, then added drop wise to culture media, centrifuged for 5 minutes at 300 x g and the cell 
pellet resuspended in fresh media.  
2.1.2 Generation of cell lines 
E14 mESCs were used throughout this project as a wild type control cell line. Lsh-/- mESCs 
were generated by Dr Donncha Dunican using the CRISPR/Cas9 gene editing system. E14 
mES cells were transfected with Cas9 and a single guide RNA designed to target exon 1 of 
the Lsh gene. XhoI restriction digest was used to screen for clones containing a mutation. 
The target site was amplified by PCR and subjected to Sanger sequencing to establish the 
nature of the mutation. The clone I have used was shown to have a homozygous 25bp 
deletion in exon 1 (Figure 2.1). 
 
Figure 2.1. Schematic of CRISPR targeted deletion. The 25bp deletion in exon 1 present 
in CRISPR generated Lsh-/- cells is represented in the diagram along with the single-guide 
RNA target site.   
From these Lsh-/- mESCs, I generated two rescue cell lines. One line named Lsh-/-(+ WT Lsh) 
was rescued with a PiggyBac vector encoding full length wild type Lsh. Another line named 
Lsh-/-(+ Mutant Lsh) was rescued with a PiggyBac vector encoding Lsh carrying a mutation in a 
conserved helicase domain (R699Q). The rescue cell lines were generated by transfecting 
Lsh-/- mESCs with PiggyBac vectors designed by Professor Meehan and produced by 
VectorBuilder. 
For transfection, Lsh-/- mESCs were plated onto gelatinised 6 well plates at a density of 
5x105 per well in Penicillin/Streptomycin free serum media. 2.5 µg of vector DNA in 50 µl of 
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Opti-MEM (ThermoFisher Scientific) with 6 µl lipofectamine (Invitrogen) and 1 µg of 
transposase vector (Transposagen) was combined, vortexed and left at room temperature 
for 20 minutes. This was then added drop wise to each well. Media was changed after 5 
hours and then again after a further hour using ES media containing Penicillin/Streptomycin 
with the addition of Puromycin 2 µg/ml in cells transfected with WT Lsh vector, or 
Hygromycin B 200 µg/ml in cells transfected with the mutant Lsh vector according to their 
selectable marker.  Cells were grown under these conditions for 10 days and viable cells 
were then single cell sorted via FACS and clones expanded. Successful transfection was 
determined by the presence of LSH on western blotting.  
2.1.3 Neurodifferentiation 
The neurodifferentiation protocol used was adapted from Pollard et al (Pollard et al., 2006). 
This protocol is thought to effectively model neurogenesis in the embryo. Initially, cells start 
to form clusters termed “neural rosettes”. These rosettes are said to resemble the neural 
tube of the embryo, as the neuroepithelial cells forming these rosettes display the typical 
apico-basal polarity of the cells of the neural tube and active notch signalling, both of which 
are crucial to both maintain a population of proliferating neural progenitors, and to coordinate 
the timely production of neurons and glia. Mature neural cells can then be seen at the 
periphery of these rosettes and neurogenesis precedes gliogenesis (Abranches et al., 2009). 
On the day prior to differentiation, ES cells were split at high density to reduce the numbers 
of differentiated cells carrying through. On the day of differentiation, ES cells were 
dissociated from flasks using Trypsin and rinsed twice in PBS to remove any traces of serum 
which would be inhibitory for differentiation. Cell pellets were then resuspended in 
neurodifferentiation media consisting of a 1:1 mix of Neurobasal (Gibco) and DMEM/F-12 
media (Gibco) with 0.5% Neuro-2 Supplement (Millipore), 0.5% B27 Supplement (Gibco), 0.2 
mM L-glutamine and 0.1 mM β-mercaptoethanol. They were then plated onto 0.1% gelatin-
coated flasks (or glass slides for use in immunocytochemistry) at a density of 3x105 cells per 
T75 flask. Media was changed on day 2 of differentiation and then daily thereafter.  
2.1.4 Cell harvesting  
Cells were harvested by dissociation with Trypsin and centrifuged at 300 x g for 5 minutes, 
washed in PBS and centrifuged again. The resulting cell pellet was either snap frozen on dry 
ice for later DNA or protein extraction, or resuspended in TRIzol (Invitrogen) and snap frozen 
for later RNA extraction. Samples were then stored at -800C.  
When cell counting was required, such as prior to neurodifferentiation, cells were harvested 
and resuspended in media. Trypan blue 0.4% (ThermoFisher Scientific), which stains non-
viable cells, was added to this suspension in a 1:1 ratio. 10 µl of this solution was then 
loaded onto a haemocytometer. The number of viable cells across all 4 quadrants was 
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counted and an average then calculated, multiplied by 2, to account for Trypan blue dilution, 
and multiplied by 1x104 to give the number of cells per ml of suspension. 
2.1.5 Magnetic Activated Cell Sorting  
In order to select for neural progenitor cells in heterogeneous cultures, cells underwent 
Magnetic Activated Cell Sorting (MACS) after 10 days of culture in neurodifferentiation 
media. Anti-PSA-NCAM Microbead kit (Miltenyi Biotec) was used as per manufacturer’s 
instructions. Polysialylated neural cell adhesion molecule (PSA-NCAM) is a marker for 
neural progenitor cells. 
A single cell suspension was obtained, following trypsinisation, by passing cells through a 30 
µm nylon mesh and resuspending in buffer (0.5% bovine serum albumin and 2 mM EDTA in 
PBS). Cells were then incubated with Anti-PSA-NCAM Microbeads 20 µl per 1x107 cells for 
15 minutes at 4oC. Following this, the cells were washed in 2 ml of buffer, centrifuged at 300 
x g for 10 minutes and the pellet resuspended in 500 µl of buffer. This was then passed 
through an LS MACS Column within a “MidiMACS” magnetic separator. This column was 
washed three times with buffer to flush through PSA-NCAM negative cells. Cells retained in 
the column were then eluted by removing the column from the magnetic separator and 
flushing through with buffer. This process was repeated over a second column to increase 
the purity of eluted cells. 
2.1.6 FACS Counting 
In order to quantify neural progenitor cell generation and subsequent purification by MACS, I 
employed Fluorescence-activated cell sorting (FACS) using anti-PSA-NCAM antibody 
conjugated to PE (Miltenyi Biotec). As per manufacturer’s instructions, 1x106 cells were 
resuspended in 100 µl of buffer and 10 µl of antibody added. The suspension was then 
stored in the dark at 4oC for 10 minutes and then washed twice in 2 ml of buffer. The cell 
pellet was then resuspended in 200 µl PBS. This process was carried out from WT and Lsh-/- 
ESCs and day 10 differentiated cells pre and post MACS. This was done on 3 biological 
replicates for each condition.  
The positive fraction in each sample was quantified on an Aria FACS machine with the aid of 
Elisabeth Freyer (HGU technical services). The positive population was determined 
according to negative controls of undifferentiated ESCs, and day 10 differentiated cells with 
no antibody. An explanation of the gating tree used is shown in Figure 2.2. A forward scatter 
height (FSC-H) vs. forward scatter area (FSC-A) density plot was used to determine gate P1 
for selection of single cells. A forward scatter vs side scatter gate (P2) was then used to 
identify cells of interest and exclude debris. Gate P3 was used to determine the population 
positive for PE fluorescence. Data was then displayed on histograms to show the overall 
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count of positive and negative cells. Percentage of positive cells was determined as the 






Figure 2.2. FACS analysis. Representative plots of FACS experiments to demonstrate 
gating used to analyse samples. Plots shown are from a WT culture following 10 days of 
neurodifferentiation stained with anti-PSA-NCAM-PE and a control sample of the same type 
with no antibody staining. Gate P1 was set by plotting forward scatter height by forward 
scatter area to select for single cells. Gate P2 was set by plotting forward scatter vs side 
scatter to select cells of appropriate size and remove debris from the analysis. Gate P3 
selects the positive population based on PE fluorescence. Histograms demonstrate the 
positive and negative populations. 
No antibody control          Day 10 differentiation 
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2.2 Cell Imaging 
2.2.1 Phase contrast imaging 
Phase contrast images of cell cultures were taken by phase contrast microscopy using the 
Nikon Eclipse Ti-S inverted microscope at 10x objective with iVision software. 
2.2.2 Immunofluorescence 
For immunocytochemistry experiments, cells were grown on gelatin coated glass coverslips. 
Media was removed and cells were washed in PBS and fixed in 4% paraformaldehyde (PFA) 
(Sigma) for 10 minutes at room temperature. PFA was then removed and fixed cells were 
washed twice in PBS and blocked in 10% Donkey serum (Sigma) in 0.1% Triton-X (Sigma) 
for 90 minutes. After blocking, cells were then incubated with primary antibodies (Table 2.1) 
diluted in 1% donkey serum in 0.1% Triton-X overnight at 4oC. Cells were subsequently 
washed three times for 10 minutes in PBS, and then incubated with AlexaFluor-555 
fluorophore-conjugated secondary antibodies (ThermoFisher Scientific) diluted in 1% donkey 
serum in 0.1% Triton-X at a concentration of 1:200, for 50 minutes in the dark. Cells were 
washed 3 times with PBS for 10 minutes in the dark and then stained with the nuclear 
counterstain DAPI (4’6-diamidino-2-phenylindole 50 µg/ml diluted 1:1000 in PBS) for 10 
minutes in the dark. Coverslips were then washed in PBS twice for 10 minutes and once in 
distilled water. Coverslips were then transferred to Superfrost glass slides (ThermoFisher 
Scientific) and mounted with Vectashield mounting media (Vector laboratories). Image 
capture and analysis was performed using a Zeiss Axioscope 2 fluorescence microscope at 




Supplier Concentration AlexaFluor-555 secondary 
antibody 
Nanog ABCAM; Ab80892 1:75 donkey-anti-goat (A21432) 
Nestin ABCAM; Ab6142 1:200 donkey-anti-mouse (A31570) 
Tuj ABCAM; Ab14545 1:1000 donkey-anti-mouse (A31570) 
Table 2.1. Antibodies used for immunofluorescence studies 
2.2.3 Metaphase spreads 
Metaphase spreads were prepared from cell cultures for assessment of karyotype as follows. 
Colcemid 1 µg/ml was added to cell media 30 minutes before harvesting. The cell pellet was 
then resuspended in 10 ml hypotonic solution (0.5% trisodium citrate, 0.25% potassium 
chloride in dH2O) and incubated at 37 oC for 10 minutes. The solution was then centrifuged 
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and the cell pellet resuspended in 3:1 methanol: acetic acid fix solution. The solution was 
centrifuged and pellet resuspended in fix solution a further 3 times before being stored at -20 
oC.  Solution was then dropped onto glass slide at arm’s length and stained with DAPI 50 
µg/ml diluted 1:1000 in PBS for 3 minutes. Slides were then imaged using a Zeiss Axioscope 
2 fluorescence microscope at 100x objective. 
2.3 Mouse model 
2.3.1 Generation 
The mouse model used in this project was generated, bred and genotyped by David Read 
and Dr Ian Adams. 
A schematic representation of the generation is shown in Figure 2.3.  Two-cell mouse 
embryo straws, heterozygous for a transgenic knock-out-first allele were purchased from The 
European Conditional Mouse Mutagenesis Programme, and implanted into a pseudo-
pregnant mouse of C57BL/6 background. The transgenic allele consists of a gene trap 
cassette containing a splice acceptor site and a downstream transcriptional termination 
sequence. This creates a mutant allele encoding a truncated and non-functional protein. The 
gene trap cassette is flanked by flippase recognition target sites (FRT). The transgenic allele 
also contains Lox-P sites around exon 12 of the Lsh gene. Transgenic heterozygous 
offspring were then crossed with mice expressing flp recombinase which excises the gene 
trap cassette at FRT sites essentially creating a functionally WT allele that is floxed around 
exon 12 which encodes the conserved helicase domain IV. Heterozygous offspring from this 
cross are then crossed with mice expressing Cre driven by the Nestin promoter. This creates 
heterozygous offspring carrying the floxed transgene and expressing Cre in neural 
progenitor cells, which can then be further crossed to result in offspring homozygous for the 
mutant allele in neural cells. PCR genotyping was carried out by David Read using DNA 













Figure 2.3. Generation of the mouse model. Schematic representation depicting 
generation of the targeted Lsh knockout mouse model. See text for detailed description. 
Green triangles represent flippase recognition target sites (FRTs) and red triangles LoxP 
sites. Tg depicts the transgenic allele, Fl the transgenic allele following flp recombination and + 
the wild type allele.  
Animal care was in accordance with institutional guidelines and UK Home Office 
regulations. Mice were housed in environmentally enriched cages with littermates and 
maintained on a 12 hour light/dark cycle with ad libitum food and water. Experiments were 
carried out in accordance with the European Communities Council Directive (86/609/EEC) 
and a project licence with approval under the UK Animals Scientific Procedures Act (1986). 
2.3.2 Sacrifice and dissection 
Mice were sacrificed at 12 weeks or 1 year of age. Sacrifice was carried out using CO2 gas 
administration and cervical dislocation was performed secondarily to ensure euthanasia. 
Dissection was then performed by David Read with removal of the brain, kidneys, spleen 
and liver. Cerebellum was separated from the forebrain, and left and right hemispheres of 
both forebrain and cerebellum were dissected. Left hemispheres, and other organs to be 
used for later nucleic acid extraction, were immediately snap frozen in liquid nitrogen and 
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then stored at -80 oC. Right hemispheres, for use in imaging, were fixed in 4% PFA at 4 oC 
for 48 hours. They were then placed in 20% sucrose solution for dehydration at 4 oC until 
they sank, before being embedded in Optimal Cutting Temperature Compound (OCT, Fisher 
Scientific) and stored at -80 oC. Brain weights were obtained using analytical balance APX60 
(Denver Instruments) and corrected for total body weight. 
For protein and nucleic acid extraction, snap frozen tissues were crushed in a mortar and 
pestle over ice and then pipetted in 4 oC PBS to dissociate tissue to single cells. Samples 
were then centrifuged and PBS removed to achieve a cell pellet.  
2.3.3 Imaging 
Sagittal tissue sections were cut from OCT embedded brain using a Leica Cryostat at 20µm 
thickness and transferred to subbed glass slides. Subbed slides were prepared by 
immersing Superfrost slides in 0.5% gelatin for 2 minutes and then drying at 50 oC overnight. 
Sections were then stored at -80 oC. 
Cresyl violet staining was used to assess morphology. This stains Nissl substance (the 
rough endoplasmic reticulum) in the cytoplasm of neurons purple/blue due to ribosomal RNA 
staining, and is one of the most commonly used stains to assess brain structure. Cresyl 
violet stock solution was prepared by adding 0.2 g of cresyl violet acetate (Sigma) to 150 ml 
dH20 and stirring for 2 hours at room temperature. Stock solution was then diluted 1:10 with 
buffer solution (282 ml 0.1M acetic acid, 18ml 0.1M Sodium Acetate) and mixed at room 
temperature for 1 hour. Brain sections were thawed to room temperature and then immersed 
in Xylene for 5 minutes, 95% ethanol for 3 minutes, 70% ethanol for 3 minutes, dH20 for 3 
minutes, cresyl violet solution for 8 minutes at 60 oC, dH2O for 3 minutes, 70% ethanol for 3 
minutes, 95% ethanol for 1 minute, dipped once in 100% ethanol and finally immersed in 
xylene for 30 minutes. They were then mounted using xylene based mounting media and 
imaged using the Olympus Dotslide microscope at 20x magnification.  
Images were analysed using Dotslide VS-ASW software. Measurements were taken from 
tissue sections from 12 week old male mice aligning to plate 14 (forebrain) and plate 9 
(cerebellum) of the Allen Mouse Brain Atlas (mouse.brain-map.org). Sections from 3 mice in 
each genotype were studied. For each mouse 3 sections were analysed and each 
measurement on each section was repeated 3 times. Therefore for each mouse, each 
measurement was calculated from an average of 9 measurements in total. Measurements 
taken are illustrated on Figure 2.4. Measurements of cortical thickness were taken from the 
pial surface to the edge of the corpus callosum. For somatosensory cortex the anterior point 
of the hippocampal formation was used as a reference, and for the somatomotor cortex a 
point just before the curve of the genu of the corpus callosum was used as a reference point. 
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Figure 2.4. Mouse brain measurements. A representative sagittal section of a 12 week old 
mouse brain with the sites of measurements highlighted. Scale bar=500µm. 
 
2.3.4 Behavioural studies 
Behavioural studies were carried out in 1 year old male mice. 3 knockout subjects and 3  
littermate controls were used. Experiments were carried out between 10 am and 2 pm. Mice 
were handled for 2 days prior to experimentation. Experiments were carried out in a quiet 
room with the light level set at 50 lux. Mice were transferred to the experimental room 1 hour 
prior to testing to allow acclimatisation. Experiments were recorded for later analysis. 
Equipment was cleaned with disinfectant between each mouse. 
2.3.4.1 Open field  
Open field test was carried out in a 50x50x38cm opaque Perspex box with a 16 12.5x12.5 
cm grid on the base. Mice were gently placed in the central square and allowed to freely 
explore the box. Behaviour was recorded for 15 minutes. The test was repeated on the 
following day as this allows one to assess novel environment exploration on the first test and 
habituation on the second. Ambulatory measurements were made by measuring entrance 
into a new square on the grid. A mouse was considered to have entered a new square when 




2.3.4.2 Y maze 
Spontaneous alternation test was carried out in a Perspex Y maze with 35cm long arms, 
5cm in width and 10cm high. The mouse was gently placed in the centre of the maze and 
allowed to move through the maze freely for 10 minutes. Mice with intact spatial and working 
memory show a preference to explore a less recently visited arm. This can be quantified by 
calculating the percentage of spontaneous alternation which is the number of successful 
triads (i.e. each of the 3 arms entered in turn) divided by the total number of possible triads 
(Miedel et al., 2017). A mouse was considered to have entered an arm of the maze if all 4 
paws passed the boundary point.  
2.4 DNA extraction and analysis 
2.4.1 DNA extraction from cells and tissue 
Cell pellets from tissue and cell lines were resuspended in 1 ml of DNA lysis buffer (10mM 
Tris pH8.0; 100mM NaCl; 10mM EDTA pH8.0; 0.5% SDS) and 5 µl of 20 mg/ml proteinase K 
(ThermoFisher Scientific). Samples were placed in a thermo-shaker at 55 oC, 1000 rpm 
overnight. Following this, samples were brought to room temperature and 2 µl of RNase 
cocktail (Ambion) added. They were then incubated in a thermo-shaker 37 oC, 1000 rpm for 
30 minutes. An equal volume of Ultrapure Phenol:Chloroform:Isoamyl Alcohol (PCI, 25:24:1 
v/v, Invitrogen) was then added to each sample which was vigorously shaken and 
centrifuged at 16,000 xg at 4 oC for 10 minutes to separate the aqueous phase containing 
the DNA from the organic phase containing protein and cell debris. The aqueous phase was 
then transferred to a new vial and the PCI extraction process repeated. An equal volume of 
chloroform was then added to the aqueous phase to remove phenol residues, vigorously 
shaken and centrifuged at 16,000 x g at 4 oC for 10 minutes before the aqueous phase was 
transferred to a fresh vial. To this vial 2.5x volume of 100% ice-cold ethanol and 1/10 volume 
of 3M sodium acetate was then added, and the sample was placed at -20 oC for a minimum 
of 2 hours to allow the DNA to precipitate. Samples were then centrifuged at 16,000 x g at 4 
oC for 5 minutes to aggregate a DNA pellet. Supernatant was removed and the pellet 
carefully washed in 70% ethanol before being centrifuged again at 16,000 x g at 4 oC for 5 
minutes. The supernatant was removed and the DNA pellet air dried before resuspension in 
TE buffer (100mM Tris pH8.0, 10mM EDTA pH8.0), or mass spectrometry grade water 
(Sigma) and stored at -20 oC. The concentration and purity of nucleic acids were measured 
using a Nanodrop ND-1000 spectrophotometer. 
2.4.2 Gel electrophoresis 
UltraPure agarose (Invitrogen) gels were made using 1xTBE (Tris/Borate/EDTA) or 1xTAE 
(Tris/Acetic acid/EDTA) with the addition of 1 µg/ml ethidium bromide to resolve nucleic 
acids. DNA samples were loaded using 1x Orange G loading buffer (50% glycerol v/v, 5mM 
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EDTA pH8.0, 0.3% orange G w/v). RNA samples were loaded with 2x RNA loading dye 
(ThermoFisher Scientific) following a 2 minute incubation at 80 oC. The size of the nucleic 
acid fragments was determined using GeneRuler DNA ladder mix (ThermoFisher Scientific) 
for DNA or RiboRuler (ThermoFisher Scientific) for RNA. Gels were visualized using a UV 
trans-illuminator or a FLA-5100 phosphoimager (Fuji). 
2.4.3 Restriction digests 
For digestion by restriction enzymes, 750 ng of DNA was added to a solution containing 10 
units of restriction enzyme (either methylation sensitive HpyCH4IV (NEB) or methylation 
insensitive MSPI (NEB)) and 1.5 µl of CutSmart buffer (NEB) in a 15 µl reaction. This 
reaction was incubated at 37 oC for 90 minutes. The digested DNA was then resolved on a 
1.5% agarose-TBE gel, run at 100 volts for 1.5 hours, and post stained in a 1 µg/ml ethidium 
bromide solution and rinsed in dH2O. Imaging of the gel was carried out on a FLA-5100 
phosphoimager (Fuji). 
2.4.4 Liquid chromatography mass spectrometry 
Liquid chromatography mass spectrometry (LC-MS) was used to determine global 5mC 
levels. LC-MS is considered the gold-standard technique for quantifying global DNA 
methylation levels (Chowdhury et al., 2017). In this method, modified and unmodified 
cytosine bases can be separated according to their size and charge and then quantified. 
1 µg of DNA was hydrolysed to single nucleotides with 10 units DNA Degradase Plus (Zymo 
Research) and 2.5 µl DNA degradase buffer (Zymo Research) in a 25 µl reaction with mass 
spectrometry grade water. Samples were incubated at 37 oC for 2 hours, then the enzyme 
was heat inactivated by incubation at 70 oC for 20 minutes. Samples were then centrifuged at 
16,000 xg for 15 minutes. The upper 10 µl of solution was transferred to a fresh tube leaving 
behind the enzyme spun down to the bottom of the vial. To this fresh tube was added 100 µl 
mass spectrometry grade methanol and 60 µl mass spectrometry grade acetonitrile (Sigma). 
Samples were then centrifuged at 16,000 x g for 5 minutes, the upper 30 µl of supernatant 
transferred to mass spectrometry glass vials and submitted to the IGMM mass spectrometry 
facility. Standards for unmodified cytosine, 5mC and 5hmC were ran alongside the samples 
for comparison.  LC-MS was performed by Jimi Wills.  
For liquid chromatography, samples were separated on a SeQuant ZIC-pHILIC column using 
a Thermo UltiMate 3000 BioRS with a flow rate of 0.3ml/min and a gradient of 90% to 5% 
acetonitrile in 10 minutes. Eluting peptides were analysed on a Thermo Q Exactive in 
negative mode, scanning from 300 to 350 m/z at resolution 70k. AGC target was set to 3 x 
106 and maximum ion injection time 500 ms. 
Data was analysed using the Xcaliber programme. Levels of 5mC were taken as a 
percentage of total cytosines (i.e. unmodified, methylated and hydroxymethylated).   
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2.4.5 Bisulphite sequencing 
Bisulphite sequencing was employed to quantify DNA methylation at particular sites. 
Bisulphite treatment of DNA converts unmodified cytosines to uracil whilst not affecting 
methylated cytosines. Following PCR amplification and sequencing, converted uracils will be 
recognised as thymines allowing their distinction from modified cytosines which will remain 
as cytosine on sequencing. I used this method to quantify DNA methylation at major satellite 
repeats in ESCs and NPCs. 
500 ng of DNA was bisulphite treated using EZ DNA Methylation-Lightening kit (Zymo 
Research) according to the manufacturer’s instructions. Each sample was made up to 20 µl 
with dH2O and 130 µl lightening conversion reagent added. Samples were then incubated at 
98 oC for 8 minutes then 54 oC for 1 hour. 600 µl M-binding buffer was added to a spin 
column and the sample was then loaded and mixed by inversion. Columns were then 
centrifuged at 16,000 x g for 30 seconds. Flow through was discarded and 100 µl M-wash 
buffer was added to the column. Columns were again centrifuged at 16,000 x g for 30 
seconds and 200 µl of L-desulphonation buffer was added to the column and allowed to 
stand at room temperature for 15 minutes. Samples were spun for 30 seconds, 200 µl of 
wash buffer was added and centrifugation repeated. This wash step was repeated. The 
column was then placed onto a collection tube, 10 µl of M-elution buffer added and the 
sample centrifuged. The eluted DNA was stored at -80 oC. 
PCR amplification of the major satellite region of interest was carried out as below. Major 
satellite primers were taken from Dunican et al (Dunican et al., 2013). 
PCR reaction: 
 1.5 µl bisulphite treated DNA 
 2.5 µl forward and reverse primer mix (10 µM of each primer, see Table 2.2 for 
sequence) 
 5 µl 10x PCR buffer (Invitrogen) 
 5 µl 2mM dNTP mix 
 1.5 µl Mg2+ (Invitrogen) 
 0.5 µl Taq polymerase (Invitrogen) 
 34 µl dH20 
Reactions were placed in a thermal cycler at 94 oC  for 3 minutes followed by 39 cycles at 94 
oC  for 45 seconds, 57 oC  for 30 seconds and finally 72 oC  for 30 seconds. 
DNA was precipitated by the addition of 5 µl 3M sodium acetate, 1 µl glycogen and 138 µl 
ice cold 100% ethanol and stored at -20 oC for 30 minutes. Following centrifugation at 16,000 
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x g for 10 minutes at 4 oC, the DNA pellet was washed in 70% ethanol, centrifuged and air 
dried before being resuspended in 6 µl dH2O. 
The PCR products were then resolved on a 1.5% TAE gel with ethidium bromide, ran at 100 
V for 1 hour. Bands were visualised using a Safe Imager Trans illuminator (Invitrogen). PCR 
products of the expected size (360bp) were cut from the gel using a scalpel. DNA was 
extracted from the agarose using the QIAquick Gel Extraction Kit (Qiagen) according to the 
manufacturer’s instructions: Gel sample weight was measured and 300 µl of buffer QG per 
100 mg of gel was added. The sample was then incubated at 50 oC for 10 minutes in a 
thermo-shaker until the gel dissolved. 100 µl of isopropanol per 100 mg of gel was then 
added and the solution placed in a quick spin column and centrifuged at 16,000 x g for 1 
minute. Flow through was discarded and 500 µl buffer QG added to the column and 
centrifuged again. 750 µl of wash buffer PE was then added and allowed to stand for 5 
minutes before centrifugation. The spin column was then placed in a collection tube and 50 
µl of buffer EB added to column. This was allowed to stand at room temperature for 1 minute 
before centrifugation and collection of the eluted DNA. 
PCR products were cloned into the pGEM-T Easy vector (Promega). This is a linearized 
vector with a thymidine overhangs. PCR products generated with Taq polymerase leave 
adenosine overhangs thereby improving the efficiency of the ligation as the DNA has 
something to “stick” to. 
Ligation reactions were set up with an insert to vector ratio of 3:1. Appropriate volume of 
insert was added to the reaction containing 5 µl 2x rapid ligation buffer, 1 µl PGEM T Easy, 2 
µl DNA ligase, and made up to a 10 µl reaction with dH20. This was incubated at 4 oC 
overnight. Control experiments were set up using the supplied Control Insert DNA as a 
positive control and as a negative control no DNA was added to the ligation reaction. 
Ligations were then transformed into library efficient DH5α competent Escherichia Coli cells 
(Invitrogen). 1 µl of ligated DNA was added to 40 µl of competent cells and incubated on ice 
for 30 minutes. Samples were then heat shocked in a 42 oC water bath for 45 seconds and 
immediately placed back on ice for 5 minutes. 500 µl of SOC media was added to each 
transformation and placed in a shaking incubator at 37 oC, 200 rpm for 1 hour. One third of 
each mixture was then aseptically spread onto L-AMP plates (L-agar plates containing 50 
µg/ml ampicillin) which had been spread with 80 µl of 20 mg/ml X-gal (Sigma) and allowed to 
air dry prior to use. Inverted plates were then incubated at 37 oC to allow bacterial colony 
growth. 
The pGEM-T Easy vector also encodes β-galactosidase. Successful cloning of an insert into 
the vector disrupts the sequence of this gene. β-galactosidase cleaves X-gal to form 5-
bromo-4-chloro-indoxyl, which then oxidizes to form 5,5’-dibromo-4,4’-dichloro-indigo, which 
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appears bright blue in colour. This allows the identification of colonies containing an insert 
which appear white, whilst colonies lacking an insert will appear blue. The white colonies 
were then picked and transferred to a 96-well mini-prep plate, each well containing 1ml 
Luria-Bertani culture broth with 50 µg/ml ampicillin. Plates were placed in a shaking 
incubator set at 200 rpm, 37 oC overnight to allow colony expansion. 
HGU technical services then isolated plasmid DNA and carried out Sanger sequencing. 
pGEM-T Easy vectors also contain T7 and Sp6 RNA polymerase promoters flanking the 
cloning region therefore Sanger sequencing was performed using T7 and Sp6 primers. This 
was done using the BigDye Terminator V3.1 sequencing kit, and samples were run on an 
ABI Prism 3720 genetic analyser. Sequences were then aligned to a reference sequence for 
the major satellite region and analysed using the BioEdit Sequence Alignment Editor V7.2.5. 
Methylation status of each CpG was assessed to create bisulphite plots.  
2.5 Protein extraction and analysis 
2.5.1 Protein extraction and quantification  
For protein extraction, cell pellets were lysed in 200 µl of Pierce RIPA solution 
(ThermoFisher Scientific) with 1x phosphatase inhibitor solution (ThermoFisher Scientific) 
and 1x protease inhibitor cocktail (Sigma). Samples were pipetted multiple times to ensure 
cell lysis and incubated on ice for 10 minutes. 1 µl of benzonase (Sigma) was then added in 
order to degrade nucleic acids and samples incubated on ice for a further 30 minutes. To 
optimise cell lysis, samples were then sonicated in a Diagenode Bioruptor at 4 oC on high for 
10 cycles at 30 seconds on/30 seconds off. To separate protein from cell debris 
centrifugation was done at 4 oC, 16,000 x g for 20 minutes. Supernatant was transferred to a 
fresh vial and stored at -20 oC. 
Protein was quantified using the Pierce BCA protein assay kit according to manufacturer’s 
instructions (ThermoFisher Scientific). Samples were diluted 1 in 5 and measured in triplicate 
in a 96 well flat bottomed plate. Kit standards were used to generate a standard curve. 
Plates were read using a Multiskan GO Microplate Spectrophotometer at 562 nm 
(ThermoFisher Scientific). 
2.5.2 Western blotting 
For western analysis, Laemmli buffer was prepared as follows: 
 1.2 g SDS 
 4.7 ml glycerol 
 1.2 ml Tris 0.5M pH 6.8 
 2.1 ml dH2O 
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This mixture was then rotated at 50 oC for 30 minutes before the addition of 0.93 g 
Dithiothretiol and 6 mg bromophenol blue 
2 µl Laemmli buffer was added to a 50 µg protein sample, made up to a 10 µl solution with 
dH2O, and incubated at 70 oC for 3 minutes before being placed directly on ice. Protein was 
then loaded onto a NuPAGE 10% Bis-Tris protein gel (Invitrogen) along with PageRuler 
protein ladder (Invitrogen) for determination of band size. Gels were run with 1xNuPAGE 
MOPS SDS running buffer (Invitrogen) at 150 V for 1 hour.  
After separation, the proteins were transferred onto a nitrocellulose membrane using the 
iBlot system (Invitrogen) using P0 template which runs at 20 V for 1 minute, 23 V for 4 
minutes and 25 V for 2 minutes. Membranes were then incubated in Western Blocking 
Reagent (Roche) overnight at 4 oC. 
Primary antibodies were diluted in block solution (α-HELLS (Proteintech 11955-1-AP) at 
1:500 or α-β-TUBULIN (Abcam ab6046) at 1:1000). Membranes were incubated in primary 
antibody solution for 90 minutes at room temperature and then washed 3x10 minutes in 
wash solution (1xTBS with 0.1% Tween-20) on a rocking platform. Secondary antibodies 
were diluted in block solution (α-rabbit or α-mouse IgG- HRP-conjugate (Sigma) at 
1:10,000). Membranes were then incubated in secondary antibody solution for 90 minutes at 
room temperature and then washed 3 x 10 minutes in wash solution. Membranes were then 
incubated with SuperSignal Western Pico Chemi Luminescence Reagent (Pierce) for 5 
minutes in the dark and developed using ECL Hyperfilm (Amersham) and an X-ray 
processor.   
2.6 RNA extraction and analysis 
2.6.1 RNA extraction 
For RNA extraction cell pellets were reconstituted in 1 ml TRIzol Reagent (Life technologies), 
mixed well by pipetting 20-30 times and incubated at room temperature for 5 minutes. 200 µl 
of chloroform was then added to each sample, shook vigorously and incubated at room 
temperature for 2 minutes. Separation of aqueous and organic phases was then achieved by 
centrifugation at 16,000 x g for 15 minutes at 4 oC. The aqueous phase was then transferred 
into a fresh vial and 500 µl of isopropanol was added. Samples were gently inverted 10 
times, incubated for 10 minutes at room temperature and then centrifuged at 16,000 x g at 4 
oC for 10 minutes. Supernatant was removed taking care not to disturb the pellet which was 
then washed in 1 ml of 70% ethanol. Samples were then centrifuged at 16,000 x g at 4 oC for 
5 minutes, supernatant removed and the pellet allowed to air-dry for 5minutes. RNA was 
then resuspended in nuclease free water.  
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RNA samples underwent treatment with DNase to remove any contaminating DNA using 
RQ1 RNase-free DNase kit (Promega) as per manufacturer’s instructions. The DNase 
reaction was set up with 10 µg RNA, 1 µl 10x RQ1 RNase-free DNase reaction buffer, 1 unit 
RQ1 RNase-free DNase made up to 10 µl reaction with dH20. Reactions were then 
incubated at 37 oC for 30 minutes. 1 µl of RQ1 DNase Stop Solution was added and sample 
incubated at 65 oC for 10 minutes to inactivate the DNase. Integrity was determined by gel 
electrophoresis. Intact RNA shows sharp 28S and 18S rRNA bands in a 2:1 ratio. Degraded 
RNA will not have these sharp bands and will have a smeared appearance. RNA was stored 
at -80 oC. 
 2.6.2 Preparation of cDNA 
1 µg of total RNA was used as a template to generate complementary DNA (cDNA) using 
the SuperScript III kit (Invitrogen) as per manufacturer’s instructions. The reaction was set up 
as follows: 
 1 µg of total RNA 
 1 µl Random Primers (Promega) 
 1 µl 10 mM dNTP mix (Invitrogen) 
 made up to 13 µl with dH2O 
Samples were incubated at 65 oC for 5 minutes and then placed on ice. To each sample was 
added: 
 200 units SuperScript III 
 4 µl 5x First Strand buffer 
 1 µl 0.1M DTT 
 1 µl RNaseIn (Promega) 
Negative controls were also set up without the addition of the reverse transcriptase enzyme 
to control for the presence of genomic DNA in qRT-PCR experiments. Samples were then 
incubated at 25 oC for 5 minutes, 50 oC for 1 hour and the reverse transcriptase enzyme was 
then inactivated at 70 oC for 15 minutes. cDNA was stored at -20 oc. 
2.6.3 qPCR 
Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to 
determine gene transcript levels using cDNA. Primers used were either in house or designed 
using the Primer-BLAST tool (Ye et al., 2012). Primers were designed to span an exon-exon 
junction and give an annealing temperature of 60 oC and product less than 300bp in length. 
Products were screened by gel electrophoresis for the formation of multiple bands or small 
bands indicating primer-dimer formation. Details of primers used are listed in Table 2.2. In 
neurodifferentiation experiments primers for lineage markers specific to each stage of 
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neurodifferentiation were chosen. Namely Sox1 was selected as the earliest 
neuroectodermal marker, Nestin as a neural progenitor cell marker and Tuj1 as a postmitotic 
neural marker. Nanog was selected as a pluripotency marker to detect undifferentiated ES 
cells. To detect differentiation to non-neural lineages Gata6 was used as an endodermal 
marker and Snail as a marker of mesodermal lineage. 
 
In chapter 5 primers were designed for selected immune response genes as follows; Irf7 was 
selected as it is a key transcription factor involved in the activation of viral inducible genes. 
Ccl3 and Ccl4 were selected as chemokines which have been shown to play a role in virally 
induced neurological conditions such as HIV dementia (Levine et al., 2009; Olivier et al., 
2018). Casp4 was selected as it plays a role in an active inflammatory response cleaving 
precursors of inflammatory cytokines. 
 
Reactions were performed in 96 well plates containing: 
 1 µl cDNA (diluted 1:25 in dH2O) 
 1x SYBR Select Master Mix (Thermo Fisher Scientific) 
 2.8 µl forward and reverse primer mix (2.5 µM of each primer) 
 3.2 µl dH2O  
PCR was carried out using the LightCyler 480 System 11 (Roche). Samples were heated at 
95 oC for 2 minutes and then underwent 50 cycles at 95 oC for 15 seconds and 60 oC for 1 
minute. 
Expression was calculated using the relative standard curve method (Cikos et al., 2007). A 
standard curve was generated from serial dilution of a cDNA sample from cells or tissue 
where the gene was suitably expressed. Results were normalised to housekeeping gene, 





Application Sequence (5’-3’) 
Nanog cDNA F:  CCTCCAGCAGATGCAAGAA 
R: GCTTGCACTTCATCCTTTGG 
Sox1 cDNA F: GCAGCGTTTCCGTGACTTTAT 
R: GGCAGAACCACAGGAAAGAAA 




Tuj cDNA F: AGCGATGAGCACGGCATAG 
R: CAGGTTCCAAGTCCACCAGA 
Gata6 cDNA F: GGTCTCCTACAGCAAGATGAATGG 
R: TGGCACAGGACAGTCCAAG 
Snail cDNA F: GTCTGCACGACCTGTGGAA 
R: CAGGAGAATGGCTTCTCACC 
Gfap cDNA F:CGGCGATAGTCGTTAGCTTC 
R:GCACTCAATACGAGGCAGTG 
β-actin cDNA F:AGAGCTATGAGCTGCCTGACG 
R:TGTGTTGGCATAGAGGTCTTTACG 
Gapdh cDNA F:GGTCCTCAGTGTAGCCCAAG 
R:ACCCAGAAGACTGTGGATGG 
5’IAP LTR cDNA F:GATGGTGCTGACATCCTGTG 
R:CTGACGTTCACGGGAAAAAC 
MAJ sat cDNA F:AAATACACACTTTAGGACG 
R:TCAAGTGGATGTTTCTCATT 




L1-5’UTR cDNA F:AATCTGTCTCCCAGGTCTGC 
R:CCTTTCGCCATCTGGTAATC 
L1 ORF cDNA F:ATCCAGGAAATCCAGGAC 
R:TTTGCTGGACCTTTGAGTTG 
HoxA5 cDNA F:CTCATTTTGCGGTCGCTATCC 
R:ATCCATGCCATTGTAGCCGTA 
HoxB5 cDNA F:CCTGCACTAACGGCGACAG 
R:TGGCCTCGTCTATTTCGGTGA 
HoxC5 cDNA F:TCCCTGCCTATAACATGCAAAC 
R:CAATCCGCCGTAGCAGTACC 







β-actin DNA F:GGCTGCAAAGAGTCTACACC 
R:TCACTCAGAACGGACACCAT 
HoxC9 DNA F:TCAGTCTGGGCTCCAAAGTC 
R:AGAGGTAGCCTCCCCAGAAC 




Casp4 cDNA F:AGCGTTGGGTTTTTGTAGATGC 
R:CCTTGTGAACTCTTCAGGGGA 
Irf7 cDNA F:GCGTACCCTGGAAGCATTTC 
R:GCACAGCGGAAGTTGGTCT 
Ccl3 cDNA F:TGTACCATGACACTCTGCAAC 
R:CAACGATGAATTGGCGTGGAA 
Table 2.2. Primer Sequences 
 
Bisulphite primers used were taken from Dunican et al (Dunican et al., 2013). Primers were 
designed to target mouse major satellite GenBank: EF028077 at chr9: 3,017,919-3,024,581. 
This 6kb region is made of repetitive units with the primers targeting a sequence in these 
units containing 3 CpGs as highlighted in figure 2.5.  
 
Figure 2.5. Map of bisulphite primers. Diagram displays primer positions on major 
satellites. Black and grey triangles indicate primer pairs. CpGs are indicated. 
 
2.7 Next generation sequencing experiments 
2.7.1 RNA-Seq 
The transcriptomes of cell and mouse models were analysed using RNA-Sequencing. Before 
library preparation the integrity of the extracted RNA was determined using the Bioanalyzer 
6000 Nano Chip (Agilent) by HGU technical services. RNA was considered fit for use if it had 
a RIN score ≥ 8. Three biological replicates for each condition were sequenced. 
I enriched for polyadenylated mRNA and prepared sequencing libraries using the NEBNext 
Poly(A) mRNA Magnetic Isolation Protocol Kit (E7490), the NEBNext Ultra Directional RNA 
Library Prep kit for Illumina (E7420s) and NEBNext Multiplex Oligos for Illumina (E7335s) 
according to the manufacturer’s instructions: 
mRNA isolation, fragmentation and priming 
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mRNA was isolated by mixing total RNA with poly (T) oligomers covalently attached to 
magnetic beads. 
20 µl Oligo d (T) 25 beads were washed twice in 100 µl 2x RNA binding buffer and placed on 
a magnetic rack to remove supernatant. Beads were then resuspended in 50 µl 2x RNA 
binding buffer and 1 µg total RNA, made up to 50 µl with nuclease free water, was added to 
the beads. Samples were incubated at 65 oC for 5 minutes and then cooled to 4 oC. Beads 
were resuspended and then incubated at room temperature for 10 minutes with gentle 
mixing half way through. Supernatant was removed and beads washed twice in 200 µl of 
wash buffer. After removal of supernatant 50 µl of Tris buffer was then added and incubated 
at 80 oC for 2 minutes and cooled to 25 oC. 50 µl 2x RNA binding buffer was added to the 
sample and it was incubated at room temperature for 5 minutes before removal of 
supernatant. Beads were then washed in 200 µl of wash buffer. mRNA was eluted from the 
beads following the addition of 6.2 µl 5x NEBNext first strand synthesis buffer, 1.55 µl 
NEBNext random primers and 7.75 µl nuclease free water. Samples were incubated at 94 oC 
for 15 minutes. 13.5 µl of eluted mRNA was transferred to a fresh PCR tube and placed on 
ice. 
First strand cDNA synthesis 
To the sample was added the following: 
 0.5 µl  murine RNAse inhibitor 
 1 µl protoscript II  reverse transcriptase 
 5 µl Actinomycin D (0.1 µg/ ul) 
Samples were then placed in a thermal cycler at 25 oC for 10 minutes, 42 oC for 15 minutes, 
70 oC for 15 minutes and then cooled to 4 oC. 
Second strand cDNA synthesis 
To the sample was added the following 
 8 µl 10x second strand synthesis reaction buffer 
 4 µl second strand synthesis enzyme mix 
 48 µl nuclease free water 
Samples were then incubated at 16 oC for 1 hour. 
Purification of ds cDNA 
144 µl AMPure XP beads was then added to the reaction and incubated at room 
temperature for 5 minutes. Supernatant was discarded and beads washed in 200 µl 80% 
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ethanol. This wash step was repeated and beads allowed to air dry. DNA was eluted from 
the beads with the addition of 60 µl 0.1xTE and stored overnight at -20 oC. 
Library Preparation 
End preparation of cDNA library 
To the sample was added 6.5 µl of 10x NEBNext end repair reaction buffer and 3 µl 
NEBNext end prep enzyme mix. Samples were then incubated at 20 oC for 30 minutes, 65 oC 
for 30 minutes and cooled to 4 oC. 
Adaptor ligation 
To each sample was then added 15 µl blunt/TA ligase master mix and 1 µl NEBNext adaptor 
diluted 1:9 with nuclease free water and 2.5 µl nuclease free water. Solution was incubated 
at 20 oC for 15 minutes. 3 µl of USER enzyme was then added and incubated at 37 oC for 15 
minutes. 
Purification of ligation reaction 
Each reaction was made up to 100 µl with nuclease free water and 100 µl of AMPure XP 
beads added. Samples were then incubated at room temperature for 5 minutes. Samples 
were placed on a magnetic rack, supernatant discarded, and beads washed in 200 µl 80% 
ethanol. This wash step was repeated and samples then air dried. DNA was eluted from 
beads with 52 µl 0.1 X TE and transferred to a clean tube. To this was added 50 µl AMPure 
XP beads and the whole process repeated with a final elution volume of 20 µl. 
PCR enrichment 
To the sample was added 2.5 µl NEBNext Q5 hot start HIFI PCR master mix, 2.5 µl 
universal primer and 2.5 µl of index primer. Samples then went into a thermal cycler with the 
following cycling conditions: 98 oC for 30 seconds followed by 13 cycles of 98 oC for 10 
seconds, 65 oC for 75 seconds followed by 65 oC for 5 minutes. 
Purification of PCR reaction 
45 µl AMPure XP beads were then added to each 50 µl PCR reaction and incubated at room 
temperature for 5 minutes. Tubes were then placed on a magnetic rack and supernatant 
removed. Beads were then washed in 200 µl of 80% ethanol and beads air dried. DNA was 
the eluted in 20 µl 0.1xTE and stored at -20 oC. 
Resulting libraries were quality checked and quantified by HGU technical services using an 
Agilent Bioanalyser high sensitivity chip. Samples were then pooled and sequenced by 





Enhanced reduced representation bisulphite sequencing was employed to generate 
genome-wide DNA methylation profiles. 250 ng of genomic DNA was sent to the 
Epigenomics Core Facility of Weill Cornell Medicine, New York where libraries were 
generated using their in-house protocol and sequenced using the Illumina CASAVA 1.8.2 
pipeline (Garrett-Bakelman et al., 2015). One replicate for each condition was sent. 
2.7.3 ChIP-seq 
Cross-linked chromatin immunoprecipitation followed by sequencing was utilised to map 
H3K27me3 genome-wide. This is done by chemically cross-linking proteins bound to the 
DNA with formaldehyde. The cells are then lysed and chromatin fragmented by sonication 
and an antibody against H3K27me3 is then used to pull down the regions of bound DNA. 
Solutions used in experiments are detailed in Table 2.3. 
 
LB1 50 mM Hepes KOH pH7.9 
140 mM NaCl 
1 mM EDTA 
10% glycerol 
0.5% IPEGAL 
0.25% Triton X-100 
1xComplete EDTA-free protease inhibitor 
tablet (Roche) 
LB2 10 mM TrisHcl pH8 
200 mM NaCl 
1 mM EDTA 
0.5 mM EGTA 
1xComplete EDTA-free protease inhibitor 
tablet (Roche) 
LB3 10 mM TrisHCl Ph8 
100 mM NaCl 
1 mM EDTA 
0.5 mM EGTA 
0.1% Na Deoxycholate 
0.5% LaurylSulphate 
1xComplete EDTA-free protease inhibitor 
tablet (Roche) 
Chip Dilution Buffer 1% Triton X-100100 
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1 mM EDTA 
20 mM TrisHcl pH8 
150 mM NaCl 
1xComplete EDTA-free protease inhibitor 
tablet (Roche) 
Block Solution 1xPBS 
0.5% BSA  
1xComplete EDTA-free protease inhibitor 
tablet (Roche) 
Low salt buffer 0.1% SDS 
1% Triton X-100100 
2 mM EDTA 
20 mM TrisHcl pH8 
150 mM NaCl  
High salt buffer 0.1%SDS 
1% Triton X-100100 
2 mM EDTA 
20 mM TrisHcl pH8 
500 mM NaCl 
LiCl buffer 0.25 M LiCl 
1% IPEGAL 
1% NaDeoxycholate 
1 mM EDTA 
10 mMTrisHCl pH8 
Elution Buffer 0.1 M NaHCO3 
1% SDS 
Table 2.3. Solutions used in ChIP experiments. 
For each sample 9x106 cells were harvested by trypsinisation and rinsed well in 1xPBS 
before being resuspended in 1.5 ml of PBS. Each sample was fixed with the addition of 40.5 
µl of 37% formaldehyde (Sigma) and incubated for 10 minutes at room temperature on 
rotation. 225 µl of 1M glycine was added to quench the formaldehyde and rotated at room 
temperature for 5 minutes. Samples were then centrifuged at 300 x g for 4 minutes at 4 oC, 
supernatant discarded and pellets resuspended in 2 ml LB1 solution and rotated at 4 oC for 4 
minutes. This process was repeated resuspending in 2 ml LB2 solution and then repeated 
resuspending in 200 µl LB3. 
Chromatin was then sheared at 4 oC using a Diagenode bioruptor set on high for 45 cycles at 
30seconds on/ 30seconds off. 20 µl of 10% Triton X-100 in LB3 was then added to each 
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sample and mixed by inversion. Samples were then centrifuged at 16,000 x g at 4 oC for 10 
minutes to remove nuclear debris and supernatant transferred to a fresh tube. 
In order to check the efficiency of the sonication process, 8 µl of sheared chromatin was 
taken, mixed with 1 µl 5M NaCl and 16 µl dH2O, incubated at 98 oC for 15 minutes and 
treated with RNase cocktail before being purified with Qiagen PCR Clean up kit as per 
manufacturer’s instructions . Sheared chromatin was then resolved on a 1.5% agarose gel 
post-stained with EtBr. The DNA smear should be between 100-500bp with a peak at 250-
300bp. 
For immunoprecipitation, 25 µl of Protein G Dynabeads (Novex Lifetech) were added to fresh 
tubes and washed 3 times in block solution and then resuspended in 500 µl of block. Beads 
were then incubated with 5 µl of antibody (H3K27me3 (Millipore 07449), IgG (Santa Cruz 
Biotech sc-2027)) and incubated at 4 oC for 4 hours on a rotator. Beads were then washed 3 
times in 500 µl block solution and supernatant removed. 
210 µl of sheared chromatin was mixed with 1890 µl of chip dilution buffer. 10% of this mix 
was stored at 4 oC and labelled as “input” samples. 1ml of the solution was added to the 
antibody bound beads and incubated at 4 oC on rotation overnight. 
Supernatant was then removed from beads and they were washed at 4 oC in a series of 
steps with 1ml low salt buffer, 1ml high salt buffer, 1ml LiCl buffer, 1ml TE and again with 
1ml TE. Beads were then resuspended in 100 µl elution buffer before being shook at 
maximum rpm in a thermomixer at room temperature for 30 minutes. Supernatant was then 
transferred to fresh tubes. To these samples, and to the input samples was added 4 µl 5M 
NaCl and samples incubated at 65 oC for 3 hours. 2 µl RNase cocktail was then added and 
reactions incubated at 65 oC for 90 minutes. 1 µl proteinase k 20 mg/ml was added and 
reactions incubated at 45 oC for 1 hour. Samples were then purified using Qiagen minelute 
kit as per manufacturer’s instructions. 
DNA was quantified using Quibit and 3 ng of DNA was then used for preparation of ChIP-
Seq libraries using NEBNExt Ultra DNA Library Prep kit for Illumina (E7370) and NEBNExt 
Multiplex Oligos for Illumina (E7335) as previously described in section 2.7.1. 
Sample quality check and quantification was carried out using an Agilent Bioanalyser high 
sensitivity chip by HGU technical services. Samples were pooled and sequenced by 
Edinburgh Genomics using Illumina HiSeq 4000 75bp paired-end reads. One replicate for 





2.8 Bioinformatic analyses and statistics 
For the majority of analyses described in this section the R programming language 
(http://www.r-project.org/) version 3.4.4 and its associated packages (https://cran.r-
project.org/) were used. 
Where sample size was large and one could not assume a normal distribution the non-
parametric Wilcoxon-Rank-Sum test in R was used to test the null hypothesis. For 
comparisons between a small number of samples or when normality could be assumed a 
Student T-test in Microsoft Excel was used to test the null hypothesis. Bar plots and line 
graphs were generated in Excel. Scatter plots, boxplots, violin plots and volcano plots were 
generated in R. Hypergeometric testing of overlapping gene lists was performed using R 
phyper. For comparisons between bisulphite samples the exact binomial test in R was used. 
Gene ontology analysis was performed using the biological processes tool of DAVID version 
6.8 (https://david.ncifcrf.gov/). This programme uses the Fisher Exact test to measure the 
gene-enrichment in annotation terms between a user supplied gene list and the genome 
background. The online tool, Interferome version 2.01 (http://www.interferome.org/) was 
used to search for interferon responsive genes within gene lists. 
The Mus musculus mm9 build from the UCSC browser was used to map all reads from next 
generation sequencing experiments and genomic annotations were taken from this build by 
downloading the RefGene and RepeatMasker tables (http://genome.ucsc.edu/cgi-
bin/hgTables).  
I am very grateful to Dr Donncha Dunican for carrying out all bioinformatic processing and 
analysis from the next generation sequencing experiments described below. For all 
experiments, paired-end sequence read sanfastq output files returned from Edinburgh 
Genomics and Weill Cornell Medicine were used. The FastQC V0.11.4 
(https://www.bioinformatics.babraham.ac.uk/projects/fastqc/) was then used to test for 
sequence read quality. Trim Galore! V0.4.1 
(https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) was then used to remove 
adaptor sequences and sequences with PHRED quality scores <20. PCA plots from RNA-
seq and CHIP-seq experiments are in Appendix Figure A4. These demonstrate that variance 
is due mainly to cell type and secondarily to genotype. They also reveal no gross outliers 
between biological replicates. 
2.8.1 RNA-Seq Analysis 
For RNA-Seq experiments, results are from three biological replicates. After initial 
bioinformatic processing described above, paired reads were then aligned to the mm9 
genome using TopHat V2.1.0 (http://tophat.cbcb.umd.edu/).  The HTSeq count tool V0.71 
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(https://htseq.readthedocs.io/) was then used to determine raw counts over mapped 
sequences and converted into an EdgeR object. The EdgeR programme V 3.12.1 
(http://www.bioconductor.org/packages/2.11/bioc/html/edgeR.html) was then used to 
normalise read counts and determine differential gene expression. Genes with a read depth 
< 10 were filtered out. Transcripts were considered differentially expressed if they had a 
greater than 2 fold change and P value <0.05.  
For repeat data only those reads with a MAPQ score of 50 were included in the analysis 
indicating the highest probablilty of uniquely mapped reads. Repeats with read depth <10 
were filtered out. Repeats were considered differentially expressed if they had a greater than 
4 fold change and FDR <0.05. Repeat expression was calculated under two different 
conditions. The first analysing reads mapping to full length annotated repeats i.e. “long” 
repeats defined as >6kb for LINE1s and LTRs and >1kb for satellites and the second 
analysing those mapping to non-full length i.e. “short” repeats.  
2.8.2 ERRBS Analysis 
Following initial processing as described above, ERRBS data was mapped to the mm9 
genome using the Bismark tool V0.16.3 
(http://www.bioinformatics.babraham.ac.uk/projects/bismark). The 
“bismark_methylation_extractor” script was used to extract methylation scores over 
individual CpGs. CpGs with a read depth <5 were filtered out. To determine methylation over 
promoter regions the average methylation across all CpGs spanning the +/- 2kb region 
across the TSS was calculated. For repeats, average methylation of CpGs mapping to long 
repeats of each class was calculated. A region was considered differentially methylated if it 
had a greater than 20% absolute methylation difference.  
2.8.3 ChIP-seq Analysis 
Following initial bioinformatic processing, ChIP data was aligned using Bowtie2 
(http://bowtie-bio.sourceforge.net/index.shtml). Again only reads with MAPQ score of 50 
were included in the analysis. HTSeq count tool was then used to determine raw counts. An 
in-house pipeline was then used. Data was normalised to library size. To calculate 
H3K27me3 over promoter regions, reads from 1kb windows, sliding by 200bp, across the +/- 
2kb region from the TSS were averaged. H3K27me3 across repeats was calculated as the 
number of reads mapping to an annotated “long” repeat. Regions with read depth < 10 were 
filtered out. Regions were considered to be differentially marked for H3K27me3 if there was 






Chapter 3. Lsh is required for DNA methylation 
during neurogenesis 
3.1 Introduction 
The requirement for Lsh to establish normal DNA methylation has been well recognised. 
Despite the fact that Lsh is highly expressed in the brain during development, there is an 
absence of research into its role specifically in the nervous system. Indeed, at the beginning 
of this project it was unknown if Lsh was required for appropriate DNA methylation during 
neurogenesis and if its presence was essential for normal neurogenesis. In this chapter I aim 
to address these questions, the importance of which became highly relevant with the recent 
discovery of Type 4 ICF syndrome caused by mutations in the human homolog of Lsh 
(Alghamdi et al., 2018; Thijssen et al., 2015).  
Early embryonic development can be modelled in vitro using embryonic stem cells derived 
from the ICM of the blastocyst. These are a pluripotent cell population that can then be 
induced to differentiate down discrete lineages. In order to demonstrate the requirement for 
Lsh during neurodevelopment I firstly optimised a cell differentiation system using N2B27 
media adapted from Pollard et al (Pollard et al., 2006) which favours neural differentiation. 
Traditional methods of neural cell derivation from ES cells have relied on generation of 
multicellular aggregates, which are then exposed to retinoic acid or grown in conditioned 
media, or co-culture with feeder cells (Bain et al., 1995; Kawasaki et al., 2000). However, the 
method I have adopted is a monolayer serum-free protocol. There are advantages to this as 
it relies on an autocrine induction mechanism where FGF signalling occurs in the absence of 
BMP4 signalling (Abranches et al., 2009). It therefore does not rely on unknown media 
components with unknown physiological relevance, or retinoic acid, which although an 
efficient inducer of neural differentiation, also induces neural progenitors to develop a more 
restricted posterior fate (Wichterle et al., 2002). Furthermore this rapid protocol allows direct 
observation of cell morphology and results in a higher yield of neural cells compared to other 
protocols (Cai and Grabel, 2007).  
I utilised this system to firstly determine whether ES cells lacking Lsh could differentiate 
normally down neural lineage. Other cell lines knocked out for key regulators of the 
methylation process have shown defects in this. For example, Dnmt1 KO ES cells undergo 
apoptosis when induced to differentiate (Jackson et al., 2004; Lei et al., 1996) and Dnmt1 
and Dnmt3a KO neural progenitor cells have accelerated glial differentiation at the expense 
of neuronal (Fan et al., 2005a; Wu et al., 2010; Wu et al., 2012). Secondly, I looked at the 
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requirement for Lsh in global DNA methylation in this system, and finally the effects of 
rescuing Lsh expression in the knockout cells. 
3.2 Results 
3.2.1 Characterisation of Lsh-/- mES cells 
Lsh knockout mES cells were generated by Dr Donncha Dunican using the CRISPR/Cas9 
gene editing system. E14 mES cells were transfected with Cas9 and a single guide RNA 
designed to target exon 1 of the Lsh gene. The clone I have used was shown to have a 
homozygous 25bp deletion in exon 1. I confirmed this line does not express LSH at the 
protein level via western blot (Figure 3.1). This line was used for all analyses, with wild type 
E14 mES cells (WT) as a control, henceforth this knockout cell line will be referred to as  
Lsh-/- .  
 
 
Figure 3.1. Lsh-/- mES cells do not express LSH at the protein level. Confirmation that 
Lsh-/- mES cells do not express LSH at the protein level is demonstrated by western blot 
analysis of protein extracts derived from WT and Lsh-/- mES cells using α-HELLS (human 
homologue of LSH) antibody and α- β-TUBULIN antibody as a loading control. 
 
The Lsh-/- cells displayed a slightly reduced growth rate, but similar morphology to WT cells 
(Figure 3.2 A & B), and importantly demonstrated comparable expression of the pluripotency 
marker Nanog as assessed by immunocytochemistry (Figure 3.2 C) and later by qRT-PCR 
(Figure 3.4 C). It should be noted that towards the end of this project an off-target mutation 







Figure 3.2. Characterisation of Lsh-/- mES cells. A. Growth rates of Lsh-/- and WT cells 
maintained in serum culture. Error bars represent the SEM of 3 replicates. B. WT and Lsh-/- 
ESCs show similar morphology. Scale bars represent 100 µm. C. Immunofluorescent images 
of WT and Lsh-/- ES cells using antibodies against the pluripotency marker NANOG. Nuclear 



























3.2.2 Lsh-/- cells show greater propensity for differentiation down neural lineage 
In order to induce neural differentiation, WT and Lsh-/-  ES cells were then put through an 
N2B27 differentiation protocol. To confirm differentiation and compare neurogenesis 
between the cell lines, cultures were examined for morphological changes and neural marker 
gene expression.  
As Lsh-/- MEFS display a replicative senescent phenotype accumulating high centrosome 
numbers, micronuclei formation and multipolar spindles (Fan et al., 2003), I examined 
metaphase spreads during neurodifferentiation of Lsh-/- cells however, I did not detect any 
accumulation of chromosomal abnormalities (Appendix Figure A2). 
 
3.2.2.1 WT and Lsh-/- cells develop neuronal cell morphology during N2B27 
differentiation  
An advantage to using a monolayer neurodifferentiation protocol is the ability to clearly 
observe changes in morphology allowing quick assessment of developmental stage and 
comparison between different cell lines. Lsh-/- and WT mESCs were grown in N2B27 
differentiation media for a total of 10 days. During this time they develop typical neuronal 
morphology with the appearance of long axons indicating mature post-mitotic neurons 
(Figure 3.3).  Consistently across 5 separate differentiation experiments, a larger proportion 




Figure 3.3. WT and Lsh-/- cells develop neuronal morphology during N2B27 
differentiation. Images of WT and Lsh-/- cells during neural differentiation at days 4, 7 and 
10 of protocol.  The black arrow indicates a neural axon. Scale bars represent 100 µm. 
 
3.2.2.2 Neural genes become expressed during N2B27 differentiation  
To better visualise and quantify neurodifferentiation, I carried out immunocytochemistry and 
qRT-PCR to evaluate expression of neural lineage markers (Figure 3.4 A-C). qRT-PCR 
experiments were carried out on RNA extracted from 3 separate differentiation experiments. 
Nanog is a transcription factor critical to self-renewal of undifferentiated ES cells and can 
therefore be used as a marker of pluripotency. Both WT and Lsh-/- ES cells highly expressed 
Nanog at comparable levels, and successfully down-regulated this upon differentiation 
(Figure 3.4 C). 
Expression of Sox1, the earliest known specific marker of neuroectodermal lineage was 
evident at day 4 in both cell lines and later down-regulated to coincide with the up-regulation 
of more mature neural markers (Figure 3.4 C).  
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The expression of Nestin by day 4 indicated the presence of neural progenitor cells. This 
staining occurred at the periphery of the neural rosettes which is where one would expect to 
see the developing neurons (Figure 3.4 A). Significantly higher expression of Nestin was 
found in Lsh-/- cultures at days 7 and 10 of differentiation (Figure 3.4 C). 
Neuron-specific class III β-tubulin gene (Tuj1) is a marker of post-mitotic neurons and was 
vastly up-regulated upon differentiation with visible staining by day 4 (Figure 3.4 B). 
Expression of Tuj1 was significantly higher in Lsh-/- line by day 7(Figure 3.4 C). 
GFAP, an astrocytic cell marker, was not greatly enriched in the cultures even by day 10 
(Figure 3.4 C). This is in keeping with the fact that glial differentiation occurs at a later stage 
in neurodevelopment, both in vivo and under the differentiation protocol used here 
(Abranches et al., 2009; Qian et al., 2000; Sauvageot and Stiles, 2002; Ying et al., 2003b). 
However, hypomethylated cell lines such as Dnmt1-/- and Dnmt3a-/- have shown precocious 
astrocyte differentiation (Fan et al., 2005a; Wu et al., 2012). The developmentally regulated 
demethylation of glial marker genes controls the timing of astrocyte differentiation. It has 
therefore been proposed that existing hypomethylation of these genes, along with 
hypomethylation of genes encoding components of the JAK-STAT pathway, triggers this 
precocious astrocyte differentiation. I did not find evidence of precocious glial differentiation 
in the Lsh-/- cell line suggesting Lsh does not play a role in methylation at these sites.  
Quantification of non-neural lineage marker gene expression namely Gata6 (an endodermal 
lineage marker) and Snail (a mesodermal lineage marker) revealed some up-regulation upon 
differentiation but to a lesser degree than neural lineage markers suggesting the presence of 
non-neural cells within my cultures (Figure 3.4 C).  This up-regulation was significantly 
greater in the WT cells. This fact, along with the significantly higher expression of neural 
markers in Lsh-/- cells, suggests that these knockout cells have a greater propensity to 
differentiate towards neural fate. 
Cells were harvested at day 10 given the high expression of the neural markers Nestin and 





Figure 3.4 A 
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Figure 3.4. Expression of neural lineage markers during N2B27 differentiation. 
Immunofluorescent images of WT and Lsh-/- cells at days 4, 7 and 10 in the differentiation 
protocol using antibodies against NESTIN (A) and TUJ1 (B). Nuclear DNA was stained using 
DAPI. Scale bars represent 100 µm. C. Quantification of expression of lineage marker genes 
by qRT-PCR. Expression is normalised to housekeeping Gapdh expression and then 
standardized to WT ES expression. Error bars represent +/- SEM of 3 biological replicates. 
P-values indicate level of significance calculated by two-tailed student t-test. Only significant 














3.2.2.3 MAC sorting successfully enriches for NPCs 
Given the heterogeneity between the day 10 cultures, it was essential to purify for neural 
progenitor cells prior to any further investigation. To do this, I employed Magnetic Activated 
Cell Sorting (MACS). Day 10 cell suspension was incubated with magnetic beads coated 
with PSA-NCAM, an NPC cell surface marker, and passed through a magnetic column. Cells 
that remained within the column were eluted and collected. In order to check the efficiency of 
this, I incubated day 10, and post MACS sorted cells with a fluorescently tagged antibody to 
PSA-NCAM and analysed the percentage of tagged cells via flow cytometry with the aid of 
Elisabeth Freyer (IGMM FACS service). This was done with cells from 3 separate 
differentiation experiments. This demonstrated that prior to MAC sorting, the percentage of 
PSA-NCAM positive cells in WT and Lsh-/-  cell lines was 66.7% vs 78.6% respectively and 
92.7% vs 96% following sorting (Figure 3.5). Not only does this confirm the efficiency of this 
method for enriching for NPCs but it also provides further evidence that the Lsh-/- cells are 
differentiating preferentially down neural lineage in comparison to WT.  MAC sorted day 10 











Figure 3.5.  MAC sorting enriches for NPCs. A. Representative histograms, generated by 
flow cytometry, of PE fluorescence of cells following incubation with PSA-NCAM antibody 
conjugated to PE, at day 0 and 10 of differentiation and post MAC sorting. B. Box plot 
showing percentage PSA-NCAM positive cells following FACS analysis.  Error bars 
represent +/- SEM of 3 biological replicates. P-values indicate level of significance calculated 








3.2.3 Lsh is required for DNA methylation upon neural differentiation 
To assess the contribution of Lsh to DNA methylation upon neural differentiation, I assessed 
global DNA methylation levels of Lsh-/- and WT ES and NP cells.  For initial assessment of 
this I carried out restriction enzyme digests of genomic DNA with the methylation-sensitive 
restriction endonuclease HpyCH4IV, which cuts at unmethylated ACGT sites which occur 
preferentially at satellite DNA. Given the abundance of normally methylated satellite 
sequences in the mouse genome, I reasoned that this would provide an indication of global 
DNA methylation levels. Following digestion, the DNA was separated by agarose gel 
electrophoresis. I observed no difference in the ability of HpyCH4IV to digest DNA from 
either cell line when maintained as ES cells, suggesting no difference in DNA methylation 
levels. However, following differentiation I observed increased digestion, indicated by 
increased smearing and the appearance of lower molecular weight fragments, in the Lsh-/- 
NPCs demonstrating hypomethylation at satellite regions (Figure 3.6 A). Digests were also 
carried out using the methylation-insensitive restriction endonuclease MspI, which cuts at 
CCGG sites regardless of methylation status, as a control for the digestibility of the DNA.  
In order to quantify these global DNA methylation changes, I then digested DNA samples to 
single nucleotides and looked at the proportion of methylated cytosines as a percentage of 
total cytosines by liquid-chromatography mass spectrometry (LC-MS) performed by Jimi 
Wills. This method demonstrated no difference in levels of global DNA methylation in WT 
and Lsh-/- ES cells at 4.3% vs 4.2% respectively. However, following neural differentiation, 
Lsh-/- cells were significantly hypomethylated with 5mC levels reaching only 68.7% of WT 
levels (Figure 3.6 B).  
Lsh therefore plays a key role in DNA methylation during neural differentiation. An 
unexpected finding was the loss of DNA methylation in the Lsh-/- cell line upon differentiation, 
with 5mC levels reducing from 4.2% in ES cells to 3.4% in NPCs. This is in contrast to WT 
cells, which show an increase from 4.3% to 4.95% as one would expect given the wave of de 
novo methylation that begins in the implanting blastocyst and continues throughout 
development. This suggests a previously less well described role for Lsh in maintenance of 
DNA methylation. Another possibility is that this is the cumulative effect of further 









                 
Figure 3.6. Global DNA hypomethylation in Lsh-/- NPCs.  A. Agarose gels displaying digestion of DNA from WT and Lsh-/- ES and NP cells by methylation 
sensitive HpyCH4IV and methylation insensitive MSP1 endonucleases. The presence of low molecular weight bands indicate hypomethylation of satellite 
sequences. Integrity and digestibility are controlled for using uncut samples and MSP1 digestion respectively.




Figure 3.6. Global DNA hypomethylation in Lsh-/- NPCs.  B. Quantification of global 5-
mC levels by LC-MS given as a percentage of total cytosines in WT and Lsh-/- ES and NP 
cells. Error bars represent the S.E.M of 3 biological replicates. P-values indicate level of 




3.2.4 Re-Expression of Lsh rescues the DNA methylation defect 
3.2.4.1 Generation of Lsh rescue cell lines 
With the purpose of confirming that the hypomethylation seen in the knockout cells is due to 
the absence of Lsh, and is not a peculiarity of the clone generated by CRISPR, or indeed a 
consequence of off-site targeting, I rescued Lsh expression in the knockout cell line by 
transfecting with a PiggyBac vector carrying wild type Lsh (Figure 3.7 A). A second cell line 
was also generated, transfecting the Lsh-/- cell line with a PiggyBac vector carrying a mutant 
version of Lsh, with a glutamine to arginine residue change at position 699 in a conserved 
helicase domain (Figure 3.7 B). This mutation is present in 2 patients with ICF syndrome 
(Thijssen et al., 2015). The PiggyBac transposon is a mobile genetic element that can 
transpose via a “cut and paste” mechanism where the PiggyBac transposase recognises a 
pair of terminal repeat sequences flanking the construct DNA and can then insert this 
construct DNA into random TTAA chromosomal sites in the host DNA. Thereby it is an 
efficient method in which multiple copies of exogenous DNA can be inserted into the genome 
(Rostovskaya et al., 2012). An mCherry/ Puromycin resistance dual reporter gene was 
inserted into the wild type rescue vector and a hygromycin resistance reporter gene into the 
mutant rescue vector to be used as selectable markers. Following transfection, cells were 
grown in media containing the appropriate antibiotic and surviving cells were then single cell 
sorted and clones expanded. For the WT rescue vector, mCherry positive cells were sorted 
via FACS prior to this. Clones were shown to express LSH at the protein level by western 
blot (Figure 3.7 C & D). Clone “T19” of the rescue cell line and clone “FZ” of the mutant 
rescue line were chosen for further experiments as the clones with LSH expression levels 
most comparable to WT.  Henceforth these cell lines will be referred to as Lsh-/-(+WT LSH) and 
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Figure 3.7. Generation of Lsh rescue and mutant rescue cell lines.  A&B. Schematic of 
the PiggyBac transposon rescue vectors used to transfect Lsh-/- ES cells. The rescue vector 
(A) contains the Lsh gene driven by an EF1A promoter and a mCherry/ puromycin resistance 
dual reporter gene to allow selection of stable expression clones (highlighted in yellow). The 
mutant rescue vector (B) contains the Lsh gene containing a missense mutation in the 
conserved helicase domain driven by an EF1A promoter and a hygromycin resistance gene 
to allow selection of stable expression clones (highlighted in yellow).  PiggyBac transposon 
terminal repeats (highlighted in pink) permit transposition of the construct into the host 
genome. The region highlighted in grey contains a pUC origin of replication and an ampicillin 
resistance gene allowing replication of the plasmid and selection in E.coli.  C&D. Western 
blot for LSH protein in rescue cell clone extracts (C) and mutant rescue cell clone extracts 
(D). Protein extracts from WT and Lsh-/- ES cells were used as positive and negative 
















3.2.4.2 Neurodifferentiation of rescue cell lines is akin to WT 
The Lsh-/-(+WT Lsh) and Lsh-/-(+Mutant Lsh) cell lines were exposed to the same neural 
differentiation protocol as previously described. Consistently, across 3 different differentiation 
experiments, morphology changes were more in keeping with the WT than the Lsh-/- cell line 
as there was a lesser abundance of mature neurons at days 7 and 10 (Figure 3.8). This was 
confirmed by analysing the same lineage markers as previously by qRT-PCR (Figure 3.9). 
This indicates that both the WT and the mutant version of Lsh were able to reverse the Lsh-/- 
cells greater propensity for neural differentiation. 
 
 
Figure 3.8. Neural differentiation of rescue cell lines. A. Images of Lsh-/-(+WT Lsh) and Lsh-/-
(+Mutant Lsh) cell lines at Day 0 in ES serum media and at days 4, 7 and 10 of 
neurodifferentiation. Scale bars represent 100 µm. 






Figure 3.9. Lineage marker expression in rescue cell lines. Quantification of expression of lineage marker genes by qRT-PCR. Expression is normalised to 
Gapdh expression and then standardized to WT ES expression. Error bars represent +/- SEM of 3 biological replicates. P-values indicate level of significance 




3.2.4.3 The DNA methylation defect is rescued by re-expression of wild type Lsh 
The key question that remains to be answered is can the methylation defect seen in Lsh-/- 
NPCs be rescued by the reintroduction of Lsh? For this analysis, I assessed DNA 
methylation at major satellite regions in WT, Lsh-/- , Lsh-/-(+WT Lsh) and Lsh-/-(+Mutant Lsh) cell lines 
using bisulphite sequencing to allow quantification of methylation levels at these sites. 
Sodium bisulphite treatment of DNA deaminates unmodified cytosine bases to uracil which 
can then be identified as thymine residues upon sequencing. At the same time methylated 
cytosines are protected from deamination and hence are read as cytosine residues upon 
sequencing. Therefore one can generate DNA methylation profiles at single nucleotide 
resolution. Bisulphite treated DNA from ES and NP cells from all 4 cell lines was amplified 
using major satellite primers and subjected to Sanger sequencing. 
This analysis revealed no gross difference in CpG methylation at major satellites in WT,   
Lsh-/-, Lsh-/-(+WT Lsh) and Lsh-/-(+Mutant Lsh) cell lines when maintained as ES cells at 84.4%, 
83.3%, 90.2% and 88.9% respectively. WT cells maintained this level of methylation upon 
differentiation to NPCs remaining at 88.9% methylated. In contrast, Lsh-/- cells were unable 
to maintain their methylation with the number of methylated CpGs reducing to 52.9% 
following differentiation. This failure to maintain methylation upon differentiation was rescued 
by the reintroduction of wild type Lsh, as the Lsh-/-(+WT Lsh) rescue cell line maintained 
methylation levels of 91.1%. The mutated version of Lsh, however, was unable to rescue this 
methylation defect with the Lsh-/-(+Mutant Lsh) cell line losing methylation upon differentiation 
such that NPCs had 35.9% of sampled CpGs methylated (Figure 3.10). 
This confirms the requirement for Lsh for appropriate DNA methylation upon neural 






Figure 3.10. DNA methylation at major satellites quantified by bisulphite sequencing.  
Each circle represents a CpG with black indicating methylated and white indicating 
unmethylated sites. The percentage of methylated CpGs is shown under each plot. P values 
display significance using the binomial test in R. Primers were designed against mouse 





















In this chapter, I have described the use of a cell culture system whereby the role of Lsh in 
early neurogenesis could be examined. The N2B27 differentiation protocol by Pollard et al 
was adapted for use as it relies on an autocrine induction mechanism. The monolayer nature 
of the system also allows easy visualisation of differentiation as it occurs. In my hands, this 
method was successful in generating neurons as evidenced by typical morphological 
changes and neural lineage marker expression. Magnetic activated cell sorting allowed for 
selection of neural progenitor cells within heterogeneous cultures. 
The work carried out using this culture system had 2 key aims; to assess if ES cells lacking 
Lsh could develop normally down neural lineage, and to determine if Lsh is required for DNA 
methylation during this process. 
3.3.1 Lsh-/- cells have a greater propensity to differentiate down neural lineage 
During the differentiation protocol I consistently observed a greater abundance of mature 
neurons, easily identifiable by their long projecting axons, at an earlier stage of differentiation 
in the Lsh-/- cells compared to wild type cultures. This was confirmed by a greater expression 
of the post-mitotic neural marker Tuj1, demonstrated by immunocytochemistry and qRT-
PCR. This could be due to a preferential or premature differentiation down neural lineage. 
The higher expression of both early and later neural lineage markers at day 10 of 
differentiation in the Lsh-/- cells combined with a lower expression of non-neural lineage 
markers would lend support to a preferential neural differentiation. Further support for this 
comes from FACs experiments that demonstrated a greater proportion of NPCs in day 10 
Lsh-/- cultures. 
Intriguingly, there are conflicting reports on the importance of Lsh in cellular differentiation. 
Lsh has been proposed to play a role in stem cell gene repression via promoter methylation 
during differentiation, as knock down of Lsh by siRNAs prevented complete silencing of stem 
cell genes and maintained stem cell characteristics in vitro (Xi et al., 2009). This was not the 
case in my cultures where Nanog was effectively down-regulated in Lsh-/- cells upon 
differentiation. More in keeping with my findings, Yu et al reported de novo formation of 
enhancer elements at hypomethylated sites in Lsh-/- MEFS as evidenced by enrichment of 
H3K4me1. They found that these regions clustered at neuronal lineage genes and 
reprogramming of these Lsh-/- MEFs to induced pluripotent stem cells was followed by 
enhanced differentiation down neural lineage (Yu et al., 2014a). In contrast, Lsh-/- ES cells 
derived from knockout blastocysts showed comparable rates of neural differentiation to wild 
type in a study by Ren et al (Ren et al., 2015). One possible reason for these different 
accounts may be the different differentiation systems used and differing timing of assement 
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of differentiation. For example Ren et al used a differentiation protocol of embryoid body 
formation followed by retinoic acid treatment therefore is not directly comparable to my work. 
My system does have an advantage over the others in that it relies on an autocrine induction 
mechanism, therefore may better reflect the effects of lack of Lsh in driving differentiation. It 
is, of course, artificial as differentiation in vivo is also driven by extracellular signals. 
Also it should always be borne in mind that different cell lines will show inherent differences 
in their ability to differentiate. For this reason it was important to repeat my experiment after 
re-expression of Lsh in the knockout cell line. The fact that this rescued the differentiation 
differences lends support to the argument that it is the lack of Lsh itself that led to the 
differences seen in neural differentiation.  
In the next chapter, I will explore possible reasons for this greater propensity for neural 
differentiation. One possibility we considered was that there may be differences in the Lsh-/- 
methylome at developmental genes. Intriguingly, however, the re-expression of Lsh with a 
mutation in a conserved helicase domain, which did not rescue the methylation defect, at 
least at major satellites, did rescue the differentiation phenotype. This suggests that the 
effects of Lsh upon differentiation may be independent of DNA methylation. 
 
3.3.2 Lsh is required for DNA methylation during neurogenesis 
At the beginning of this project, little was known about the developmental time point at which 
Lsh acted to ensure appropriate levels of DNA methylation. In this chapter, I have 
demonstrated a key role for Lsh in DNA methylation during differentiation of pluripotent 
embryonic stem cells to neural progenitor cells as demonstrated by LC-MS, restriction 
enzyme digest and bisulphite sequencing. During my time carrying out research on this 
project a paper was published corroborating this finding (Ren et al., 2015). 
Of particular interest is the fact that global DNA methylation levels as seen by LC-MS were 
lower in Lsh-/- NPCs than Lsh-/- ES cells. This suggests a role for Lsh in maintenance 
methylation as opposed to its widely reported role in de novo DNA methylation. An 
alternative explanation could be that there are further demethylation/remethylation events at 
this developmental timepoint. 
Having confirmed the requirement for Lsh in DNA methylation during early neurogenesis I 
was interested in assessing exactly where in the genome this methylation defect occurred as 
the majority of previous studies have focused only on specific loci. Furthermore, I was 
intrigued to examine whether this methylation defect had any transcriptional consequences. 




Chapter 4. Mapping the Lsh-/- methylome, 
transcriptome and H3K27me3 deposition upon 
neurodifferentiation 
4.1 Introduction 
In chapter 3, I demonstrated the requirement for Lsh for normal DNA methylation during 
neurogenesis by assessing global DNA methylation levels. In this chapter, I intend to further 
scrutinise the genomic sites at which Lsh contributes to methylation at this developmental 
stage, by mapping the genome-wide DNA methylome. There are very few previous studies 
that examine the genome wide methylome in Lsh-/- models and none using neural cells. 
I will then go on to answer a key question; is this methylation defect linked with 
transcriptional consequences? There are several reports of up-regulated genes in Lsh-/- 
models, which authors have accredited to hypomethylation of single copy gene promoters 
and suggested that Lsh plays a role in targeting DNA methylation to these sites (Fan et al., 
2005b; Myant et al., 2011; Xi et al., 2009; Xi et al., 2007). 
Despite the established role for Lsh in ensuring appropriate satellite repeat DNA methylation, 
less attention has been paid to the transcriptional consequences of repeat hypomethylation 
in Lsh-/- models. Although previously considered as “junk DNA” there is a growing recognition 
of the importance of these regions in genome integrity and regulation (Garcia-Perez et al., 
2016). I therefore intend to explore the transcriptional consequences of repeat 













4.2.1 DNA methylome mapping by ERRBS 
In order to establish the regions of the genome at which Lsh contributes to DNA methylation 
during neurogenesis, genome-wide 5-mC profiles generated by Enhanced Reduced 
Representation Bisulphite Sequencing (ERRBS) were analysed. “Reduced representation” 
refers to the prior digestion of the DNA with a MspI restriction enzyme, followed by size 
fractionation to select for CG-rich DNA fragments (Meissner et al., 2005). This method 
therefore provides coverage of important features of the genome such as promoters, whilst 
reducing the total volume of sequencing required by other methods such as whole genome 
bisulphite sequencing. The obvious disadvantage to this reduced coverage is the lack of 
information it provides about methylation at non-CGIs. Enhanced RRBS increases the 
coverage of RRBS by also including larger DNA fragments post MspI digest, which have a 
lower CG content, and using a whole genome alignment approach rather than aligning to the 
Msp1 fragmented genome. This is reported to result in a 75% increase in the coverage of 
CpG sites, providing information not only about promoter regions but also about introns, 
exons and CpG shores (the regions immediately flanking CpG islands) (Akalin et al., 2012; 
Garrett-Bakelman et al., 2015).  
DNA from one replicate each of Lsh-/- and WT ESC and NPC samples, were sent to the 
Epigenomics Core Facility of Weill Cornell Medicine who performed ERRBS and processed 
the raw data. Data was then mapped to the mm9 build of the mouse genome and analysed 
by Dr Donncha Dunican. 
4.2.1.1 Lsh is required for DNA methylation of repetitive elements during 
neurogenesis 
As experiments in chapter 3, and previously published reports, had established a role for Lsh 
in DNA methylation of satellite sequences, I initially scrutinized the ERRBS dataset for 
methylation over different repeat subclasses. Only CpGs mapping to long repeats, 
considered as full length repeats, were included in this robust analysis (defined as >6kb for 
LTRs and LINE1s and >1kb for satellites). This was done to prevent the overwhelming 
inclusion of reads from multitudes of short retrotransposon remnants with unknown biological 
relevance. In contrast, full-length repeats would be predicted to have a greater consequence 
upon local chromatin environment and possibly retain the potential to retrotranspose.  
To calculate repeat methylation the average methylation of individual CpGs, with a minimal 
depth of 5 reads, mapping to long repeats were plotted in violin plots (Figure 4.1).  
Surprisingly, LINE1s and LTRs were marginally, but significantly, hypomethylated in Lsh-/-  
ES cells compared to WT at 40% vs 46% (p<2.2x10-16) and 79% vs 86% (p=2.4x10-11) 
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respectively. In satellite repeats, significant hypomethylation was not seen with Lsh-/- ES cells 
showing 73% compared to 79% (p=0.87) methylation in WT. It should be noted, however, 
that that the number of CpGs in the satellite repeat dataset is far less than the number of 
LINE1s or LTRs (139 vs 33127 and 2870 respectively) which will clearly have an effect on 
significance testing.  
Upon differentiation to NPCs, LINE1s, LTRs and satellite repeats all became grossly 
hypomethylated in Lsh-/- cells compared to WT at 50% vs 77.4% , 47.1% vs 86.9% and 
46.2% vs 75% respectively. Concentrating on the change in methylation upon differentiation, 
one can see that in wild type cells, LTR and satellite sequences maintained their methylation 
level whereas LINE1s gained methylation. In the knockout cell line, LINE1s also gained 
methylation upon differentiation but failed to do so to the same extent as wild type cells. This 
is in keeping with the reported role Lsh plays in facilitating de novo methylation. However, 
the knockout cells actually lose methylation at LTR and satellite sequences upon 
differentiation lending further support for a role for Lsh in maintenance of DNA methylation. 
However, one cannot exclude the occurrence of demethylation / remethylation events at 
these sites during ESC to NPC transition. Repeating these experiments at multiple time 
points during this developmental window would be required to confirm this.  
The role Lsh plays in DNA methylation is clearly context dependent. Despite its high 
expression in ES cells it appears largely dispensable for DNA methylation until these cells 
differentiate to neural progenitors. Although there is a small degree of hypomethylation in ES 
cells, the levels are not consistent with Lsh playing a major role in maintenance of 












   
 
Figure 4.1. Repeats are hypomethylated in Lsh-/- cells.  Violin plots demonstrate the distribution frequency with which individual CpGs within a family of 
full length repeats are methylated in WT and Lsh-/- ESCs and NPCs. White spots indicate median values and black bars represent the interquartile range. 
P values show results of significance testing by Wilcoxon rank sum test.  
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4.2.1.2 Gene promoters associated with immune function are hypomethylated in Lsh-/- 
NPCs 
As mentioned earlier, previous reports exist of Lsh playing a role in DNA methylation at 
promoters of single copy genes, including those of stem cell genes (Fan et al., 2005b; Xi et 
al., 2009). I therefore explored promoter methylation in the ERRBS data set. Promoter 
methylation was calculated as the average methylation of all CpGs spanning the +/- 2kb 
region across the TSS. 
In order to define promoters that lost or gained methylation, a threshold change of 20% 
absolute methylation difference was set. Although arbitrary, this threshold was chosen to 
make results comparable to other work published in this area (Velasco et al., 2018b). This 
revealed very few differentially methylated promoters between WT and Lsh-/- ES cells, with 
41 showing increased and 66 decreased methylation compared to WT. However, following 
differentiation 395 promoters showed a more than 20% reduction in methylation in Lsh-/- 
NPCs and only 39 demonstrated a gain in methylation compared to WT (Figure 4.2).  
 
 
Figure 4.2. Promoter methylation in Lsh-/- cells. The scatter plots display the average 
methylation across promoters (defined as +/- 2kb from TSS) in WT and Lsh-/- cells. 
Differentially methylated promoters (defined as >20% methylation difference) are highlighted 
in red for those that were hypomethylated and blue for those that were hypermethylated in 







In chapter 3, I demonstrated that ES cells lacking Lsh displayed a greater propensity for 
neural differentiation compared to wild type. I was keen to see if this could be explained by 
differences in promoter methylation at key pluripotency or lineage commitment genes. 
Contrary to previous reports (Xi et al., 2009), Lsh does not appear to be required for de novo 
methylation of promoters of stem cell specific genes (as defined in the Xi et al paper) upon 
differentiation as Lsh-/- NPCs displayed similar levels of methylation to WT (Figure 4.3 A). 
This is in keeping with my finding that there was no inhibition of differentiation capability of 
the Lsh-/- ES cells in chapter 3. 
Gene ontology analysis of the hypomethylated gene promoters in NPCs did not reveal an 
enrichment for neural differentiation pathways, demonstrating that the preferential neural 
differentiation seen in the Lsh-/- cell line was not due to a widespread hypomethylation of 
neural lineage genes. Instead ontology analysis revealed an enrichment of terms to do with 
inflammatory and innate immune responses (Figure 4.3 B). In saying this, 2 genes known to 
play a role in differentiation were found to be hypomethylated in both Lsh-/- ES and NP cells; 
namely Nefm (a neurofilament protein involved in nervous system development) used as an 
NPC marker and Ttll4 (involved in polyglutamylation of tubulin proteins) which plays a role in 
early embryonic development and possibly in neurite outgrowth (Song and Brady, 2014; Ye 


















Figure 4.3. Innate immune genes display hypomethylation in Lsh-/- NPCs. A. Boxplot 
displays average methylation across stem cell promoters in NPCs from ERRBS data. B. 
Gene ontology analysis of hypomethylated promoters in Lsh-/- NPCs. Table shows the top 
ten most significant biological process terms as found using David V6.8. The red dashed line 





































4.2.1.3 L1 repeats are enriched at hypomethylated promoters in Lsh-/- NPCs  
The ERRBS data has clearly shown that Lsh is required for repeat methylation upon 
neurodifferentiation, but also that a number of gene promoters, particularly those of immune 
response genes, are hypomethylated in the absence of Lsh. A possible explanation for the 
methylation defect seen at these promoters is that they are in a region of the genome rich in 
repeat content and are therefore hypomethylated due to a position effect rather than by 
direct targeting by Lsh.  
To investigate this I analysed the repeat content of the genome surrounding these 
hypomethylated promoters. This was carried out by dividing the genome into 800bp 
windows, 10kb up and downstream of TSSs of genes that were hypomethylated in Lsh-/- 
NPCs, and those genes with no change in promoter methylation. These files were then 
intersected with repeat masker files from the UCSC genome browser. Percentage repeat 
content was analysed using the IRanges package in R and displayed as the percentage of 
base pairs within an 800bp window that are part of an annotated repeat.  
Analysis was carried out for all annotated L1, LTR and satellite repeats regardless of length. 
Data from satellite repeats is not shown as the number of these in the vicinity of gene 
promoters was too small to extract meaningful data. 
This analysis demonstrated that the 20kb stretch of genome surrounding TSSs of 
hypomethylated promoters was enriched for L1 elements, when compared to regions 
surrounding promoters that displayed no difference in promoter methylation between Lsh-/- 
and WT NPCs. This was also true, although to a lesser extent, for LTR content at these 
regions (Figure 4.4).  
This could indicate that, in contrast to what previous authors have reported when examining 
single copy loci, Lsh does not target specific promoters for methylation, but rather these 
promoters become hypomethylated in the absence of Lsh due to loss of methylation at 
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Figure 4.4. Repeat content of genome surrounding hypomethylated promoters in 
Lsh-/- NPCs. This graph divides the genome surrounding the TSS of genes with 
hypomethylated promoters in Lsh-/- NPCs (orange) and genes with unchanged promoter 
methylation status when compared to WT (blue), into 800bp bins 10kb up and 
downstream of the TSS. Each bin is represented by a point on the graph. The average 
percentage of base pairs within each 800bp bin that form part of an annotated L1 or LTR 
repeat, regardless of length, is shown on the y axis. The number of genes in each group is 





4.2.2 RNA-Seq analysis of the transcriptome 
A key question that arises is: does this wide scale reduction in methylation have any effects 
upon transcription? In order to assess the effects, if any, of lack of Lsh on the transcriptome, 
I isolated polyadenylated mRNA and prepared libraries from WT and Lsh-/- ES and NP cells 
and sent samples to Edinburgh Genomics for Illumina sequencing. Each sample had 3 
biological replicates. Raw data was processed by Dr Donncha Dunican. 
 
4.2.2.1 Repeats are not up-regulated in Lsh-/- NPCs 
Having established gross hypomethylation of repeat sequences, it seemed logical to analyse 
their transcription. As previously stated, transposable elements are usually strictly repressed 
in somatic cells, although there is evidence for more activity in the brain compared to other 
somatic cells for reasons as yet unclear (Goodier, 2016). We analysed repeat expression 
within the RNA-Seq dataset for both reads aligning to full length (long) LINE1, LTR or 
satellite sequence and those reads aligning to non-full length (short) repeats, as defined in 
section 4.2.1.1. In many cases a “short” repeat is actually likely to form part of a long, not 
fully annotated, repeat therefore their inclusion in the analysis is highly relevant. Furthermore 
aberrant transcription from retrotransposon remnants retains the potential to influence 
expression of host genes. A repeat was considered differentially expressed if there was a 
greater than 4 fold change in expression and FDR <0.05. 
In ES cells, full length repeats showed no differential expression with only 2 L1s showing 
some degree of up-regulation. When the analysis was extended to short repeats, again there 
was no evidence for repeat de-repression (Figure 4.5). Despite hypomethylation occurring at 
these sites upon neurodifferentiation, there was also no evidence of up-regulation in repeat 
transcription in Lsh-/- NPCs (Figure 4.6).  qRT-PCR confirmed that there was no significant 





Figure 4.5. Repeat Expression in ESCs.  Scatter plots display read counts of LINE1 (L1), long terminal repeat (LTR) and satellite (Sat) sequences from RNA-Seq 
analysis from 3 biological replicates of WT and Lsh-/- ES cells. Repeats defined as differentially expressed in Lsh-/- cells (>4 fold change and FDR<0.05) are 
highlighted in red if up-regulated and blue if down-regulated. Data is shown for reads mapping to full length repeats (long) and non-full length repeats (short).  
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Figure 4.6. Repeat Expression in NPCs.  Scatter plots display read counts of LINE1 (L1), long terminal repeat (LTR) and Satellite (Sat) sequences from RNA-Seq 
analysis from 3 biological replicates of WT and Lsh-/-  NP cells. Repeats defined as differentially expressed in Lsh-/- cells (>4 fold change and FDR<0.05) are 






Figure 4.7. qRT-PCR of repeat expression. Bar charts display results of qRT-PCR for 
major satellites, LINE1s and LTRs. The error bars represent the SEM from 3 biological 
replicates. The Y axis displays arbitrary expression units (AEU) and results are normalised to 
Gapdh. No significant difference was seen between WT and Lsh-/- cells as calculated by 




4.2.2.2 Differential gene expression in the absence of Lsh 
I then went on to examine differential gene expression in the RNA-Seq data (defined as >2 
fold change in expression and P value < 0.05 across 3 biological replicates). This revealed a 
total of 597 differentially expressed genes in Lsh-/- ES cells with 412 genes showing down-
regulation and 185 up-regulation. The reason for this differential expression in ES cells when 
Lsh does not appear to be required for DNA methylation is unclear, and points to additional 
roles for Lsh at this pluripotent stage when it is certainly highly expressed. The number of 
differentially expressed genes increased following differentiation to 640 genes showing 
down-regulation and 249 up-regulation (Figure 4.8A). The fact that there is a skew to down-
regulation as opposed to up appears to be contradictory to the global hypomethylation seen 
in Lsh-/- NPCs. This fact in itself highlights the growing recognition that, for the majority of 
genes, transcription is not governed by DNA methylation. The relationship between DNA 
methylation and gene transcription will be explored further in later sections. There was a 
small but significant degree of overlap between those genes differentially expressed in Lsh-/- 
ES cells and Lsh-/- NPCs. 33 genes that were down-regulated in Lsh-/- ESCs were also down-
regulated in Lsh-/- NPCs (more than would be expected by chance, p=0.002 by 
hypergeometric testing) and 11 genes that were up-regulated in Lsh-/- ESCs were also up-
regulated in Lsh-/- NPCs (p=0.0005) (Figure 4.8B). The fact that the majority of genes did not 
overlap demonstrates an important role for Lsh in regulating gene transcription during the 
differentiation process. 
In order to determine if any particular class of genes were misexpressed, gene ontology 
analysis was carried out using David V6.8 utilising the biological processes category (Figure 
4.9).  Analysis of down-regulated genes in Lsh-/- ESCs revealed an enrichment of terms 
related to transcriptional processes whereas up-regulated genes were mainly to do with 
differentiation processes suggesting that in the absence of Lsh, ES cells may be more 
“primed” for differentiation. In neural cells developmental terms also featured strongly in the 
ontology analysis. This highlights a role for Lsh in ensuring appropriate timing of 
developmental gene expression and may explain the differentiation differences seen in 









                  
 
                             
Figure 4.8. Differential gene expression in Lsh-/- cells. A. Volcano plots comparing 
transcriptomes of WT and Lsh-/- ES and NP cells respectively. Differentially expressed genes 
(>2 fold difference in expression and p < 0.05) are highlighted in red. Total numbers of 
differentially expressed genes are provided in the boxes. B. Venn diagrams display the 
overlap of differentially expressed genes in Lsh-/- ES and NP cells with total gene numbers 
displayed (overlapping gene lists are displayed in Appendix List A1&2). 








Figure 4.9. Gene ontology of differentially expressed genes. Charts show the top ten most significantly enriched gene ontology terms of differentially expressed 
genes in Lsh-/- ES and NP cells as analysed by the biological process direct tool of David V6.8. Red line indicates p value =0.05.
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4.2.2.3 Differential methylation at promoter regions does not account for 
transcriptional changes  
As demonstrated earlier, the global hypomethylation that occurs upon differentiation in Lsh-/- 
cells did not appear to be associated with a widespread up-regulation in gene expression. 
However, the question remains as to whether the hypomethylation seen over individual 
promoters in the absence of Lsh results in increased transcription from these genes. To 
examine this, I integrated my ERRBS and RNA-Seq datasets. This revealed that of the 118 
genes that overlapped between these datasets from ES cells, only 2 of the genes that were 
defined as transcriptionally up-regulated were also defined as having promoter 
hypomethylation; namely Nefm and Ttll4 (previously discussed). Similarly, only 5 of the 
overlapping 184 genes defined as up-regulated in NPCs were also defined as having 
hypomethylated promoters; namely Nefm, Ttll4, Cldn15 (a component of tight junction 
complexes), Fv1 (a retroviral restriction gene) and Gm5124 (a pseudogene) (Figure 4.10). 
One can conclude from this, that the vast majority of genes up-regulated in the absence of 
Lsh are not so due to promoter hypomethylation. I chose a rather robust definition of a 
reduction in 20% across the whole promoter, reasoning that anything less than this would be 
unlikely to alter local chromatin conformation and access for the transcriptional machinery. 
However it is unknown to what degree methylation has to change to alter transcription and 
this would depend on chromatin context. Indeed methylation loss at even a single CpG could 

















4.2.2.4 Repeats are depleted near genes up-regulated in Lsh-/- NPCs 
Another possible explanation for differential gene expression in the knockout cell line would 
be hypomethylation of repeats creating a more transcriptionally permissive environment for 
nearby genes. I therefore interrogated the RNA-Seq data to analyse if those genes that were 
up-regulated in Lsh-/- NPCs tended to be in a more repeat rich region of the genome than 
non-differentially expressed genes. In order to do this, I utilised the same methods as 
previously described in section 4.2.1.3. Analysis was carried out for all annotated L1 and 
LTR repeats regardless of length.  Again data from satellite repeats is not shown as the 
number of these in the vicinity of gene promoters was too small to extract meaningful data. 
Results are shown as the percentage of base pairs which form part of an annotated repeat in 
800bp windows up to 10kb up and downstream of the TSS (Figure 4.11). This revealed that, 
as a whole, up-regulated genes actually had fewer L1 or LTR repeats in close proximity to 
their TSS than genes that were not differentially expressed. 
The data presented here and in section 4.2.2.3, suggests that DNA methylation is not the 
primary factor regulating the differential gene expression.   
 
Figure 4.10. Lack of correlation between transcriptional upregulation and promoter 
hypomethylation. The scatter plots display the average promoter methylation of genes up-
regulated in Lsh-/- ES and NP cells. Those genes with differentially methylated promoters (defined 
as a change of >20%) are shown as red circles for hypomethylated and blue for hypermethylated 





Figure 4.11. Repeat content of genome proximal to up-regulated genes in Lsh-/- NPCs.  
This Graph represents the repeat content of the genome proximal to the TSS of genes up-
regulated in Lsh-/- NPCs (orange line) compared to those genes not differentially expressed 
(blue line). The region of genome analysed is 10kb up and downstream of the TSS divided 
into 800bp bins. Each bin is represented by a point on the graph. The average percentage of 
base pairs within each 800bp bin that form part of an annotated L1 or LTR repeat, regardless 
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4.2.2.5 Hox genes are misexpressed in the absence of Lsh 
Of particular note was the up-regulation of developmentally regulated Hox genes in Lsh-/- 
NPCs (Figure 4.12). These genes encode homeobox transcription factors which play key 
roles in development, as their downstream targets direct cellular and positional identity of 
differentiating cells along the anterior-posterior axis of the embryo (Mallo and Alonso, 2013).  
Hox genes are organised into clusters of which there are 4 in the mouse termed A-D, and 
expression is tightly regulated in a spatiotemporal manner during development, in part by 
epigenetic changes (Soshnikova and Duboule, 2009).  
Their expression has been found to be up-regulated in other models lacking Lsh and it has 
been suggested that this up-regulation is due, at least in part, to hypomethylation at Hox 
gene promoters (Xi et al., 2007). In my ERRBS analysis however, Hox gene promoters in 
Lsh-/- cells were not found to be hypomethylated. Although DNA methylation may play a role 
in silencing some Hox genes during development, the key epigenetic regulatory system at 
these gene clusters is the Polycomb repressive complex, which mediates deposition of the 
repressive mark, H3K27me3 (Barber and Rastegar, 2010).  
I was therefore interested to investigate if there were any abnormalities in the Polycomb 
system in the Lsh-/- NPCs which could account for the up-regulation of Hox genes. Also, I 
hypothesised that deficits in this system could explain the differential expression of other 

































Figure 4.12. Hox Genes are misexpressed in Lsh-/- NPCs.  IGV genome browser shots displaying RNA-Seq expression data across 
Hox clusters A-D from 3 biological replicates of WT and Lsh-/- NPCs 
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4.2.3 Analysis of H3K27me3, a Polycomb repressive mark, by ChIP-seq 
So far, I have focused only on DNA methylation during development. However, the finding of 
up-regulated expression of developmental genes in my RNA-Seq analysis prompted me to 
investigate the distribution of Polycomb repression in my model system. Polycomb group 
proteins form two major repressive complexes, PRC1 and PRC2, and provide a further level 
of epigenetic control of transcription via post translational modification of histone N-terminal 
tails. The repressive H3 modification of H3K27me3 is deposited by the histone 
methyltransferase Ezh2/Ezh1, a member of the PRC2 complex. 
Similarly to DNA methylation, chromatin modifications are also highly dynamic during 
development, with modifications associated with active chromatin reducing globally 
concomitant with an increase in repressive histone marks as development proceeds 
(Meshorer and Misteli, 2006). Developmentally important genes, such as Hox genes, display 
“bivalent” chromatin marks in ES cells, i.e. both active H3K4me3 and inactive H3K27me3. 
This maintains them in a non-expressed, but poised state ready for transcriptional activation 
upon differentiation, thereby maintaining their pluripotent status (Bernstein et al., 2006). 
As cells differentiate, a proportion of these bivalently marked genes lose either their 
repressive or active mark, dependent upon the specific lineage. Some that are silenced may 
also be associated with DNA methylation. Some cells will lose the repressive mark and 
become active during differentiation only to regain the mark at later stages of differentiation. 
Almost all Hox genes are bivalently marked in ES cells. Upon in vitro differentiation to NPCs, 
Hox A1/4/5 are known to lose H3K27me3 to become actively marked with the other Hox 
genes either remaining bivalent or losing their active mark to become marked by H3K27me3 
only. In mature brain tissue all are marked by H3K27me3 (Meissner et al., 2008a). Hox 
genes are however expressed in the brainstem and spinal cord and have central roles in 
neuronal subtype specification within regional domains (Philippidou and Dasen, 2013). 
In order to investigate the distribution of H3K27me3 I performed ChIP-seq. In this approach 
histone proteins are chemically cross-linked with formaldehyde to bound DNA. The cells are 
then lysed, chromatin fragmented by sonication and an antibody against H3K27me3 is then 
used to pull down the regions of bound DNA. Following preparation of libraries, one sample 
from each genotype in each cellular context (i.e. ESC or NPC) was sent to Edinburgh 
Genomics for next generation Illumina sequencing and bioinformatic analysis was carried out 
by Dr Donncha Dunican.  
I carried out quality control checks in my ChIP samples. Firstly, gel electrophoresis of 
sonicated chromatin was carried out for each sample to ensure appropriate and equal 
fragment size. Sonication was optimised to result in chromatin fragments of 100-300bp 
(Figure 4.13 A). This fragment length is a compromise, being long enough to allow unique 
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mapping but short enough to improve specificity and give tighter ChIP-seq peaks. In order to 
assess the specificity of the H3K27me3 antibody, qRT-PCR was performed on samples 
incubated with the antibody and those incubated with a non-specific antibody to IgG. 
H3K27me3 is known to be enriched over Hox genes in ES cells therefore Hox C9 was 
selected as a positive control region. The active housekeeping gene β-actin, which is devoid 
of H3K27me3 in ES cells, was selected as a negative control region. Results confirmed 
enrichment over positive control regions with low background from IgG pull down (Figure 
4.13 B).  
 
 
      
 
Figure 4.13. ChIP quality control. A. A representative agarose gel following sonication of 
cross-linked chromatin demonstrating fragments of 100-300bp. B. ChIP-qPCR at positive 
and negative control regions for H3K27me3 in ES cells. Enrichment is shown as percentage 
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4.2.3.1 There are widespread losses of the Polycomb repressive mark, H3K27me3, 
from promoter regions in Lsh-/- cells following neurodifferentiation 
I previously hypothesised that the increased expression of Hox genes in NPCs, in the 
absence of Lsh, could be due to a loss of Polycomb repressive marks from these sites. I 
therefore looked at H3K27me3 across promoter regions of Hox genes from the ChIP-Seq 
dataset, defined as +/- 2kb from TSS, and indeed found a small reduction in the mark across 
all 4 Hox clusters (Figure 4.14 A). 
Rather than looking at candidate genes only, I then went on to examine H3K27me3 across 
all promoter regions in the dataset. H3K27me3 across a promoter was defined as the 
average number of reads from 1kb sliding windows (sliding by 200bp) over the +/- 2kb region 
from the TSS. In order to define promoters that lost or gained H3K27me3 in Lsh-/- compared 
to WT, a threshold of 2 fold change was set excluding all promoters with less than 10 reads 
per million. This method revealed that very few promoters in Lsh-/- ES cells had altered 
Polycomb occupancy, with only 9 showing a gain in H3K27me3 and 13 a reduction. 
Following differentiation however, Lsh-/- cells demonstrated 5 promoters with increased 
H3K27me3 and a substantial 248 with reduced mark demonstrating that Polycomb 
regulation is altered in Lsh-/- NPCs (Figure 4.14 B). 
As can be seen in Figure 4.14 B, not only do these 248 promoters have a >2 fold reduction 
in H3K27me3 compared to WT NPCs, but also there appears to be a more global reduction 
in H3K27me3 across promoters.  
Interestingly, gene ontology terms for those promoters with >2 fold reduction in H3K27me3, 
were to do with neural differentiation (Figure 4.14 C). It is therefore tempting to hypothesise 
that as cells differentiate, the absence of Lsh results in a redistribution of Polycomb away 
from traditional target sites, including neurodevelopmental genes, resulting in their premature 








          
   
Figure 4.14. Polycomb regulation is altered in Lsh-/- NPCs. A. Boxplot demonstrates the 
log2 fold change in reads from H3K27me3 ChIP across Hox clusters in Lsh-/- NPCs 
compared to WT. A negative value demonstrates reduction of the mark in Lsh-/- cells. B. 
Scatter plots display the log2 value of the average number of reads from H3K27me3 ChIP 
across promoter regions of genes in Lsh-/-and WT ES and NP cells. The number of reads 
across a promoter was taken as the average number of reads from 1kb sliding windows 
(sliding by 200bp) +/- 2kb from TSS. Promoters that had a greater than 2 fold change in Lsh-
/- cells compared to WT are shown in blue for those that were enriched in Lsh-/- ,and red for 





             
                    
   
Figure 4.14. Polycomb regulation is altered in Lsh-/- NPCs. C. Top ten most significant gene ontology enrichment terms of promoters with >2fold reduction in 




4.2.3.2 H3K27me3 is reduced over differentially expressed genes 
As revealed earlier in this chapter, the changes in gene expression seen in Lsh-/- cells were 
not due to alterations in promoter DNA methylation status. However, having demonstrated 
disruption of the Polycomb repressive system in the absence of Lsh, I was keen to test the 
hypothesis that alterations in this system may correlate with gene transcription. 
In order to test if those genes that were differentially expressed in Lsh-/- NPCs were also 
differentially marked by H3K27me3, I integrated my ChIP-seq and RNA-Seq data sets. This 
analysis revealed a greater reduction in H3K27me3 across promoters of genes that were 
differentially expressed compared to those genes which maintained WT expression levels. 
Interestingly this occurred in both up and down regulated genes (Figure 4.15 A). 
Furthermore, when looking at WT NPC levels of H3K27me3 across promoters of those 
genes differentially expressed in Lsh-/- NPCs, it was revealed that differentially expressed 
genes are normally enriched for Polycomb when compared to non-differentially expressed 
genes (Figure 4.15 B). This confirms that differentially expressed genes in Lsh-/- NPCs are 
Polycomb targets. This implies that the initial hypothesis - that there is a redistribution of 
Polycomb away from gene promoters resulting in increased expression - although possibly 
accounting for some differential expression, is too simplistic. This is because the down-
regulated genes are also Polycomb targets and lose H3K27me3 in the absence of Lsh. It 
could be that these down-regulated Polycomb targets are so as a consequence of repressive 
signalling pathways caused by the up-regulation of other Polycomb targets. What can be 
concluded is that at this early stage of differentiation, Lsh plays a key role in H3K27me3 















Figure 4.15. H3K27me3 over differentially expressed genes. A. Log2 fold change in 
H3K27me3 over promoters of genes differentially expressed in Lsh-/- vs WT NPCs. Negative 
values indicate reduced polycomb in Lsh-/- cells. B. Analysis of WT NPC levels of H3K27me3 
across promoters of genes differentially expressed in Lsh-/- NPCs reveals that these genes 
are Polycomb targets. P values indicate significance from wilcoxon rank sum test. 
 
4.2.3.3 H3K27me3 is redistributed to repeats in the absence of Lsh 
This loss of H3K27me3 from target sites has been demonstrated in other hypomethylated 
models including Dnmt1-/- MEFs (Reddington et al., 2013). This does not appear to be due to 
any loss of activity of Polycomb as demonstrated by consistent global levels of H3K27me3, 
but instead appears to be due to a redistribution of the mark. Dunican et al demonstrated this 
in Lsh-/- MEFs, where H3K27me3 was found to be increased over repeat sequences 
(Dunican et al., 2013). As DNA methylation and H3K27me3 are usually mutually exclusive 
modifications in the genome, rarely being found in the same place, it is hypothesised that 
loss of methylation causes an increase in potential binding sites for Polycomb thereby 
“diluting” the mark across the genome. 
Having found a loss of H3K27me3 over promoter regions I then examined the mark over full 
length repeats in order to test this theory of redistribution in my model. This was done by 
averaging reads across individual full length satellites, LTRs and LINE1s. This revealed no 
difference in H3K27me3 over repeats between Lsh-/- and WT ES cells, however following 





This would be in keeping with a loss of methylation at repeats, occurring upon differentiation 
in the absence of Lsh, opening alternative binding sites for Polycomb thereby resulting in its 
distribution away from target sites to these hypomethylated regions. 
 
                       
Figure 4.16. Polycomb is redistributed to repeats in Lsh-/- NPCs.  Boxplot displays the 
log2 fold change in reads from H3K27me3 ChIP across full length repeats in Lsh-/- vs WT ES 
and NP cells. A positive value indicates an increase in H3K27me3 in Lsh-/- cells.  
 
4.2.3.4 Re-expression of wild type and mutated Lsh restores Hox gene repression 
To further test the hypothesis that Lsh plays a role in regulating expression of developmental 
Polycomb target genes, I performed qRT-PCR for Hox gene expression in the Lsh-/-(+WT Lsh) 
and Lsh-/-(+Mutant Lsh)  cell lines both when maintained as ES cells and following NPC 
differentiation.   
This revealed that re-expressing wild type Lsh in the knockout cells resulted in a rescue of 
repression of Hox genes in NPCs. Interestingly; re-expressing the mutated version of Lsh 
also rescued Hox gene repression (Figure 4.17). 
This argues against the theory that the up-regulated transcription of developmental genes in 
Lsh-/- NPCs is due to a redistribution of Polycomb complexes away from these sites due to 
hypomethylation. This is because the Lsh-/-(+Mutant Lsh) cell line failed to rescue the methylation 
defect (Section 3.2.4.3). 
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From this one could hypothesise either, that Lsh plays a direct role in targeting Polycomb to 
developmental genes or it alters transcription at these sites via interaction with other 
epigenetic pathways independent of its role in DNA methylation. 
As these hypotheses are drawn from results of Hox gene expression only, in the future they 
will need to be tested further by ChIP and RNA-Seq in the Lsh-/-(+WT Lsh) and Lsh-/-(+Mutant Lsh) 
rescue cell lines. The fact that Lsh-/-(+Mutant Lsh) cells behaved similarly to WT on 
neurodifferentiation would support restoration of developmental gene transcriptional 
regulation in these cells.
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Figure 4.17. Re-expression of wild type and mutated Lsh restores Hox 
gene repression. Bar charts display results of qRT-PCR for selected Hox 
genes in WT, Lsh-/-, Lsh-/-(+WT Lsh) and Lsh-/-(+Mutant Lsh) cell lines. Both when 
maintained as ESCs and following differentiation to NPCs. Error bars 
represent the SEM from 3 biological replicates. The Y axis displays 







The aims of the work presented in this chapter were to examine the Lsh-/- DNA methylome in 
NPCs in more detail by ERRBS and also to examine any transcriptional consequences of the 
global hypomethylation that occurs upon neurodifferentiation via RNA-Seq. My discovery 
that many of the differentially expressed genes were involved in developmental processes 
led onto the examination of the Polycomb system. 
 
4.3.1 Lsh is required for DNA methylation across repeats and single copy gene 
promoters upon neurodifferentiation, but does not influence transcription at these 
sites 
ERRBS confirmed a requirement for Lsh in appropriate DNA methylation at all repetitive 
elements included in the analysis, namely full length Satellites, LINE1s and LTRs. 
Interestingly, this analysis revealed hypomethylation at repeat elements even in Lsh-/- ES 
cells, which was not detected by global methylation analysis in chapter 3. This may point 
towards Lsh playing a minor role in maintenance methylation at this stage, this could be 
tested by repeating the analysis after multiple passages. It could, however, be argued that 
the slight degree of hypomethylation seen, may be due to a population of primed cells as ES 
cells in culture cycle between a primed and naïve state. Irrespective of this, the key role of 
Lsh in DNA methylation was during differentiation to NPCs, when Lsh-/- cells achieved only 
57.1%, 64.4% and 54.1% of WT methylation at Satellites, LINE1s and LTRs respectively. 
Supporting the “established” role for Lsh in de novo methylation, LINE1s gained methylation 
upon neurodifferentiation but to a lesser extent than in WT cells. However, ERRBS 
demonstrated a reduction in DNA methylation in Lsh-/- cells when differentiating from ESCs to 
NPCs at LTRs and Satellites. This may suggest Lsh is playing a role in maintenance 
methylation at these sites during development. Although one cannot exclude the possibility 
of these sites being demethylated at some point during the differentiation process. The role 
of Lsh in regulating DNA methylation therefore appears to be complex, being dependent on 
both genomic and cellular context. Despite this severe hypomethylation, there was no up-
regulation of repeat transcription in Lsh-/- NPCs. 
As there have been several reports of Lsh playing a role in methylation at some single copy 
loci, I also examined methylation at gene promoters and found a significant number of these 
(395) with reduced methylation. However, when examining these sites further, I noted that 
these hypomethylated promoters were more likely to be in regions of the genome enriched 





differentially methylated. Although not conclusive, this would lend support for the main 
targets of Lsh being repeat elements and that changes in methylation at single copy loci may 
simply be an effect of their proximity to retrotransposons. 
4.3.2 There is misregulation of developmental gene expression in Lsh-/- NPCs 
Although a number of genes were differentially expressed in Lsh-/- cells, particularly upon 
differentiation, the trend was not towards an overall up-regulation which might be expected in 
a hypomethylated model system. Indeed there was no correlation between promoter 
methylation and transcriptional state for the vast majority of genes. Those genes that did 
show up-regulation were not in repeat rich regions of the genome.  
Differentially expressed genes mainly had functions involved in developmental processes. 
This prompted me to investigate Polycomb regulation in my system by carrying out ChIP for 
the repressive H3K27me3 modification which is deposited by PRC2. 
4.3.3 Lsh is required for appropriate deposition of H3K27me3  
ChIP experiments revealed a redistribution of H3K27me3 away from promoter sites to 
hypomethylated repeats. Gene ontology terms of promoters losing this Polycomb mark in 
Lsh-/- NPCs were to do with neurodevelopmental processes. This may therefore account for 
the greater propensity for Lsh-/- cells to differentiate down neural lineage as demonstrated in 
chapter 3. Unlike promoter DNA methylation, the loss of H3K27me3 was correlated with 
transcriptional changes seen in Lsh-/- NPCs. 
This redistribution mirrors what is seen in other hypomethylated models. The working theory 
being that hypomethylation provides more binding sites for Polycomb, usually mutually 
exclusive from DNA methylation, resulting in a dilution effect across the genome. 
Re-expression of wild type Lsh, which rescued the methylation defect, also rescued Hox 
gene repression. However, somewhat unexpectedly, Hox gene repression, but not DNA 
methylation, was rescued in Lsh-/- cells re-expressing a mutated version of Lsh. This 
suggests something more complex than a simple redistribution of H3K27me3 to 
hypomethylated sites causing an up-regulation of Polycomb target genes is occurring. 
Possibilities include: firstly, that Lsh may play a direct role in targeting Polycomb, at least to 
Hox genes. Secondly it may be that Lsh is playing a role in regulating the transcription of 
developmental genes via interaction with other epigenetic modifiers for example via the 
intact N-terminal coiled coil domain, independent of any effects it has on DNA methylation. 
This does not argue against a redistribution hypothesis due to hypomethylation across the 






In the future it would be interesting to further explore these hypotheses with ChIP-seq 
experiments for H3K27me3 and the LSH protein in the Lsh-/-(+WT Lsh) and Lsh-/-(+Mutant Lsh) cell 
lines. 
So far the work I have presented has focused on the requirements for Lsh very early in 
neurogenesis in a cell line model which, whilst very informative, does not necessarily reflect 
the role of Lsh in vivo. In Chapter 5, I will discuss the use of a mouse model to investigate 
the role of Lsh at a later stage in neurodevelopment and the consequences of the absence 

























Chapter 5. The use of a novel targeted 
knockout mouse model to investigate the role 
of Lsh in vivo 
5.1 Introduction 
In chapters 3 and 4, I demonstrated the requirements for Lsh in early neurogenesis i.e. from 
ES to neural progenitor cell stage using a cell culture model. Whilst a very useful model 
system, it does not necessarily reflect the role Lsh plays in DNA methylation during 
neurodevelopment in vivo. Additionally, one cannot use this system to investigate the 
consequences of Lsh loss during development on the mature adult brain. Furthermore, it is 
unknown if Lsh also has a role later in neurodevelopment as NPCs differentiate to mature 
neurons. 
As previously described, Lsh knockout mice die within a few hours of birth, or in the case of 
a hypomorphic model 40% can survive up to several weeks postnatally with many 
comorbidities (Geiman et al., 2001; Sun et al., 2004). This limits their role as models for 
studying the longer term effects of any developmental DNA methylation abnormalities. 
Furthermore, the effects solely on neurodevelopment and functioning are difficult to assess 
when there are failures in multiple body systems. Similar difficulties are found in Dnmt 
knockout mouse models which are lethal in embryonic or early postnatal stages. Even 
neurally targeted Dnmt knockout models are either lethal, show no hypomethylation or are 
only targeted to a subpopulation of neurons (Fan et al., 2001) (Golshani et al., 2005) 
(Hutnick et al., 2009) (Nguyen et al., 2007) (Feng et al., 2010a).   
Our hope was that by using a neurally targeted Lsh knockout mouse model, we would have 
a novel model, that exhibited methylation defects during development, and would survive to 
adulthood without comorbidities in body systems outside of the central nervous system. 
Such a mouse was generated by Dr Ian Adam’s laboratory. Using this model, I aimed to 
assess the requirement for Lsh in DNA methylation at a later stage of neurodevelopment. As 
a Nestin-Cre model, Lsh will not be deleted until NPC stage. I also wished to examine any 
consequences upon the mature brain. This has not been feasible with previous models and 
is of great import given the recent discovery that mutations in Lsh can be causative for ICF 








5.2.1 Characterisation of a targeted Lsh knockout mouse model 
5.2.1.1 Genotype of pups resulting from final cross 
The generation of the mouse model is described in section 2.3.1. The scheme essentially 
created a targeted deletion in neural progenitor cells of exon 12 of Lsh, which encodes the 
conserved helicase domain IV. Table 5.1 displays the genotype of pups across a sample of 
litters from the final cross (Lshfl/+ Nestin Cre x Lshfl/+) in the generation of the mouse model. 
Genotype Lsh+/+ Lsh+/fl Lshfl/fl 
Cre+ 4 (10.5% vs 12.5%) 4(10.5% vs 25%) 7(18.4% vs 12.5%) 
Cre- 5 (13.2% vs 12.5%) 11(29.0% vs 25%) 7(18.4% vs 12.5%) 
 
Table 5.1. Genotype of pups. The table shows the genotype of pups across a sample of 
litters from the final cross (Lshfl/+ Nestin Cre x Lshfl/+) in the generation of the mouse model. 
Displayed are the total number of pups with each genotype and in brackets the percentage 
of pups with this genotype versus expected percentage according to Mendelian inheritance. 
Lsh+ refers to the wild type allele and Lshfl to the transgenic floxed allele. 
 
Average litter size was 7 pups which is in keeping with the average mouse litter size of 6-8 
signifying no high rates of embryonic death. Males and females were born at the expected 
ratio (42.9% and 57.1% respectively). Although genotyping of the pups was not quite at 
Mendelian frequency this is likely due to the fact that, by necessity, this analysis was done 
over a relatively small sample size of 38 pups. The fact that there were normal rates of pups 
homozygous for the transgenic allele and carrying Cre rules out any embryonic lethality due 
to the transgene itself. From this point on, mice with the genotype Lshfl/fl Cre+ will be referred 
to as the knockout model (KO). Control mice are of the genotype Lshfl/fl Cre-. Only males 
were used in all analyses. 
5.2.1.2 Verification of Recombination 
Nestin expression occurs in the developing mouse brain at around E10 reaching a peak 
globally at E14-E15 although different brain regions will show different expression levels 
according to areas of ongoing neurogenesis (Mignone et al., 2004). Nestin expression is 
down-regulated as neural differentiation reaches its terminal stages. In order to verify Cre-
Lox recombination I carried out PCR genotyping on different tissues derived from KO and 
control 12 week old mice using the primer pair illustrated in Figure 5.1 spanning the floxed 





band (820 bp) on the gel represents a recombined allele, i.e. a knockout sequence whereas 
the larger band (1540 bp) represents a non-excised floxed, i.e. wild type, sequence. This 
verified successful recombination of Lox-P sites in the Lsh gene within target tissues of 
forebrain and cerebellum as consistently in all mice tested there was no larger band visible 
on the gel.  There was also some evidence of partial recombination in other tissues such as 





Figure 5.1. Verification of recombination.  A schematic of the primer pair used to verify 
recombination in KO target tissues spanning the floxed exon 12 of the Lsh gene and a 
representative agarose gel from various tissues in KO and control mice.  Successful 
recombination (shown by the presence of a smaller band) is shown in knockout mouse 
forebrain and cerebellum with a lesser degree of recombination also occurring in non-target 








5.2.1.3 Gross brain morphology 
As regulation of developmental gene expression and neurodifferentiation was perturbed in 
Lsh-/- cells one might hypothesise that if this was occurring in vivo, there may be alterations 
in brain morphology due to the precise nature of neurogenesis timing. For example, 
premature neural differentiation could result in reduced brain weight, reduced cortical 
thickness and a reduction of the adult neural stem cell pool. 
The brains of 12 week old mice (at which point the brain is considered “adult”) were 
examined. This revealed no significant difference in total brain weight between control and 
KO mice (Figure 5.2). 
 
 
Figure 5.2. Lsh knockout mouse brains are of normal size. Image of control and KO 
mouse brains. Bar chart displaying no difference in total brain weight. Error bars represent 
SEM from measurements from 5 mice. P-values indicate level of significance calculated by 






Neuroanatomy was analysed using cresyl violet staining, which stains Nissl substance in the 
cytoplasm of neurons, revealing no anatomical abnormalities in the knockout mouse model 
(Figure 5.3 A). Brain sections were also reviewed by consultant neuropathologist Dr Colin 
Smith, who confirmed no gross changes in morphology. Measurements were also taken of 
specific brain areas including somatosensory and somatomotor cortical thickness, 
hippocampal area and the area of the granular layer of the dentate gyrus (the site of the 
adult neural stem cell pool) which again revealed no significant differences between control 
and knockout models (Figure 5.3 B). Although no gross morphological differences were 
found, it would be interesting, in the future, to investigate this using more sophisticated 
means such as staining for neural stem cells and for markers specific for each cortical layer 
with larger numbers of mice. 
In the in vivo situation there are obviously other external factors, such as diffusible signalling 
molecules, driving neurogenesis which may explain why we do not see alterations in brain 
morphology hypothesised from cell culture work where neurogenesis is largely driven by 
autocrine signalling (Hoch et al., 2009). Another reason we may not see morphological 
changes are that in this knockout mouse model, Lsh has not been deleted until the NPC 
stage. Therefore, any consequences Lsh has upon developmental gene expression and 
subsequent neurogenesis prior to neural progenitor cell stage may be missed in this model. 
In saying this, no gross changes in brain morphology have been described in models where 
Lsh is absent from the very beginning of development (Geiman et al., 2001; Sun et al., 
2004).   









Figure 5.3. Lsh knockout mouse brains show no alterations in gross morphology. A. Cresyl violet staining of mouse forebrain and cerebellum revealed no gross 
anatomical abnormalities in the knockout model. Scale bars=500µm B.  Bar charts display the average measurements of the somatomotor and somatosensory cortical 
thickness, area of the granular layer of the dentate gyrus and hippocampal area. No significant difference (tested by two-tailed student t-test) between control and 























































5.2.1.4 Behavioural Analysis 
A large proportion of ICF patients have intellectual disability, including those with causative 
mutations in Hells (Alghamdi et al., 2018). Therefore, I was keen to learn if our mouse model 
showed any deficits in behavioural testing. Furthermore, other hypomethylated mouse 
models, namely knockouts of Dnmts targeted to specific neural subtypes, show deficits in 
learning and memory and motor abnormalities (Feng et al., 2010a; Hutnick et al., 2009; 
Nguyen et al., 2007). Given limited mouse numbers with which to carry out the behavioural 
analyses the type of tests that could be performed was restricted. I reasoned, however, that 
if there were gross motor abnormalities or memory defects that these would be detectable 
with open field and spontaneous alternation tests. Three one year old mice from each group 
were analysed. 
The open field test is one of the most commonly used tests of animal behaviour, allowing 
measurements of both general locomotor activity and of anxiety-like behaviours. Ambulatory 
behaviour of the mice was measured by counting line crossings. Anxiety-like behaviours 
were also measured by recording the time spent in the centre square and crosses into the 
centre square. These recordings were used as the degree of thigmotaxis (which is the 
tendency to remain close to the outer walls) has been validated as a measure of anxiety in 
mice, with thigmotaxis increasing as anxiety increases (Simon et al., 1994). I reasoned any 
gross motor abnormalities such as a cerebellar ataxia should be detected in an open field 
test even with a small number of test subjects. The anxiety measures are likely 
underpowered, I nevertheless felt it was important to display these results as the measures 
of anxiety and locomotion are clearly intertwined and can impact on each other. Recordings 
were taken over 2 separate tests as this also allows one to assess novel environment 
exploration and habituation.  
It would be really interesting to assess learning and memory in the knockout mice. 
Behavioural paradigms used to evaluate this typically require large numbers of test subjects. 
With the limited numbers of mice available, I reasoned that it would only be suitable to 
assess working memory by spontaneous alternation in the y maze as this should be subject 
to less variability than other behavioural paradigms such as novel object recognition or the 
Barnes maze test. This test allows assessment of both working memory and exploratory 
behaviour. The test subject is placed in the maze and allowed to explore the three arms 
freely. Mice with intact cognition should show a preference to explore a less recently visited 
arm. This can be quantified by calculating the percentage of spontaneous alternation which 
is the number of successful triads (i.e. each of the 3 arms entered in turn) divided by the total 





No significant differences were found in all measures in the open field and y maze tests 
(Figure 5.4 A&B). One can conclude from this that there were no differences in exploratory 
behaviour, general motor activity or working memory. With larger numbers of mice it would 
be interesting to carry out more detailed assessment of cerebellar motor coordination for 
example on the rota rod test and more complicated learning paradigms would be necessary 




























Figure 5.4 A 
     
 
     
        
Figure 5.4. Behavioural testing in open field and Y maze. A.  Recordings from 2 separate 
open field tests of line crossings, time spent in centre square and crossings into centre 
square providing information on ambulatory and anxiety-like behaviours in the mice. 









































































































5.2.2 Global DNA methylation levels are reduced in Lsh knockout mouse brain  
To compare global DNA methylation levels between the knockout and control mouse brains I 
employed the same methods as used for the cell culture experiments described in chapter 3. 
Firstly I carried out restriction enzyme digest with HpyCH4IV which cuts DNA at 
unmethylated ACGT sites. On the gel I observed the appearance of low molecular weight 
bands following digestion in the knockout mouse forebrain and cerebellum which was not 
seen in DNA from control mice. This demonstrated hypomethylation of satellite regions in 
knockout mouse neural tissue (Figure 5.5). Digests were also carried out with MspI, a 
methylation-insensitive restriction endonuclease which cuts at CCGG sites regardless of 
methylation status as a control for the digestibility of the DNA.  
Given that I found some Cre-Lox recombination also occurring in non-target tissues, namely 
the kidney and spleen, I also screened for hypomethylation in these tissues. Using restriction 




Figure 5.4. Behavioural testing in open field and Y maze. B. Bar charts display percentage 
spontaneous alternation in the y maze, a test of working memory.  There were no significant 










Figure 5.5. DNA methylation in Lsh knockout tissue A.  Agarose gels displaying 
digestion of DNA from control and knockout mouse forebrain (FB), cerebellum (C), liver, 
kidney and spleen by methylation sensitive HpyCH4IV enzyme. DNA integrity and 
digestibility are controlled for using uncut samples and MSPI digestion respectively. Arrows 






In order to better quantify global DNA methylation I then digested DNA to single nucleotides 
and LC-MS was performed on the samples by Jimi Wills to measure 5-mC. This 
demonstrated significant hypomethylation in knockout neural tissue with a ~12% reduction in 
methylation in knockout mouse forebrain and a~ 23% reduction in knockout mouse 
cerebellum (Figure 5.6). These results establish, for the first time, that Lsh is playing an 
important role in DNA methylation during neural progenitor cell differentiation to mature 
neurons. As Lsh is not expressed in mature neural tissue, this result also demonstrates that 
a protein expressed during early neurogenesis can have a lasting impact on the mature 
neuronal methylome.  
 
 






Figure 5.6. DNA hypomethylation in Lsh knockout neural tissue Quantification of 
global 5-mC levels by LC-MS given as a percentage of total cytosines in control and KO 
mouse forebrain (FB) and cerebellum (C). Error bars represent the S.E.M of 3 biological 





5.2.3 Methylation analysis by ERRBS 
To interrogate the mature neural methylome further, and identify which regions of the 
genome had altered DNA methylation in the absence of Lsh, I employed ERRBS. DNA from 
one replicate each of KO and control forebrain and cerebellum was sent to the Epigenomics 
Core Facility of Weill Cornell Medicine who performed ERRBS. Bioinformatic processing was 
then performed by Dr Donncha Dunican. 
5.2.3.1 Repeat elements are hypomethylated in the Lsh knockout brain 
Given the finding from cell culture experiments in chapter 4, that the main role of Lsh 
appears to be methylation at repeats, I firstly looked at these regions in the tissue ERRBS 
data. As for cell culture experiments, to calculate repeat methylation the average methylation 
of individual CpGs, with a minimal depth of 5 reads, mapping to long repeats were plotted in 
violin plots in Figure 5.7. LINEs, LTR and Satellite repeats were all significantly 
hypomethylated in the knockout mouse forebrain reaching only 84.3% (p<2.2x10-16), 77.8% 
(p<2.2x10-16) and 79.2% (p=0.01) of control methylation levels respectively. The 
hypomethylation in the knockout cerebellum was far more striking with LINE1, LTR and 
Satellite repeats reaching only 47.8% (p<2.2x10-16), 31.9% (p<2.2x10-16)  and 30.1% 


















Figure 5.7. Repeats are hypomethylated in Lsh knockout mouse brain.  Violin plots demonstrate the distribution frequency with which individual 
CpGs within a family of repeats are methylated in control and knockout mouse forebrain and cerebellum. White spot indicates median value and 






5.2.3.2 Genes associated with immune function display hypomethylation in knockout 
neural tissue  
I was then interested to see if there would be any evidence of gene promoter 
hypomethylation as was found in the cell culture model. Promoter methylation was 
calculated as the average methylation of all CpGs spanning the +/- 2kb across the TSS and 
a threshold change of 20% absolute methylation difference was set to define differentially 
methylated promoters. This revealed hypomethylation of 164 promoters in the knockout 
forebrain and 99 that were hypermethylated. In knockout cerebellum a substantial 708 
promoters were hypomethylated and 42 displayed increased methylation (Figure 5.8).  
 
Figure 5.8. Promoter methylation in neural tissue. Scatter plots display average 
methylation across promoters (defined as +/- 2kb from TSS) in control and KO forebrain and 
cerebellum. Differentially methylated promoters (defined as >20% absolute methylation 
difference compared to control) are highlighted in red for hypomethylated and blue for 
hypermethylated in KO tissue.  
Gene ontology analysis using the biological processes tool in David V6.8 revealed an 
enrichment of terms to do with innate immune responses (Figure 5.9 A), bearing a striking 
resemblance to those gene ontology terms found to be enriched in hypomethylated 
promoters of Lsh-/- NPCs in chapter 4. In order to assess this similarity more stringently, I 
overlapped hypomethylated promoter files from KO mouse forebrain, cerebellum and Lsh-/- 
NPCs. This revealed an overlap of 69 genes between forebrain and cerebellum and 29 
genes between all 3 models (significantly more than would be expected by chance (by 
hypergeometric testing). This suggests that similar pathways are affected by loss of Lsh both 
in NPCs and mature neurons but that the effects of loss of Lsh clearly varies depending on 
the cellular context (Figure 5.9 B). 






            
           
                    Figure 5.9. Genes associated with innate immunity are hypomethylated in KO neural tissue. A. Gene ontology analysis of 
hypomethylated promoters in KO neural tissue. Table shows the top most significant biological process terms. Red line demarcates 
p=0.05 B. Venn diagram displaying the overlap of hypomethylated gene promoter lists across KO mouse forebrain and cerebellum and 







5.2.3.3 L1 repeats are enriched at hypomethylated gene promoters in KO neural tissue  
Given the main role of Lsh in methylating repeats, there exists the possibility that the 
promoters found to be hypomethylated are simply so because they are in the vicinity of 
hypomethylated repeats. This was tested using the same method as in section 4.2.1.3. 
In agreement with what was seen in the cell culture model, this analysis revealed that that 
the 20kb stretch of genome surrounding the TSSs of hypomethylated promoters in KO 
neural tissue was enriched for L1 elements when compared to the regions surrounding non-
differentially methylated promoters. This was also true, although to a lesser extent, for LTR 
content at these regions in KO cerebellum. LTR content however was not enriched at these 
regions in forebrain although the data had more noise due to the smaller number of 









Figure 5.10. Repeat content of genome surrounding hypomethylated promoters in KO neural tissue. Graphs divide the genome surrounding the TSS of 
genes, with hypomethylated promoters in KO forebrain and cerebellum (orange line) and genes with unchanged promoter methylation status when compared to 
control (blue line), into 800bp bins 10kb up and downstream of the TSS. Each bin is represented by a point on the graph. The average percentage of base pairs 
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5.2.4 Analysis of the transcriptome by RNA-Seq 
Given the hypomethylation seen in the knockout mouse brains, RNA-Seq was utilised to 
analyse if there were any transcriptional changes. Bioinformatic processing was carried out 
by Dr Donncha Dunican. 
5.2.4.1 Repeat sequences are aberrantly expressed in the Lsh knockout mouse brain  
Expression of repetitive elements was analysed initially. As with cell data, these were 
analysed separately in terms of full length (>6kb in the case of LINE1s and LTRs and >1kb in 
the case of satellites) and “short” repeats.  In contrast to the findings in the Lsh-/- NPCs in 
chapter 4, this analysis did reveal aberrant repeat expression within the KO mouse model 
(Figure 5.11 & 12). 
This deregulation of repeat suppression occurred at LTRs and LINE1s and was more 
marked in the cerebellum. The up-regulation of LTRs and LINE1s was confirmed by qRT-
PCR which also demonstrated a huge up-regulation of major satellite repeat expression in 
KO cerebellum which was not evident from RNA-Seq analysis (Figure 5.13). I suspect this is 
due to the fact that RNA-Seq was carried out from polyA-selected libraries and that these 
repeats do not undergo polyadenylation. This is supported from a recent paper comparing 
repeat expression in human tumour tissue using both polyA-selected and total RNA-Seq 
which revealed that repeat elements were not properly detected in polyA selection 
methodologies and that this was most striking for satellites which were barely detected at all 
(Solovyov et al., 2018). It would therefore be beneficial to repeat analysis using total RNA-
Seq.  
For a read to be included in this analysis it had to map uniquely to the genome. Whilst this 
provides a robust dataset for analysis of an individual repeat’s influence over neighbouring 
genomic regions, it of course means that a lot of data is lost due to conservation of 
sequences between retrotransposons and the fact that the same repeat may be found at 
multiple genomic regions. The results shown in Figure 5.11 &1 2 are therefore likely to be an 
underestimate of repeat differential expression and so results for non-uniquely mapped 










Figure 5.11. Repeat expression in forebrain.  Scatter plots display read counts of LINE1 (L1), long terminal repeat (LTR) and satellite (Sat) sequences from RNA-
Seq analysis from 3 biological replicates of control and KO forebrain tissue. Repeats defined as differentially expressed in KO tissue (>4 fold change and FDR<0.05) 
are highlighted in red if up-regulated and blue if down-regulated. Data is shown for reads mapping to full length repeats (long) and non-full length repeats (short). 
Control log2(read count) Control log2(read count) Control log2(read count) 









Figure 5.12. Repeat expression in cerebellum.  Scatter plots display read counts of LINE1 (L1), long terminal repeat (LTR) and satellite (Sat) sequences from 
RNA-Seq analysis from 3 biological replicates of control and KO forebrain tissue. Repeats defined as differentially expressed in KO tissue (>4 fold change and 
FDR<0.05) are highlighted in red if up-regulated and blue if down-regulated. Data is shown for reads mapping to full length repeats (long) and non-full length repeats 
(short).
Control log2(read count) Control log2(read count) Control log2(read count) 






Figure 5.13. Repeat expression by qRT-PCR. Bar charts display results of qRT-PCR for major satellites, LINE1s and LTRs. The error bars represent the SEM 
from 3 biological replicates from control and KO forebrain (FB) and cerebellum (C). The Y axis displays arbitrary expression units (AEU) and results are normalised 





5.2.4.2 Genes associated with immune response are differentially expressed in the 
knockout mouse 
Analysis of gene expression from the RNA-Seq dataset revealed fewer genes were 
differentially expressed in mouse knockout forebrain and cerebellum than in the cell culture 
experiments. Genes were considered differentially expressed if they had an >2 fold change 
in expression and P value <0.05 across 3 replicates. Genes with read depth <10 were 
excluded from the analysis. In KO forebrain 34 genes were down-regulated and 150 up-
regulated and in cerebellum 41 genes were down-regulated and 224 up-regulated (Figure 
5.14).  
 
Figure 5.14. Differentially expressed genes in Lsh knockout mouse brain. Volcano plots 
display log 2 fold change in expression of genes between control and knockout forebrain and 
cerebellum. Genes defined as differentially expressed are shown in red with others displayed 
in black. Total numbers are displayed on the graph.  
Up-regulated gene lists were subjected to gene ontology analysis using DAVID V6.8. This 
revealed a significant enrichment of terms to do with innate immune response reflecting the 
ontological categories enriched in the hypomethylated gene promoter lists in both Lsh-/- 
NPCs and KO neural tissue (Figure 5.15 A).  As the number of genes in each category was 
limited I also uploaded the up-regulated gene lists into Interferome V2.01, an online tool 
which reports back on those genes which are known to be interferon regulated (Rusinova et 
al., 2013). This revealed that a large percentage of the up-regulated genes, 53% in forebrain 
and 29% in cerebellum, were known to be interferon regulated (Figure 5.15 B) therefore 
providing further evidence to validate gene ontology findings. A selection of these genes 

























Figure 5.15. Innate immune genes are up-regulated in knockout mouse brain. A. 
Tables display the top ten most significant gene ontology biological process terms for genes 
up-regulated in KO forebrain and cerebellum. Red line demarcates p=0.05. B. Pie charts 
display the percentage of up-regulated genes that are known to be interferon regulated  as 
analysed by the online tool Interferome (Lists of these up-regulated interferon regulated 
genes are displayed in Appendix Lists A7-8). C. qRT-PCR validation of expression of a 
selection of immune response genes found to be up-regulated in KO neural tissue. Error 
bars represent the SEM from 3 biological replicates. The Y axis displays arbitrary expression 









In order to see if the models overlapped in their transcriptional changes I merged the up-
regulated gene files of KO mouse forebrain, cerebellum and Lsh-/- NPCs. This revealed a 
large degree of similarity between KO mouse forebrain and cerebellum with 56 genes in 
common (See Appendix List A9). This was a significantly greater overlap than would be 
found by chance (p=7.78x10-70), however unlike the overlap seen in the hypomethylated 
promoter files there was essentially no overlap with genes differentially expressed in Lsh-/- 
NPCs (Figure 5.16). 
 
Figure 5.16 Overlap of up-regulated genes in knockout models. Venn diagram 
displaying the overlap of up-regulated genes across KO mouse forebrain, cerebellum and 
Lsh-/- NPCs. 
Of particular note is the fact that up-regulated gene ontology terms from knockout tissue are 
devoid of developmental processes, the major terms found in the analysis of differentially 
expressed genes in Lsh-/- NPCs in section 4.2.2.2. The absence of key developmental genes 
such as Hox genes from the up-regulated gene list in tissue is curious given that these 
genes are found to be derepressed in tissues from other Lsh-/- mouse models (Xi et al., 
2007). This may be due to the different timing of Lsh deletion between the models such that 
by NPC stage the majority of Polycomb target genes have been silenced for example by 
remodelling or DNA methylation (Liu et al., 2017; Mikkelsen et al., 2007; Mohn et al., 2008). 
Looking specifically at 539 genes defined as gaining H3K27me3 upon NPC to terminal 
neuron differentiation by Mohn et al (Mohn et al., 2008) only 7 were found to be upregulated 
in the KO cerebellum and  6 in KO forebrain. Another possibility is that  this model is a 
hypomorph and a truncated protein is present that, whilst lacking DNA methylation functions, 
still retains the ability to regulate developmental gene transcription.  
In order to discern if promoter hypomethylation correlated with transcription, I integrated the 





overlapped between these datasets in KO forebrain only 2 were hypomethylated (Serpina1b 
and Usp9y). In KO cerebellum a significant (p=1.59x10-20 by hypergeometric testing) minority 
of 22 (See Appendix List A10) out of the 85 up-regulated genes that overlapped in the 
dataset also had hypomethylated promoters (Figure 5.17). This suggests that contrary to 
what was seen in NPCs, promoter hypomethylation is more correlated with transcriptional 
activation in up-regulated genes in the KO cerebellum.  
   
 
Figure 5.17 Overlap of up-regulated and hypomethylated gene promoters in KO brain. 
Scatter plots display the average promoter methylation of genes up-regulated in KO mouse 
forebrain and cerebellum. Those genes with differentially methylated promoters (defined as a 
change of >20%) are shown as red circles for hypomethylated and blue for hypermethylated 
in KO tissue.  
 
5.2.4.3 Repeats are not enriched at up-regulated genes in KO neural tissue 
As repeat transcription was shown to be up-regulated in KO neural tissue, it is possible that 
this would influence the expression of nearby genes. For example there may be spreading of 
the euchromatic state from the repetitive region to the TSS of the gene and increased 
availability of the transcriptional machinery recruited to the site. Another possibility is that 
nearby LTRs could act as alternative promoters as is well described in the literature (Dunn et 
al., 2003; Feuchter and Mager, 1990; Medstrand et al., 2001; Romanish, 2007). I therefore 
examined the repeat content of the genome surrounding the TSS of up-regulated genes 
using the method described in section 4.2.1.3. This revealed that promoters of up-regulated 
genes in KO mouse forebrain and cerebellum were actually found in genomic regions with 
less L1 or LTR content than non-differentially expressed genes (Figure 5.18). 






Figure 5.18. Repeat content of genome proximal to up-regulated genes in KO neural tissue. This graph divides the genome surrounding the TSS of up-
regulated genes in KO forebrain and cerebellum (orange line) and genes not differentially expressed between control and KO mice (blue line) into 800bp bins 10kb 
up and downstream of the TSS. Each bin is represented by a point on the graph. The average percentage of base pairs within each 800bp bin that form part of an 
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To look at the effect individual de-repressed repeats may be having on gene transcription I 
identified de-repressed repeats which could be considered in the regulatory domain of a 
gene. This was done using the default settings of the Genomic Regions Enrichment of 
Annotations Tool (GREAT) (McLean et al., 2010). This tool assigns a gene basal regulatory 
region that extends 5kb upstream and 1 kb downstream of the TSS. The gene’s regulatory 
domain is then extended up to the basal regulatory region of the nearest up and downstream 
genes (to a maximum of 1MB). This tool has been used by others to identify 
retrotransposons in human cells with the potential to regulate immune genes (Chuong et al., 
2016). In this paper the authors elegantly demonstrated that certain LTRs in the human 
genome have been co-opted to act as enhancers of genes involved in the immune response. 
Given the gene ontology findings described in section 5.2.4.2, I was interested to investigate 
if de-repressed retrotransposons could be acting as enhancer / promoter elements of 
immune genes in the mouse model. 
This analysis revealed a total of 43 genes in forebrain and 211 in cerebellum which 
contained up-regulated repeats in these defined regulatory regions in knockout tissue. Of 
these genes, 16 were found to be up-regulated in knockout cerebellum and only 1 in 
knockout forebrain (Appendix Table A1). Three of these up-regulated genes, namely Hamp2, 
Serpinb1c and Cyp2a5 were identified by the online Interferome tool to be interferon 
responsive genes. However, this is not described as their primary role and they are not 
described as upstream regulators of innate immune pathways. Therefore their up-regulation 
is not known to drive an innate immune response. This demonstrates that de-repression of 
retrotransposons cannot directly account for the vast majority of up-regulated genes in 
knockout tissue and does not explain activation of the innate immune system by proximity of 
immune genes to upregulated repeats. A caveat to this is that there may be up-regulated 
repeats missed by our analysis due to exclusion of reads that did not match our robust cut 
offs for unique mapping or due to polyA selection. Other potential explanations for the 












5.2.5 Overlap of models with human ICF syndrome 
A key and exciting prospect is the potential for this knockout mouse model to be used as a 
tool for the investigation of neurological deficits in ICF syndrome. A note of caution is that 
one of the main roles of Lsh is methylation of repeats and there is divergence of repeat 
family subclases and activity between species. Therefore cross-translation of results to 
humans should be done with care. In saying this, models of other subtypes of ICF do show 
phenotypes reminiscent of the human condition (Rajshekar et al., 2018; Ueda et al., 2006).  
I was interested to compare my findings with published data from human studies in ICF 
patients. A recent study analysed the methylome from whole blood in patients with all 4 
known subtypes of ICF syndrome. Findings revealed that although there was overlap of 
hypomethylation at pericentromeric repeats and some common loci, methylomes could 
actually distinguish between subtypes. Although the majority of hypomethylation occurred at 
intergenic regions, there were a number of gene clusters which were found to be 
hypomethylated in patients, these were the PCDH cluster (hypomethylated in all subtypes 
but more so in DNMT3b subtypes) and the OR and KRTAP gene clusters which were 
hypomethylated in ICF2-4 subtypes (Velasco et al., 2018a).  
I therefore analysed methylation of these gene clusters in both my cell and mouse models. 
This analysis revealed a trend for hypomethylation of promoters in all of these gene clusters 
in each of the models. Increased expression across the PCDH locus was also found (Figure 
5.19). Although expression was unchanged in the other clusters these genes are not 
normally expressed in control cells. 
These similarities between human sites of hypomethylation and findings in the mouse lend 
some support to the use of this mouse as a model of ICF syndrome. Ideally more 
comparisons would be made with neural tissue or neural cells derived from ICF type 4 
patients if this becomes available. Further behavioural testing in the mouse model would 

















Figure 5.19.  Methylation over gene clusters hypomethylated in ICF patients. Box plots display 
the average methylation across promoters of gene clusters; protocadherin B (Pcdhb), olfactory 
receptors (Or) and Keratin associated proteins (Krtap) in mouse neural tissue and Lsh-/- and WT ES 
and NP cells. The final boxplot displays the average expression across the Pcdhb gene cluster in 
mouse neural tissue and Lsh-/- and WT ES and NP cells extracted from RNA-Seq data expressed in 









In this chapter I have presented the characterisation of a novel mouse model with a targeted 
deletion of Lsh in neural tissue. It is the first mutant Lsh model that survives to adulthood. 
Furthermore it is the first model surviving to adulthood, with hypomethylated neural tissue as 
a result of abnormal DNA methylation across all neural cell types during development. Not 
only did this model permit me to investigate the requirement for Lsh in DNA methylation at a 
later stage in neurodevelopment than has previously been investigated, but it also allowed 
me to investigate the consequences of the absence of Lsh during neurodevelopment on the 
mature brain. 
 
5.3.1 Lsh is required during development for appropriate DNA methylation and 
repression of repeats in the mature brain 
I have demonstrated, by ERRBS, a requirement for Lsh during differentiation of NPCs for 
appropriate DNA methylation at repetitive elements, namely satellites, LTRs and LINE1s. As 
Lsh is not expressed in the mature brain, it demonstrates that an abnormal methylome 
deposited during neurodevelopment persists into later life. This role for Lsh at later stages of 
cell differentiation has not previously been described and is interesting given the fact that 
Lsh is down-regulated upon differentiation. Furthermore, de-repression of repetitive elements 
was also seen in the KO adult brain.  
This hypomethylation and subsequent repeat de-repression was more pronounced in 
cerebellar compared to forebrain tissue. One explanation for this could be that cerebellar 
Purkinje cells are proposed to undergo a more extensive  de-methylation, re-methylation 
event than neurons of the forebrain (Zhou et al., 2016). It would be interesting to investigate 
if this de-repression of repeats results in an increase in retrotransposition events. 
Given the greater propensity for Lsh-/- cells to differentiate towards neural lineage and the 
mis-regulation of expression of genes involved in developmental processes uncovered in 
chapter 3, I was interested to examine the morphology of the KO mouse brain. One might 
expect this to be perturbed given the requirement for strict control of spatiotemporal gene 
expression during neurogenesis. The KO model, however, demonstrated that despite the 
gross changes in the neural methylome that occur in the absence of Lsh, neurodevelopment 
proceeds unperturbed with no severe effects on mature brain morphology or behaviour. 
Although this model does not ascertain that this would be the case if Lsh is absent from the 
very beginning of development, there are also no reported gross morphological brain 
changes in full Lsh-/- models (Geiman et al., 2001). Cerebral malformations have been 





atrophy and corpus callosum hypoplasia (Weemaes et al., 2013). It should be noted that the 
majority of ICF patients do not undergo brain imaging therefore the true incidence is 
unknown. A large proportion of patients with ICF suffer from intellectual disability of varying 
degrees. This mouse model displayed no gross abnormalities in working memory or gross 
motor abilities. It would be very interesting, with larger numbers of mice, to carry out more 
sensitive testing of learning and memory to assess if there are any behavioural phenotypes 
akin to ICF syndrome.  
 
 5.3.2 Immune genes are up-regulated in the Lsh KO mouse brain 
Of particular interest is the apparent activation of the immune system in the KO mouse brain, 
as evidenced by up-regulation of genes involved in the innate immune response in the RNA-
Seq data. This analysis suggests that this was not a direct consequence of up-regulated 
repeats regulating the transcription of these genes as has been shown for some individual 
repeats in human cells (Chuong et al., 2016). A strong possibility is that the innate immune 
system is responding to the inappropriate accumulation of transcripts from retrotransposons 
via the cytosolic nucleic acid sensing pathway. 
The innate immune system is a first line defence against viral pathogens. Viral nucleic acids 
and proteins are recognised as non-self pathogen-associated molecular patterns (PAMPs) 
by host nucleic acid-binding pattern-recognition receptors (PRRs). 
It is now recognised that transcripts from endogenous retroviruses can also be recognised 
as PAMPs by these receptors and lead to human disease. The classical example of this 
being the autoimmune disease, Aicardi-Goutières’s Syndrome (AGS), caused by mutations 
in Trex1. This gene encodes a protein with a role in metabolizing reverse-transcribed 
cDNAs. In these patients, intracellular accumulation of endogenous retroelement transcripts 
is linked to activation of the interferon response leading to clinical symptoms of neurological 
dysfunction and cutaneous inflammation (Stetson et al., 2008). 
Products of endogenous retroelement transcription could act as PAMPs by several different 
means. Firstly, the transcripts could be translated for the production of viral proteins leading 
to budding of viral particles which could be recognised by PAMPs on the plasma membrane. 
Secondly, cDNA or intermediates generated during reverse transcription could be detected 
by cytosolic PAMPs (Hurst and Magiorkinis, 2015).  
The major families of PRRs are; the Toll-like receptors (TLRs) present on the plasma and 
endosomal membrane (O'Neill et al., 2013), cGAMP synthase (cGAS) which detects ssDNA, 
dsDNA and RNA:DNA hybrids in the cytosol (Gao et al., 2013), the DNA-dependent activator 





and the RIG-1 like receptors (RLRs) which detect dsRNA (Loo and Gale, 2011). DAI was 
found to be up-regulated in the KO mouse forebrain and cerebellum. 
Detection of PAMPs by these PRRs activates complex signalling cascades leading to altered 
gene expression and ultimately production of pro-inflammatory cytokines and interferons. 
Activation of interferon signalling gives rise to induction of IRF and STAT TFs which bind to 
cis-regulatory elements upstream of interferon responsive genes (Crosse et al., 2018). Some 
interferon stimulated genes have been shown to directly inhibit the viral life cycle and 
enhance early innate immune signalling. Examples of these include DDX60 which has the 
ability to degrade viral RNA as well as augmenting the RLR pathway (Oshiumi et al., 2015). 
A number of members of the TRIM family also have the ability to directly restrict viruses and 
also enhance PAMP detection of viral nucleic acids (Carthagena et al., 2009). PKR is 
another protein which can detect dsRNA in the cytoplasm and augment other innate RNA 
detection pathways (Der et al., 1997; Pham et al., 2016) (Figure 5.20). 
 
 
Figure 5.20. Innate immune signalling. This illustration provides a simplified view of innate 
immune signalling cascades in response to detection of viral / endogenous retroviral proteins 
and nucleic acids. See text for full description. Host nucleic acid-binding pattern-recognition 
receptors (PRRs), highlighted in blue boxes detect pathogen-associated molecular patterns 
(PAMPs), highlighted in red. This leads to the induction of complex signalling cascades, 
highlighted in purple which lead to the production of proinflammatory cytokines (CKNs) and 
interferons (IFNs) and downstream activation of interferon stimulated genes (ISGs). A 
number of these interferon responsive genes have been shown to play direct roles in 
detection and inhibition of viruses as well as augmenting the innate immune response 
(highlighted in green). Red stars highlight genes found in up-regulated gene lists from KO 
mouse neural tissue. (Figure adapted from (Crosse et al., 2018)) 
Alternatively, up-regulation of immune genes could reflect a Senescence-associated 





did not find any induction of p53 (a TF with key roles in modulating cellular senescence) or 
related gene targets (Appendix Table A2). This will be discussed further in chapter 6. 
These findings open up further exciting avenues of research into the aetiology of intellectual 



























Chapter 6. Discussion 
6.1 Summary 
A number of neurodevelopmental disorders are linked with deficits in the DNA methylation 
pathway. There has also been a recent upsurge in the amount of research investigating 
altered methylomes in health and disease, particularly in my own field of psychiatry (Liu et 
al., 2018). Despite this, we still do not fully understand the mechanisms underlying DNA 
methylation reprogramming during neurodevelopment. The aim of my thesis was to broaden 
our understanding of this process by investigating the role of a particular protein, Lsh, and its 
contribution to DNA methylation at this time. 
How defects in DNA methylation pathways during development may affect the mature brain 
and lead to neurological symptoms is unknown. This is largely a result of a lack of suitable 
models. Lsh and Dnmt mouse knockouts are lethal (Geiman et al., 2001; Okano et al., 1999; 
Walsh and Bestor, 1999). Even neural targeted Dnmt knockouts are limited in their use as 
models for investigating this question due to: lethality, lack of effects on methylation in post-
mitotic neurons or only a subpopulation of neurons being targeted (Fan et al., 2001; Feng et 
al., 2010a; Golshani et al., 2005; Hutnick et al., 2009; Nguyen et al., 2007). 
At the beginning of this project little was known about Lsh. With the recent finding of a 
mutation in this gene being causative for ICF syndrome (Thijssen et al., 2015), more has 
been published on this subject. Lsh is down-regulated upon differentiation of mESCs and 
during development, however most studies have focused their examination on end-state 
somatic tissue rather than during the differentiation process. Furthermore, the majority of 
research on this protein has focused on specific loci rather than looking at genome-wide 
consequences of its loss and has not fully investigated the consequences of Lsh inactivation 
on transcription states. 
The aim of this project was to investigate the potential contribution of Lsh to DNA 
methylation during neurogenesis. This was done using a CRISPR generated Lsh-/- mES cell 
line and inducing neural differentiation using an N2B27 protocol. This allowed assessment of 
its role in DNA methylation at an early stage of neurogenesis, i.e. formation of neural 
progenitor cells. In contrast to the majority of previous studies, a genome-wide approach was 
adopted, utilising ERRBS and RNA-Seq to assess the methylome and transcriptome 
respectively. The discovery of the misregulation of developmental genes in Lsh-/- cells led 
onto a genome wide analysis of Polycomb distribution.  
In the second part of this project a novel Nestin-Cre targeted Lsh-/- mouse generated by Dr 





progenitor cells. In contrast to the previous models mentioned, this mouse with inactivation 
of exon 12 of Lsh in neural lineage cells: survived to adulthood, demonstrated 
hypomethylated neural tissue and deletion was not targeted to only a subpopulation of 
neurons. As Lsh was not deleted until NPC stage (beginning E10 when Nestin is expressed), 
the contribution of Lsh to DNA methylation at a later stage of neurodevelopment could be 
examined. This was done through genome-wide interrogation of the methylome and 
transcriptome of forebrain and cerebellar tissues. 
It was hoped that by using this model, we would gain a better understanding of the 
consequences of aberrant DNA methylation during development on the mature brain with the 
possibility of gaining new insights into the aetiology of the neurological symptoms found in 
ICF syndrome. 
The major findings of this body of work have resulted in the following conclusions: 
 Lsh contributes to DNA methylation of repetitive elements at both early and later 
stages of neurogenesis 
 Lsh is required for appropriate distribution of Polycomb 
 Lsh plays a role in regulating Polycomb targeted developmental gene transcription 
which may be independent of its role in DNA methylation 
 Lsh is required to repress repeat transcription in the mature mouse brain 
 Innate immune pathways are activated in the murine brain in the absence of Lsh 
 The role of Lsh is context dependent  
 
6.2 Lsh contributes to DNA methylation during neurogenesis 
The requirement for Lsh for appropriate global DNA methylation during early neurogenesis 
was demonstrated by LC-MS. This revealed no difference in global 5mC between WT and 
Lsh-/- ES cells, but following differentiation to NPCs the knockout cells became 
hypomethylated, reaching only ~70% of the methylation level of WT cells. ERRBS data 
revealed a specific loss of methylation at repeat sequences following differentiation and at a 
number of single copy gene promoters.  
The established role for Lsh is in de novo methylation. This was concluded largely as a result 
of work transfecting episomal vectors into Lsh-/- MEFs. These experiments revealed a 
requirement for Lsh to establish novel methylation patterns, but no requirement for 
maintenance of previously methylated vectors (Zhu et al., 2006). Furthermore, the 
association of Dnmt3b with repeat sequences in ES cells is impaired in the absence of Lsh 





gained in both WT and Lsh-/- cells upon differentiation to NPCs, but to a lesser extent in the 
absence of Lsh. This would be in keeping with the aforementioned role in de novo 
methylation. This replicates the pattern seen in another study examining L1 repeat 
methylation by bisulphite sequencing following neural differentiation of Lsh-/- cells (Ren et al., 
2015). Of particular interest, however, was the pattern of methylation at Satellite and LTR 
repeats. ERRBS revealed that whilst WT cells maintained their methylation level at these 
sites upon differentiation, Lsh-/- cells failed to do so. This would suggest a role for Lsh in 
maintenance methylation in this context. The reduction in global methylation upon 
differentiation of Lsh-/- ESCs to NPCs as demonstrated by LC-MS supports this. This could 
be tested by maintaining a population of dividing NPCs and repeating methylation analysis at 
different passages.  
An alternative explanantion is that there may be further demethylation / remethylation events 
at these sites during the transition from ESC to NPC. Repeating methylation analysis at 
these sites at multiple time-points during this developmental window would be required to 
confirm this.  Support for a role in maintenance methylation comes from the finding that 
knockdown of Lsh in primary human fibroblasts leads to progressive loss of methylation at 
repeat sequences (Suzuki et al., 2008), and that Lsh has also been shown to directly interact 
with the maintenance methyltransferase Dnmt1 (Dunican et al., 2015). It would be interesting 
to carry out a ChIP for Dnmt1 upon differentiation of WT and Lsh-/- cells to assess its 
association at Satellite and LTR sites. 
Not only did the work presented in this thesis demonstrate a requirement for Lsh in DNA 
methylation from ESC to NPC differentiation, but it also revealed a previously unknown 
requirement for Lsh at later stages of neurogenesis also. This was demonstrated by 
methylation analysis of neural tissue from the Nestin-Cre Lsh-/- mouse, where global 
methylation levels in forebrain and cerebellum reached 88% and 77% of control levels 
respectively. In this model, Lsh is not depleted until NPC stage when Nestin is expressed. 
Therefore, despite the down-regulation of Lsh expression upon differentiation (which was 
confirmed in my RNA-Seq data set (Appendix Figure A4)), it is still required at these later 
stages for appropriate DNA methylation. 
This is the first study looking at genome-wide promoter methylation levels in Lsh-/- NPCs and 
mouse neural tissue. This was done given the reports of selected single copy loci 
hypomethylation in other Lsh-/- models (Fan et al., 2005b; Xi et al., 2009; Xi et al., 2007). 
ERRBS data revealed hypomethylation of 395 gene promoters in Lsh-/- NPCs, 164 in KO 
forebrain and 708 in KO cerebellum. Given the role for Lsh in methylating repetitive 
elements, I considered the possibility that these promoters were hypomethylated due to their 





LINE1s, and to a lesser extent LTRs, were enriched in the 20kb region surrounding these 
hypomethylated promoter TSSs when compared to non-differentially methylated promoters 
in KO NPCs, forebrain and cerebellum suggesting that this was, indeed, the case. 
Despite the finding that a number of promoters displayed hypomethylation in the knockout 
models, this did not translate into an increased transcription of these genes in NPCs or 
mouse forebrain. There was, however, a stronger correlation between expression and 
promoter methylation status in the KO cerebellum.  
In this study, ERRBS was employed as the main method by which to study DNA methylation. 
Its many advantages include, the ability to carry out genome-wide assessment of the 
methylome with greater coverage than traditional RRBS methods, at reduced cost and 
sequencing requirements of whole-genome bisulphite sequencing. However, it does not 
possess the coverage of the latter, favouring CpG dense genomic regions, therefore may 
have missed regions where Lsh plays a role in methylation. This is particularly important to 
highlight given the recently published paper comparing the methylomes of patients with all 4 
subtypes of ICF syndrome (although this only included one patient with a mutation in Hells). 
In this paper 36% of hypomethylated probes in Type 1 patients were in CGIs compared to 
only 4% in Type 4 where 71% were in “open sea”, defined as isolated CpGs in the rest of the 
genome (Velasco et al., 2018b). Additionally, sites of non-CpG methylation, which are 
enriched in neural tissue, will be missed. Furthermore, bisulphite sequencing cannot 
distinguish between 5mC and 5hmC (Nestor et al., 2010). This may be particularly relevant 
in these model systems given the abundance of 5hmC in neural tissue (Khare et al., 2012; 
Spiers et al., 2017). In order to distinguish between these modifications, methods such as 
methylated and 5-hydroxymethylcytosine DNA immunoprecipitation would have to be used 
(Lentini et al., 2018). 
 
6.3 Lsh represses repeat transcription 
An important consequence of this hypomethylation was the reactivation of normally 
repressed repetitive sequences. RNA-Seq demonstrated a derepression of LTRs and 
LINE1s in KO forebrain and cerebellum.  
PolyA-selected RNA-Seq was employed as opposed to total RNA-Seq. This has the 
advantage of selecting against ribosomal RNA, which can overwhelm the data by 
contributing a high proportion of reads.  However, recent papers have demonstrated the 
inferiority of polyA-selection compared to total RNA-Seq when looking at repeat sequences 
(Solovyov et al., 2018). This is particularly true for satellite sequences, which may explain 





Seq data. It would therefore be interesting to examine repeat transcription profiles using total 
RNA-Seq. 
As discussed in chapter 1, repetitive elements are normally strictly repressed as their activity 
could have a broad range of detrimental consequences (Crichton et al., 2014; Garcia-Perez 
et al., 2016). The consequences of retrotransposition can be severe resulting in genomic 
instability and insertional mutagenesis. De-repression of repeat elements could have effects 
on gene expression independent of retrotransposition. They can also promote aberrant 
transcription as some L1 and LTRs contain bidirectional promoters and enhancer elements 
thereby promoting transcription of flanking sequences (Cruickshanks and Tufarelli, 2009; 
Speek, 2001). Intronic insertions can lead to aberrant splicing or premature polyadenylation. 
Futhermore the retrotransposon may attract repressive epigenetic modifications silencing 
nearby genes by spreading of heterochromatin (Cruickshanks et al., 2013).  Finally, protein 
products of retrogenes could alter cell functions. It would be very interesting to determine if 
retrotransposition was occurring within the Lsh-/- models for example by whole genome 
sequencing or by using transposition reporters (Macia et al., 2017). 
To determine if de-repressed repeat elements have effects on gene expression in my mouse 
model I examined the repeat content of the genome 10kb up and downstream of the TSS of 
those genes found to be up-regulated in the KO mouse. This revealed that the genome 
surrounding up-regulated genes was actually less rich in repeats than that of surrounding 
non-differentially expressed genes. This however does not exclude a role for individual 
repeats in influencing transcription. I therefore looked into this by examining the presence of 
up-regulated repeats within regulatory domains of up-regulated genes. This revealed that of 
the 150 genes up-regulated in KO forebrain only 1 had an up-regulated repeat in its 
regulatory domain. Of the 224 genes up-regulated in cerebellum, 16 had up-regulated 
repeats within their regulatory domains. Therefore the majority of differentially expressed 
genes do not appear to be so as a direct result of transcriptional regulatory control by up-
regulated repeats. This analysis is of course limited to those repeats meeting our robust cut 
offs for inclusion within the analysis. Furthermore I cannot absolutely exclude that up-
regulated repeats may be acting as distal enhancers given the method in which I defined 
regulatory domains. ChIP for enhancer associated marks such as H3K27 acetylation would 
have to be carried out to examine this possibility.  
 
6.4 Lsh regulates the expression of developmental genes 
Analysis of the transcriptome of Lsh-/- ESCs and NPCs by RNA-Seq revealed a number of 





an enrichment of genes to do with developmental processes.  As well as by DNA 
methylation, developmental genes are known to be regulated by the Polycomb system 
during differentiation. Given the lack of correlation between differential expression and 
promoter methylation status, it led me to consider whether mis-regulation of the Polycomb 
system may account for the transcriptional changes seen. 
This hypothesis was drawn on our knowledge of Polycomb redistribution in other 
hypomethylated models, including cancer, where it is proposed that hypomethylated regions 
provide new binding sites for Polycomb, diluting its deposition across the genome (Dunican 
et al., 2013; Reddington et al., 2013). In order to investigate this, I carried out ChIP-Seq for 
the Polycomb repressive mark H3K27me3. This revealed a widespread depletion of this 
mark across promoter regions in Lsh-/- NPCs and redistribution to hypomethylated repeats 
suggesting a requirement for appropriate DNA methylation to allow correct targeting of 
Polycomb. 
This was also correlated with transcriptional status, as differentially expressed genes were 
shown to have a greater reduction of this mark across promoter regions compared to non-
differentially expressed genes. Furthermore, genes differentially expressed in Lsh-/-  NPCs 
were enriched for H3K27me3 in WT cells compared to those that were not differentially 
expressed. This establishes a role for Lsh in regulating expression of Polycomb targeted 
genes and concurs with previously reported findings of aberrant Hox gene expression in Lsh-
/- mice (Xi et al., 2007). 
Initially I considered this transcriptional regulation by Lsh occured secondary to its effects on 
DNA methylation. In this model, in the absence of Lsh, repetitive elements become 
hypomethylated upon differentiation resulting in redistribution of Polycomb away from target 
sites of genes associated with development to hypomethylated repeats resulting in 
deregulation of developmental genes and the greater propensity for Lsh-/- cells to 
differentiate to neural lineage. However, I found that repression of Hox gene expression was 
rescued by the reintroduction of a mutant version of Lsh that did not rescue the methylation 
defect. This would argue against this theory. In keeping with this, Lsh-/-(+ mutant Lsh) cells 
behaved like WT upon differentiation. Furthermore, a depletion in Polycomb was not only 
associated with up-regulated but also with down-regulated genes in Lsh-/- NPCs.  
This therefore provides preliminary evidence for a role for Lsh in regulating developmental 
gene expression independent of its role in DNA methylation. This may be through direct 
targeting of Polycomb, indeed, Lsh has been found to co-immunoprecipitate with 
components of the PRC1 complex (Xi et al., 2007) or association with other epigenetic 
modifiers. For example the N-terminal portion of Lsh containing the coiled coil domain alone, 





silence a reporter gene. Silencing of this reporter was compromised in the presence of a 
deacetylase inhibitor suggesting it may achieve this suppression through interaction with 
HDACs (Myant and Stancheva, 2008). 
There are unquestionably caveats to the above. Firstly I have used Hox gene expression as 
a proxy measure for developmental gene regulation as a whole. Furthermore, although I 
demonstrated hypomethylation at major satellite repeats in the Lsh-/-(+mutant Lsh) NPCs this 
does not necessarily indicate global hypomethylation. In the future it will be necessary to 
carry out H3K27me3 ChIP and RNA-Seq experiments on both the Lsh-/-(+WT Lsh) and Lsh-/-
(+mutant Lsh) cells. It would also be interesting to carry out ChIP for the LSH protein itself to 
determine if it is in fact associated with these developmental genes during differentiation.  
In the future, it will be useful to test an Lsh mutant spectrum for their ability to rescue the 
different aspects of Lsh function that I have identified in my work. 
 
6.5 The role of Lsh is context dependent 
The different models used in this thesis reveal that the role of Lsh is dependent upon 
developmental, cellular and genomic context. 
Despite its high expression in ES cells, it does not appear to be playing a major role in DNA 
methylation at this stage as only minor degrees of hypomethylation were seen at repetitive 
sites despite multiple passages. Dnmt3b-/- / Dnmt3a-/- double mutant ES cells show loss of 
methylation after repeated  passaging (>30) suggesting these methyltransferases may play a 
role in “filling in” hemi-methylated sites missed by Dnmt1 (Chen et al., 2003). Therefore, it 
may be that Lsh plays some role in this. It would be interesting to see if further 
hypomethylation occurred following multiple passages.  
As Lsh is not playing a major role in DNA methylation at this stage it does make one wonder 
what its role is, given it is so highly expressed (Assou et al., 2007). It may be that its 
methylation-independent function at this stage is related to the high rates of proliferation 
seen in these cells, given its expression in adult tissues is restricted to highly proliferative 
tissues. It has also been proposed to play a role in “priming” sites for DNA methylation upon 
differentiation by altering chromatin accessibility (Ren et al., 2018).   
Certainly loss of Lsh did seem to affect ES cells to a certain extent in terms of transcription, 
as I found 597 differentially expressed genes at this stage. Gene ontology revealed an 
enrichment of developmental terms. At this stage there was very little alteration of 





a more direct role, perhaps directly by chromatin remodelling or association with other 
epigentic modifiers, in regulating expression of developmentally important genes.  
The effects of Lsh loss also depended upon cellular context. For example, hypomethylation 
and subsequent repeat de-repression occurred to a greater extent in the KO cerebellum than 
forebrain. This may be explained by the differences in cellular composition between these 
brain regions. Zhou et al proposed that neural cells undergo a cellular de-methylation and re-
methylation (CDR) event, previously only thought to occur at the very early stages of 
development. The timing and extent to which this happens appears individual to each cell 
type and for the most part is on a small scale. The exception to this are cerebellar Purkinje 
cells, which undergo an extensive CDR at P14-30 in the mouse brain coinciding with 
dendritogenesis and synaptogenesis (Zhou et al., 2016). 
Interestingly, despite gross hypomethylation, repetitive elements were not de-repressed in 
Lsh-/- NPCs. There could be several explanations for this. It could be that hypomethylation 
alone is not sufficient for their de-repression and that, for example transcription factors only 
expressed in mature neurons drive their expression. Alternatively there could be other 
factors present in NPCs repressing their transcription that are no longer present upon 
differentiation. Another possibility is that there may be a retrotransposition window upon NPC 
differentiation with the increased number of transcripts actually being secondary to an 
increased copy number. Finally the redistribution of Polycomb may be sufficient to repress 















6.6 The Nestin-Cre targeted Lsh knockout mouse provides a 
novel model for investigating the consequences of aberrant 
developmental DNA methylation processes on the mature 
brain 
Aberrations in DNA methylation deposition during development, or mutations in genes which 
form part of the DNA methylation machinery, are associated with neurodevelopmental 
disorders (Bell et al., 1991; Hendrich and Bickmore, 2001; Klein et al., 2011; Neul et al., 
2010; Winkelmann et al., 2012). As well as these identified disorders with known causative 
mutations, there is now evidence of an altered DNA methylome in screening of those 
patients with no identified cause of neurodevelopmental disorder (Barbosa et al., 2018).   
Understanding these processes and their impact on the mature brain is therefore important, 
but as previously mentioned, there is a lack of suitable models for investigating this. The new 
mouse model I have described in this thesis could therefore prove to be a useful tool, as it 
survives, with apparent health, to adulthood with hypomethylated neural tissue. The 
hypomethylation seen in the neural tissue of this model demonstrates that the role of a 
protein early in development can have a lasting impact on the neural methylome in the adult, 
despite the fact it is no longer present in this tissue at this stage. This allows one to study 
purely the effects of hypomethylation during development, as other proteins such as the 
Dnmts and Mecp2 continue to have roles in the adult brain (Bayraktar and Kreutz, 2018; Du 
et al., 2016; McGraw et al., 2011; Oliveira et al., 2012). 
The absence of morphological abnormalities in the knockout mouse brain, although 
expected as previous Lsh-/- knockout mouse models showed no gross changes in brain 
morphology, is intriguing given the vast disruption of DNA methylation, thought to be a key 
process necessary for development.  
I discussed earlier the role Lsh plays in regulating developmental genes. One might 
therefore have predicted this would influence neurodevelopment, where the timing of each 
stage of neurogenesis is tightly controlled, and disruption of this process could result in 
altered cortical thickness and layering. This, however, was not found in the knockout mouse. 
It is also true, however, that ontology analysis did not reveal aberrant expression of 
developmental genes in knockout neural tissue. One could argue that this is because of the 
timing of Lsh deletion, such that by NPC stage it may have already performed its important 
roles in regulating transcription at these sites. It could also be that our mouse model has a 
truncated Lsh protein capable of carrying out transcriptional regulation of developmental 





was seen in the Lsh-/-(+ mutant Lsh) cell line which behaved more like WT cells upon 
differentiation.  However, Hox genes are aberrantly expressed in previous non-targeted Lsh 
knockout mice, in which there is no reported abnormality in cortical thickness etc. suggesting 
that this has little consequence for brain development (Geiman et al., 2001).  
Despite gross hypomethylation, this knockout mouse displayed no obvious behavioural 
phenotypes. Given the limited number of mice available, more sensitive behavioural testing 
for detection of learning and memory defects was not possible. It would be of great interest 
to carry this out in the future to determine if these mice have a phenotype comparable to the 
intellectual disability seen in patients with ICF syndrome. 
This leads me on to consider if the mouse would be a suitable neurological model for ICF 
syndrome. The important caveats to take into account are that in this model Lsh is absent 
only from NPC stage whereas in patients it will be absent from the very beginning of 
development. Furthermore, there are distinct differences between repeat families and activity 
between mice and humans. In mouse, centromeric and pericentromeric regions are 
composed of minor and major satellites whereas in humans they are represented by alpha 
satellite DNA. In saying this, there is a striking resemblance of an ICF phenotype in mice 
carrying human ICF mutations in Dmnt3b (Ueda et al., 2006). The characteristic 
hypomethylation at satellite sequences, and the overlap between hypomethylation at 
particular gene clusters in our mouse model and the methylome of ICF patients, as shown in 
chapter 5, would lend support for the use of this mouse as a tool to investigate the 
pathogenesis involved in the neurological deficits seen in ICF syndrome as discussed below. 
 
6.7 The innate immune system is activated in the absence of 
Lsh    
Of particular interest was the finding that genes involved in innate immunity were up-
regulated in the knockout mouse brain. A chronic inflammatory state is a common feature of 
many neurological disorders including MS, lupus, neurodegenerative and psychiatric 
conditions and therefore could be an aetiological factor in the neurological defects seen in 
ICF syndrome (Amor et al., 2010; Leighton et al., 2017; Najjar et al., 2013; Wee Yong, 
2010). So what could be causing this inflammatory state? 
A strong possibility is the activation of repeats. Innate immune detection of  viral nucleic 
acids and proteins is achieved through pattern recognition receptors located on cell 
membranes and in the cytoplasm and activation of these pathways results in an interferon 





products of endogenous retroelement transcription. The discovery of this occurred during 
research into the autoimmune disease Aicardi-Goutières Syndrome (AGS) in which patients 
suffer from neurological dysfunction and cutaneous inflammation. This disease is caused by 
mutations in Trex1. Generation of Trex1 deficient mice revealed activation of the interferon 
response and accumulation of intracellular DNAs mapping to endogenous retroelements. 
Trex1 was found to play a role in metabolizing reverse-transcribed cDNAs (Stetson et al., 
2008). Activation of the innate immune response by aberrant LINE1 transcription has also 
recently been shown to occur in ageing cells suggesting this could be a common pathway in 
many pathological states (De Cecco et al., 2019). 
In support of this, Dai a key cytosolic dsDNA sensor was up-regulated in KO mouse neural 
tissue. Furthermore, a new zebrafish model of ICF, null for Zbtb24, demonstrates de-
repression of pericentromeric transcripts and activation of an innate immune response that 
was blocked by mutating the dsRNA-sensing machinery (Rajshekar et al., 2018). 
It would be interesting to test this theory in our model further by, for example, crossing the 
mice with Dai-/- mice or treating with reverse transcriptase inhibitors in conjunction with 
behavioural testing. If this indeed does play a role in the pathogenesis of ICF it does offer 
exciting therapeutic options. For example reverse transcriptase inhibitors already used in 
HIV and currently under trial in AGS may be of benefit 
(https://clinicaltrials.gov/ct2/show/NCT02363452). 
Hypomethylation of repeats could cause the observed up-regulation of immune genes by 
alternative mechanisms. Firstly, hypomethylated gene promoters in the Lsh-/- models, when 
subjected to ontology analysis, were found to be enriched for innate immune terms and were 
enriched for LTR and LINE1 repeats in the 20kb region surrounding their TSS. It could 
therefore be that hypomethylation of these gene promoters, and subsequent activation is 
simply due to their proximity to hypomethylated repeats. However, Lsh-/- NPCs displayed 
hypomethylation at immune response genes but no activation of the immune response 
pathway. Another explanation could be the use of hypomethylated LTRs as promoters or 
enhancers of immune genes. Specific examples of this have been identified by the Feschotte 
group in human cells who demonstrated that many LTRs contained binding sites for 
interferon-inducible transcription factors, that these elements were enriched near genes 
annotated with immune functions, and gained H3K27ac (a hallmark of enhancer activity) on 
treatment with interferons. Deletion of one particular ERV resulted in failure of activation of 
the nearby immune gene and a subsequent deficit in the inflammatory response, whereas 
this ERV was sufficient to drive interferon inducible reporter expression (Chuong et al., 
2016). However, as previously mentioned, I examined the presence of up-regulated repeats 





tissue found to have an up-regulated repeat within their regulatory domain, 3 were interferon 
responsive genes although are not upstream regulators of immune response pathways. 
Therefore this explanation for immune activation appears less likely in my model. 
It would also be very interesting to investigate if there are increased rates of 
retrotransposition within the knockout mouse brain. This may lead to “sick” neurons if such 
events resulted in insertional mutagenesis, double strand breaks or genomic 
rearrangements. These dysfunctional neurons may then result in an inflammatory response. 
In the brain, somatic retrotransposition has been shown to occur and possibly occurs even in 
postmitotic neurons (Coufal et al., 2009; Kuwabara et al., 2009; Macia et al., 2017; Muotri et 
al., 2005). However we lack understanding as to how, or why, this occurs and its influence 
on neural biology and disease. Having a model in which there are increased rates of 
retrotransposition would therefore prove a very useful tool for investigation of this process. 
There are other potential reasons why there may be an up-regulation of interferon stimulated 
genes. It is reminiscent of a senescence-associated secretory (SASP) phenotype. 
Senescence was a term originally coined to describe an irreversible loss of proliferative 
potential in cells capable of self-renewal as a consequence of DNA damage. The term has 
recently, however, been applied to post-mitotic neurons which can respond to DNA damage 
using similar pathways to mitotic cells (Fielder et al., 2017). In this model there may be 
activation of the DNA damage response pathway either through increased rates of damage 
or ineffective repair. As Lsh is not expressed in adult tissue, ineffective repair is unlikely. 
DNA damage could be incurred during retrotransposition events as described above or it 
could be that hypomethylated repeats results in genomic instability even in postmitotic cells. 
However, RNA-Seq data did not show evidence for a DNA damage response as there was 
no differential expression of p53 target genes (as defined by Wei et al (Wei et al., 2006)) in 
mouse neural tissue (Appendix Table A2). Interrogation of the knockout mouse brains by 
gamma-H2AX and TUNEL staining to detect any evidence of DNA double strand breaks and 
apoptosis would be desirable to confirm this. A recent study by Han et al, revealed a small 
increase of 3% in apoptotic cells in the subventricular zone in Lsh-/- embryonic brain (Han et 
al., 2017). However, the lack of any difference in cortical thickness or brain weight in my 
model would argue against a large-scale apoptosis of neurons in our model.  
 
 
6.8 Final comments 
In this thesis, I have demonstrated a role for Lsh in DNA methylation throughout 





demonstrated by the failure of reintroduction of Lsh carrying a mutation in this domain to 
rescue the methylation defect in knockout cells. As the helicase domain has key roles in 
chromatin remodelling, this further supports the theory that Lsh is required for nulceosomal 
remodelling at repeat regions to allow access for the DNA methyltransferases. 
Furthermore, this work has uncovered a role for Lsh in regulating the expression of 
polycomb targeted developmental genes. In concurrence with other hypomethylated models, 
lack of Lsh resulted in a redistribution of the repressive Polycomb mark H3K27me3. 
Intriguingly, however, I discovered preliminary evidence to suggest that Lsh may regulate 
developmental gene expression independently of its role in DNA methylation or chromatin 
remodelling. I drew these conclusions from the fact that Lsh carrying a mutation in the 
helicase domain which did not rescue the methylation defect did rescue Hox gene 
repression. It is therefore possible that Lsh interacts with epigenetic regulators, for example 
via the coiled-coil or ATP domain, to control transcription at these sites (Figure 6.1). 
 
Figure 6.1. Lsh methylation model. This body of work demonstrates the necessity of the 
helicase domain of Lsh for its roles in DNA methylation. Our model is therefore that 
chromatin remodelling allows access for the DNA methylation machinery to repetitive sites. 
In contrast this domain is not required for the regulation of developmental gene expression. 
Therefore we propose that this role is achieved through Lsh interacting with other epigenetic 
regulators such as the Polycomb complexes or HDACs at its coiled coil or Snf2 ATP domain 
which is intact in our Lsh-/-(+mutant Lsh) system.   
In the second part of this thesis I described the investigation of a novel, neurally targeted, 
Lsh-/- mouse which demonstrates hypomethylation of repeats resulting in their transcriptional 
derepression. Of particular interest was the finding of activation of the innate immune system 





results in an immune response due to cellular detection of cytoplasmic nucleic acids 
generated via reverse transcription. This opens up exciting new avenues of research into the 
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Figure A1. PCA plots from RNA-seq and CHIP-seq data demonstrate that variance is mostly 




It should be noted that towards the end of this project an off-target mutation was identified in 
the Lsh-/- cells by Dr Ailsa Revuelta. This was a 17bp out of frame deletion in exon 3 of the 





which binds to TBK1 and forms part of the interaction network in the TNF/NFκB pathway 
(Bouwmeester et al., 2004). I therefore looked at expression of this gene in my experimental 
culture systems by RNA-Seq (Figure A1). This protein is not known to be involved in DNA 
methylation processes therefore it is unlikely that this would account for the major findings 
presented in this chapter, however it does highlight the problem of off-target genome editing 
when using CRISPR technology. In order to confirm that any major findings were indeed due 
to Lsh depletion a rescue experiment was performed with re-expression of Lsh in the Lsh-/- 
cell line (section 3.2.4). 
 
Figure A2. Expression of Tbkbp1. Bar chart displays expression of Tbkbp1 (in which an off 
target mutation was found) from RNA-Seq analysis on Lsh-/- and WT ESCs and NPCs. Data 
displayed in reads per million aligned reads (RPM). Error bars represent +/- SEM of 3 




















Figure A3. Lsh-/- cells show no signs of genomic instability upon neurodifferentiation. 
Figure shows representative images of metaphase spreads from day 6 of 
neurodifferentiation protocol. Presence of a robertsonian translocation in Lsh-/- cells is 
indicated by the blue arrow. This translocation was visible from ES cell stage. As can be 
seen from images there were no other chromosomal abnormalities noted in Lsh-/- cells upon 



















Figure A4. Expression of neural lineage markers during N2B27 differentiation. Quantification of expression of lineage marker genes by qRT-PCR. 
Expression is normalised to housekeeping Gapdh expression and then standardized to WT ES expression. Error bars represent +/- SEM of 3 biological 














Figure A5 Repeat expression in neural tissue from non-uniquely mapped reads.  Scatter plots display read counts of LINE1 (L1), long terminal 
repeat (LTR) and satellite (Sat) sequences from RNA-Seq analysis from 3 biological replicates of control and KO forebrain tissue. Repeats defined as 
differentially expressed in KO tissue (>2 fold change and FDR<0.05) are highlighted in red if up-regulated and blue if down-regulated. Data is shown for 






List A1: Overlapping down-regulated genes in Lsh-/- ES and NP cells 
2200002D01Rik, AC154842.1, Ankrd33b, Atp6ap2, AU015836, AY036118, Cbr3, Ddx3y, 
Dsc2, Frem2, Gm13227, Hhip, Igf2, Moxd1, Myh9, Nexn, Nup62cl, Pdzk1, Perp, Plac8, 
Prrg4, Rhox6, Rnf128, Sfmbt2, Sfrp2, Slc23a1, Slc30a3, Slc40a1, Stard8, Synj2, Tek, Uty, 
Wnt7b 
 
List A2: Overlapping up-regulated genes in Lsh-/- ES and NP cells 
AI854703, Bcas1, Grin2c, Miip, Nefm, Nfib, Pla2g4c, Ptgs1, Rftn1, SNORA42.3, Ttll4 
 
List A3: Overlapping hypomethylated gene promoters in KO cerebellum, forebrain and 
NPCs 
4930571K23Rik, 9030619P08Rik, Adam6a, Bsph1, Catsper1, Csta, Cyp2d34, Cyp8b1, 
Defb7, Gm11213, Gm16501, Gm6026, Gm904, LOC100009614, Mageb16, Nlrp5, Olfr1340, 
Olfr1415, Olfr1474, Olfr406-ps, Olfr775, P2ry4, Serpina1b, Serpina3c, Serpinb9c, Sult2a4, 
Tbx19, Usp9y, Vmn1r65 
 
 
List A4: Overlapping hypomethylated gene promoters in KO cerebellum and forebrain 
1700013B16Rik, 3830403N18Rik, Adh4, Aif1, Ccdc108, Chrna2, Cyp1a2, Defb50, Egam-1c, 
Fcgr4, Gm12888, Gm16378, Iigp1, Klra21, Klra8, Krt6b, Lce3c, Mat1a, Mir1936, Mir673, 
Morc2b, Nr0b2, Olfr1362, Olfr52, Olfr742, Pcdhb18, Pklr, Pramef12, Prss40, Sfi1, Slc38a4, 
Speer2, Sycn, Tas2r109, Tectb, Tnfsf14, Vmn2r106, Xlr3c, Xlr4a, Zfp345 
 
 
List A5: Overlapping hypomethylated gene promoters in KO forebrain and NPCs 
Ccl11, Chrm2, Clec4a1, Elf3, Enpep, Heatr7b2, Krt32, Ly6i, Magea8, Olfr796, Ppp1r3a, 
Tgm4, Vmn2r116 
 
List A6: Overlapping hypomethylated gene promoters in KO cerebellum and NPCs 
1700023I07Rik, 1700027A23Rik, 1700108M19Rik, 1700111N16Rik, 1810009J06Rik, 
4921523A10Rik, 4930403N07Rik, 4930474M22Rik, 4930562C15Rik, 4933421I07Rik, 
5830405N20Rik, A1cf, A630001G21Rik, A930017M01Rik, AF067063, Actl9, Art2a-ps, Art2b, 
Asb17, BC117090, C130026I21Rik, Ccdc153, Ccdc27, Ccl12, Ccl3, Cd177, Cd200r2, 





Dnahc8, Doxl2, Fbxw22, Fcgbp, G6pd2, Gm1006, Gm1027, Gm13251, Gm16387, Gm5065, 
Gm5072, Gm5077, Gm5416, Gm5736, Gm6904, Gm8096, Gm9731, Gml, Gprc2a-rs5, 
Gsdma3, Gsdmcl-ps, H2-DMb1, H2-M10.3, H2-M10.4, Hemt1, Hhipl2, Hmgb1-rs17, Hnf4a, 
Htr3b, Itih1, Klk6, Klkb1, Klra5, Krt1, Krt74, Krt77, Krt84, Krtap10-4, Lcn14, Lcn6, Lpcat2b, 
Lrrc39, Ly6c2, Magea2, Mir684-2, Mrgprb8, Ms4a5, Ms4a6c, Ms4a7, Mslnl, Mup21, Nkg7, 
Nlrc5, Nlrp2, Nlrp4c, Oas2, Olfr1342, Olfr1395, Olfr1396, Olfr1416, Olfr1494, Olfr215, 
Olfr222, Olfr368, Olfr506, Olfr527, Olfr54, Olfr633, Olfr655, Olfr656, Olfr678, Olfr734, 
Olfr872, Parp10, Pcdha8, Pde6g, Pilra, Pilrb1, Pira6, Psg22, Ptk6, Rbm31y, Rhox2h, Rhox8, 
Rnf222, Ropn1, Rprl2, Sbpl, Serpina1a, Serpina9, Serpinb3b, Slc34a1, Slpi, Smok2b, 
Spata3, Spt1, Svs2, Sytl3, Tmem150b, Tmem195, Tmem92-ps, Trcg1, Trim60, Trim61, 
Trim75, Trpv3, Tsks, Upp2, Vmn1r89, Vmn2r16, Vmn2r69, Vmn2r92, Was, Wfdc10, Xlr4b 
 
List A7: Interferon regulated genes up-regulated in KO forebrain 
 
1700030C10Rik, Ahsg, Alb, Ambp, Apoa1, Apoc3, Apol9b, AV099323, BC094916, Bcl3, 
C920025E04Rik, Casp4, Cbx3, Ccl24, Ccl3, Ccl4, Ccl5, Ccrn4l, Cd2, Cd52, Cdkn2a, Ces1c, 
Clec7a, Cst7, Cxcl10, Cyp2a5, Cyp2f2, Cyp3a11, Ddx60, F2, Fabp1, Fbp1, Fev, Fga, Fgb, 
Fgg, Gbp10, Gbp6, Gc, Gm10068, Gm16340, Gm2619, Gm4841, Gm4951, Gm5431, 
Gm7609, H2-Q10, H2-Q5, Hal, Hamp2, Hpx, Ifi204, Ifi27l2a, Ifitm1, Itgax, Kng1, Lgals3, 
Mug1, Mup10, Mup11, Nr5a1, Pcp2, Pet2, Pigr, Pira2, Pyhin1, Pzp, Rgn, Sectm1a, 




List A8: Interferon regulated genes up-regulated in KO cerebellum 
 
2010005H15Rik, A530032D15Rik, AC168977.1, Actn3, Ahsg, Akap14, Alb, Apoc3, Apoh, 
Bst2, C130026I21Rik, Ccnb1, Ccrn4l, Cd209f, Cd79b, Cdcp1, Cdk6, Cks1b, Cryba4, Cxcl10, 
Ddx60, Dpep1, Epcam, Fam167b, Fgb, Gbp10, Gbp6, Gc, Gdf15, Glipr1, Gm11127, 
Gm11427, Gm12856, Gm15753, Gm6264, Gm6531, Gp49a, Hamp2, Hp, Ifi205, Ifi27l2a, 
Ifi44, Irf7, Itgax, Lilra6, Mndal, Mx1, Ncapg, Nr5a1, Oas2, Pet2, Pira2, Plbd1, Scn5a, 
Sectm1a, Serpinb1-ps1, Serpinb1c, Soat2, Sp140, Spc25, Trim5, U6, Ugt3a2, Usp18, Zbp1 
 
List A9: Overlapping genes up-regulated in KO cerebellum and forebrain 
A430078G23Rik, AC110247.1, AC151987.1, AC155816.1, AC155933.1, Ahsg, AL672068.1, 
Alb, Apoc3, Btnl7, Ccrn4l, CT033780.1, Cxcl10, Ddx60, E030037K03Rik, E430029J22Rik, 





Gm6969, Gm9864, Gstp2, Hamp2, Heatr7b1, Ifi27l2a, Igsf1, Itgax, Klra5, Ly9, Mrgprx2, 
Mup17, Mup20, Mup3, Mup7, Nr5a1, Nxf3, Olfr1054, P2rx3, Pcdhb6, Pet2, Pira2, Sectm1a, 
Serpina1c, Serpinb1c, Strc, Trim5, Usp9y, Zbp1 
 
 
List A10: Up-regulated genes in KO cerebellum with hypomethylated promoters 
 
A430078G23Rik, Aurkc, Bglap-rs1, Brs3, C130026I21Rik, Cd79b, Dpep1, Fgb, Gstp2, Klra5, 






Figure A6. Lsh is down-regulated upon differentiation. Bar chart displays expression of 
Lsh from RNA-Seq analysis on WT ES and NP cells. Data displayed in reads per million 










































Gene  Repeat class (distance from TSS bp) 
Up-regulated in KO 
Cerebellum 
 
Ccrn41 LTR short(157,300)  LTR short(20,645) 
Cpxm2 LTR short(77,322) LTR short (82,822) LTR short (83,069) 
Eps811 Sat short(11,377) 
Gm10800 Sat short(363) 
Gm11127 LTR short(2428) LTR long(5798) LTR short(9168) 
Gm14406 LTR short(26,451) L1 short(25,741) L1 short (9364) LTR 
short (11,246) LTR short (11,956) LTR short (12,658) 
Gm14444 L1 short(10,421) 
Hamp2 LTR short(3413) 
Lilrb3 LTR Long(47,208) 
Mrgprx2 LTR short(19,523) 
Olfr922 L1 short(3037) 
Pcdhb10 LTR short (4423) 
Pcdhb11 LTR short (5321) 
Serpinb1c LTR short(5823)  L1 short (22,625) LTR short(23,296) 
Strc LTR short(2150) 
Wdr31 LTR short(23,656) 
Up-regulated in KO 
forebrain 
 
Cyp2a5 LTR long(72,894) 
 
Table A1. Up-regulated genes in KO tissue with de-repressed repeats in regulatory 
domains. Table displays up-regulated genes in KO mouse neural tissue from RNA-Seq 
analysis that contain an up-regulated repeat within their regulatory domain as defined by 
default settings of the genomic regions enrichment of annotations tool (GREAT) (McLean et 
al., 2010). The class of the up-regulated repeat(s) in the domain and whether they are full 
length (long) or not (short) are displayed with the distance from the transcription start site, in 






P53 target genes 
 
Forebrain Cerebellum 
log2(FC) P value control average 
RPM 
KO average RPM log2(FC) P value control average 
RPM 
KO average RPM 
adora2b 0.401969 0.012989 140.3333 191 0.130501 0.585321 147 161.3333 
adrb1 -0.21859 0.048353 1391 1210.667 0.021232 0.918609 199 202.3333 
ank1 -0.1017 0.29711 4288 4062.667 -0.1182 0.301726 28049 26210.67 
ankrd10 -0.12018 0.232002 2404.667 2284.333 0.082947 0.405917 2658.667 2846 
arhgap5 0.122623 0.266386 4948.667 5580.667 -0.28451 0.066028 8217.667 6912.667 
astn2 -0.16777 0.114765 2143 1960.667 0.071235 0.674341 6045.667 6508 
atf3 0.26455 0.247804 65 78.66667 -0.15158 0.555403 86 79 
bax -0.02469 0.803855 1433.333 1438.667 0.151871 0.115872 1843.333 2062 
bcas3 -0.05158 0.583658 2438.667 2409.667 -0.02141 0.82468 2374 2358.667 
bcl2a1 1.241078 0.07809 2.666667 6.666667 0.570144 0.457859 4 6 
bicd2 -0.11925 0.201284 4562 4306 -0.07072 0.406241 5241 5045 
mmadhc 0.023862 0.809622 1448.333 1498.667 -0.1026 0.284063 1897 1784 
cald1 0.140236 0.179911 2191.667 2492.667 0.034832 0.721756 3348.667 3447.667 
cblc 0.334759 0.79562 1 1.333333 0.930237 0.366899 1.666667 3.333333 
ccng2 -0.05439 0.581594 1844.333 1819.333 -0.18535 0.249156 3153 2829 
cdc42ep3 0.078257 0.472404 620.3333 672.3333 -0.03147 0.8325 533.6667 527 
cdkal1 0.037549 0.747007 459 488 -0.09405 0.421292 635.3333 601.3333 
cdkn1a 0.177988 0.108937 734 845.3333 0.297357 0.031026 775.3333 957.3333 
chd2 -0.10253 0.269994 3451.667 3318.333 -0.08016 0.405691 5464.333 5235.667 
chst12 -0.16314 0.185355 754.3333 689 0.062579 0.690094 697.3333 731 
ncapd2 -0.24213 0.01751 1396 1210.333 -0.01311 0.922168 2704.333 2706.667 
col4a1 0.046812 0.61513 4154 4381 0.375135 0.006479 2398.667 3128.667 
ctnna3 -0.22469 0.239824 81.66667 72.33333 -0.50244 0.016826 322 232.3333 





ddit4 -0.02647 0.803698 1909 1921.667 -0.22292 0.061533 2586.333 2220.667 
dkk3 -0.19475 0.05502 12448 11136.67 0.07547 0.713762 1728.667 1818.333 
eea1 -0.04629 0.632311 2746.667 2751.333 -0.19702 0.037246 3484.333 3079.333 
eif2ak -0.02963 0.742698 3281.333 3312.333 -0.12296 0.172183 3707.667 3436.667 
erbb4 -0.00016 0.998884 3188.333 3295 -0.26556 0.071509 1885.667 1596.667 
fat -0.15271 0.163741 3080.333 2831.333 -0.21166 0.225247 13077.33 11588.33 
fgf2 -0.21505 0.338645 50 44.33333 -0.26395 0.349053 49 41.66667 
frmd4a 0.076014 0.407849 2474.333 2690 0.035292 0.703784 2727.333 2820.333 
gadd45a 0.224221 0.09932 284.3333 338.3333 0.157704 0.240415 429.3333 481 
gml 0 1 0 0 1.866178 0.344034 0 0.333333 
gnai1 0.02218 0.812579 6975 7344 -0.32022 0.003813 7683.333 6237.333 
gnaq 0.08363 0.370581 9508.333 10476 -0.10524 0.24914 9186 8615.333 
gpr39 0.23589 0.676625 6 7.333333 0.75153 0.370653 2.333333 4 
gspt1 0.084473 0.376742 5193 5708.333 -0.20893 0.031832 6028 5279.667 
hdac9 -0.02066 0.830819 1719 1757.333 -0.20955 0.179305 771.3333 671.6667 
ier5 -0.13736 0.177834 3206.333 2950 0.039264 0.689202 1148.667 1187 
itgam 0.300321 0.009839 1081.333 1367 0.09618 0.603127 434.3333 471 
kcnma1 -0.33294 0.005569 2968 2444.333 -0.26933 0.30234 2155.667 1856.667 
lats2 -0.10357 0.273233 1760.333 1687 -0.15457 0.167513 3073.667 2809 
ltbp1 0.182837 0.127 519.3333 602.6667 -0.01728 0.916313 318 316 
mdm4 -0.22472 0.043106 2025 1792 -0.18404 0.220136 2793 2516.667 
mlh1 -0.09854 0.57639 441.3333 442.6667 0.083328 0.749995 606 642.6667 
msh6 -0.10119 0.350581 1088.333 1033.667 -0.08253 0.434161 1646.333 1577.333 
mybl1 -0.03739 0.797559 213.6667 214.3333 -0.30083 0.055832 522 430 
myo1a -0.36596 0.072393 74.33333 59.33333 -0.06597 0.774931 129.3333 125 
nab1 -0.0336 0.726308 1788.333 1803.333 -0.05262 0.598773 2884.333 2811.667 
nav3 -0.15537 0.108365 3217 2987 -0.10688 0.441884 960.3333 907.6667 
nck2 -0.04236 0.66536 1244.333 1244.333 0.027739 0.803196 961 992.3333 





neo1 -0.15116 0.149136 5045 4718.333 -0.10098 0.335774 4815.667 4553 
nid2 0.325388 0.013737 306.6667 397.3333 0.535868 0.005387 235.6667 345.6667 
nlgn1 -0.02904 0.796764 2784 2841 0.04029 0.765447 1257.333 1315.667 
nmu -1.7035 0.255935 1.333333 0.333333 -2.68404 0.025323 11.33333 1.666667 
notch1 -0.10815 0.254189 2066 1983 -0.02223 0.807172 1955 1943.333 
nr6a1 -0.25653 0.038133 569.3333 497.3333 -0.17678 0.41067 549.3333 494 
osbp -0.10684 0.243318 3834 3670.333 -0.08372 0.315399 4024 3837.667 
pcca 0.023797 0.807153 1425 1503 -0.05026 0.686185 2953.667 2883.333 
pcdh7 -0.44825 0.000454 2919 2181 -0.4645 0.10005 1150.667 841.3333 
pcna -0.01413 0.885255 1645.333 1694.333 -0.15242 0.087579 1940 1759 
phf14 -0.02778 0.767777 2203.667 2227 -0.04893 0.56221 2077.667 2029 
pias2 -0.02098 0.825667 2729.333 2790.333 -0.20375 0.033034 3335.667 2933 
ppm2c -0.03269 0.741919 6030.667 6103 -0.19327 0.068492 2327.333 2060.333 
prdm1 0.088098 0.660348 72.66667 78.33333 0.070634 0.796596 40.33333 42.66667 
prkag2 -0.00892 0.922082 3675.333 3784 0.02426 0.827628 3757.333 3858.667 
pstpip2 -0.50909 0.001176 274 200 -0.49733 0.052337 283.6667 201 
ptk2 -0.15629 0.090962 6055 5594.667 -0.07257 0.37588 3466.667 3325.667 
ptpre -0.12635 0.196561 1737.333 1649 0.013181 0.908948 2538.333 2602 
ptprm -0.09468 0.33182 2453.333 2350.333 -0.02257 0.860753 3422.333 3429.333 
ptpro -0.10127 0.477283 1973 1846.667 0.48426 0.122865 496 715.6667 
rbl1 0.234735 0.196169 127.6667 156 0.018313 0.921212 313.3333 322 
rps27l 0.367893 0.00519 376.6667 502.3333 0.231794 0.15478 489.6667 574.6667 
rrad 0.184621 0.302363 84.66667 99.33333 0.197061 0.484389 83.33333 97.66667 
rrm2b 0.090235 0.387858 1600 1768 -0.08864 0.425166 1420.333 1344.667 
shrml -0.271 0.048124 332.6667 281.6667 -0.18574 0.21472 577.6667 514 
slc4a10 -0.14147 0.220329 11021.33 10325.33 -0.10089 0.508174 8311.667 7937.333 
smarcb1 -0.05496 0.569695 2918.667 2884 0.022572 0.80221 3308.333 3383.667 
snk -0.04492 0.617641 7237.667 7240.333 0.015571 0.879359 1319.667 1344 





spag9 -0.03216 0.741107 19450.33 19620.67 -0.1931 0.106298 21310 18925.33 
stard4 -0.09663 0.344787 1629 1562.667 -0.31533 0.004684 2739.667 2232 
stau 0.044566 0.622176 3333.333 3543 -0.07199 0.404225 3782.667 3623.333 
tgfa -0.18848 0.049111 2138.333 1942 -0.37578 0.026939 1491.667 1151.667 
tif1 -0.00524 0.955597 1721.333 1762 -0.07941 0.367912 1835.333 1748.667 
tnfaip8 0.404967 0.00225 323.6667 439.3333 0.086879 0.539507 378 405 
tnfrsf10b -0.04797 0.78944 94.33333 93.66667 0.223758 0.279885 99.66667 118 
tpo 0.170101 0.590352 30.66667 34.33333 -0.28265 0.341132 29.66667 24.66667 
trpm1 -0.02111 0.945334 23.33333 24 -0.04811 0.875773 21.66667 21.33333 
ubp1 -0.02845 0.761555 4349.333 4426.333 0.005493 0.963948 6434.667 6519.667 
usp34 -0.08805 0.402447 8145.333 7981.667 -0.21834 0.062732 9121.667 7981 
usp9x 0 1 0 0 0 1 0 0 
vim 0.002794 0.975489 2736 2815.333 0.087499 0.445684 7380.333 7945 
wig1 -0.03721 0.679981 4071.333 4085.667 -0.09063 0.345319 4183.667 3962.333 
xpc -0.09163 0.353693 1151 1107.333 0.124427 0.190963 1239.667 1360 
 
Table A2. Expression of p53 target genes in mouse neural tissue. Table displays RNA-Seq data of expression of p53 target genes from control and 
KO mouse and cerebellum. Average RPM is the average read count per million over 3 replicates. Highlighted are those genes considered differentially 
expressed i.e., displaying >2fold change in expression and p value <0.05.
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